















ABSTRACT!Liver! transplantation! (LT)! is! a! definitive! treatment! for! endNstage! liver! disease! and!hepatocellular! cancer.! As! donorNrecipient! HLA! matching! is! not! employed,! there! is!potential! for! natural! killer! (NK)! cellNmediated! alloreactivity.! In! practise! this! is! not!observed,!and!to!date!the!recipient!NK!response!to!LT!has!not!been!characterized.!This!thesis! describes! a!detailed! investigation! into!LT! recipient!NK! cell! phenotype,! function!and!activity.!!!Lymphocytes!were!extracted! from!peripheral!blood!samples! taken! from!LT!recipients.!Expression! of! activating! receptors! on! NK! cells! was! assessed! using! flow! cytometry!assays,! and! NK! function! was! analysed! with! functional! assays.! Recipient! NK! cells!exhibited!a!downregulated!phenotype!with!reduced!expression!of!activating!receptors!NKp30! and! NKp46.! There! was! associated! hypofunctionality,! with! impaired! NK! cell!cytotoxicity,!degranulation!and!IFNγ!production.!These!changes!were!found!only!within!the! differentiated! CD56dim! subset,! and! not! in! CD56bright! cells,! implying! a! maturation!defect!between!the!two!stages!of!development.!Similar!findings!were!not!observed!in!LT!recipients! infected!with! hepatitis! C! virus! (HCV),! indicating! a! counteracting! activating!effect!of!HCV.!!!To!explore!a!mechanism!for!the!downregulation!observed!a!microarray!experiment!was!performed,!with!subsequent!qPCR!analysis.!In!LT!there!was!downregulation!of!STATN4!with!associated!reduction!in!miRN155,!a!microRNA!target!of!STATN4!and!a!key!regulator!of!NK!differentiation.!Functional!assays!demonstrated!impairment!of!the!ILN12/STATN4!pathway! in! LT! recipients.! The! altered! NK! phenotype! and! gene! expression! were! not!recapitulated!in!vitro!with!immunosuppressants.!The!influence!of!HLA!mismatching!on!LT!outcome!remains!controversial,!and!this!was!addressed!by!analysing!donor!HLA!and!recipient!HLA!and!KIR!typing.!No!associations!between!HLA!and!HLA/KIR!mismatching,!NK!cell!activation,!and!clinical!outcomes!were!found.!!!!Taken!together,!the!data!presented!in!this!thesis!indicate!that!LT!induces!recipient!NK!cell!tolerance!through!altered!peripheral!maturation!at!a!step!prior!to!the!acquisition!of!inhibitory! receptors! for! HLA! class! I.! Consistent! with! this,! HLANC! matching! does! not!influence!NK!alloreactivity!in!LT.! !
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1.1.1!Discovery!and!characterization!The!innate!arm!of!the!immune!system!recruits!humoral!and!cellular!components!with! the! ability! to! respond! rapidly! to! cell! stress! and! injury.! These! include! a!subset!of! lymphocytes!that,!unlike!the!TNcells!and!BNcells!of!adaptive!immunity,!do! not! require! immune! sensitization! to! carry! out! their! functions.! This!distinguishing! feature,! which! was! first! described! in! 1975,! led! to! the! term!"natural! killer"! (NK)! cells! (Herberman,!Nunn! et! al.! 1975,! Kiessling,! Klein! et! al.!1975).! Human! NK! cells! are! traditionally! characterised! by! the! absence! of! CD3!expression! (therefore! excluding! TNcells)! and! expression! of! the! surface!marker!CD56,!an! isoform!of!neural!cell!adhesion!molecule!(NCAM)!(Ritz,!Schmidt!et!al.!1988,! Lanier,! Testi! et! al.! 1989).! NK! cells! are! present! in! nonNhuman!mammals,!with! orthologs! in! other! vertebrates,! and! this! conservation! across! species!suggests!a!fundamental!role!in!the!host!immunological!response!(Jansen,!van!de!Haar!et!al.!2010).!Because!of!their!ancient!lineage!and!lack!of!antigen!specificity,!NK! cells! were! once! thought! primitive! and! functionally! less! sophisticated! than!their! TN! and! BNcell! cousins! from! the! adaptive! arm! of! the! immune! system.!However,! the! last! 3! decades! have! seen! substantial! advances! in! our!understanding! of! NK! cell! biology,! shedding! light! on! the! complexities! of!repertoire! diversity,! finely! tuned! systems! controlling! selfNtolerance! and!activation,! and! key! interactions! between! NK! cells! and! adaptive! immune! cells.!Indeed! there! is! now! accumulating! evidence! that!NK! cells! exhibit! properties! of!
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adaptive!immunity!including!longevity!and!immunological!memory,!analogous!to!features! of! T! cell! development! (O'Leary,! Goodarzi! et! al.! 2006,! Sun! and! Lanier!2011).! ! However,! several! issues! remain! unresolved,! particularly! related! to!NK!cell!development!and!education,!further!underlining!the!intricate!nature!of!these!key!effector!cells.!!!




Representative, flow, cytometry, plot, showing,
NK, cells, and, subsets, when, gating, on,
peripheral, blood, lymphocytes., NK, cells, are,
characterized,as,CD3−,and,CD56+.,Within,the,
NK, cell, population, 2, distinct, subsets, can,
clearly, be, distinguished:, CD56dim, (leftGhand,
red,box),and,CD56bright,(rightGhand,red,box).,,!!!NK!cells!can!be!further!subdivided!on!the!basis!of!CD16!(FcγRIIIA)!expression!so!that!overall!five!NK!populations!have!been!defined!(Poli,!Michel!et!al.!2009):!1)!CD56dimCD16−!2)!CD56dimCD16bright!3)!CD56−CD16bright!4)!CD56brightCD16−!and!5)!CD56brightCD16dim.! Population! 2! comprises! the! majority! of! CD56dim! NK! cells!which!exhibit!high!effector!functionality,!whilst!the!roles!of!populations!1!and!3!are!unclear.!!!









A, Once, activated,, NK, cells, can, kill, target, cells, directly, through, exocytosis, of, preformed,
granules, containing, perforin, and, granzyme., B' NK, cells, express, the, Fc, receptor, and,
therefore,also,have,the,ability,to,perform,antibodyGdirected,cell,cytotoxicity.,C,Additionally,
NK, cells, are, producers, of, important, cytokines, and, chemokines,, influencing, the, TGcell,
response, and, APC, recruitment, and, activation,, including,DC,maturation., In, turn,, factors,
secreted,by,these,cells,promote,NK,cell,activation,,proliferation,and,maturation.,
,Activated!NK!cells!are!potent!killers!with!a!similar!mechanism!of!cytotoxicity!to!CD8+! cytotoxic! TNcells.! Upon! engagement! with! target! cells,! NK! cells! form! an!immune!synapse,!which!is!stabalised!by!the!interactions!of!integrins!(eg.!LFAN1)!with! ligands! on! target! cells! (eg.! ICAMN1)! (Barber! and! Long! 2003,! Bryceson,!March! et! al.! 2005).! This! is! followed! by! polarization! of! secretory! lysosomes!containing! granzymes,! perforin! and!Fas! ligand! (Trapani! and!Smyth!2002),! and!finally! degranulation! (exocytosis! of! the! secretory! granules).! Degranulation! is!calcium! (Ca2+)Ndependent! as! evidenced! by! studies! demonstrating! defective!NK!cell! degranulation! in! phospholipase! CNγNdeficient! mice,! which! have! inhibited!
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intracellular! Ca2+!mobilization! (Caraux,! Kim! et! al.! 2006).! Killing! by!NK! cells! is!also! achieved! indirectly! through! antibodyNdependent! cell! cytotoxicity! (ADCC).!The!majority!of!CD56dim!NK!cells!express!CD16,!which!binds!to!the!Fc!portion!of!IgG!antibodies!and!therefore!antibody!coated!target!cells!trigger!CD16Nmediated!NK!activation!and!degranulation!(Bryceson,!March!et!al.!2005).!!!NK! cells! are! not! only! cytolytic! effector! cells,! but! are! also! potent! producers! of!cytokines,!particularly!interferonNγ!(IFNNγ).!Through!IFNNγ,!NK!cells!direct!a!Th1!immune! response,! activate! and! promote! dendritic! cell! (DC)! maturation,! and!upregulate!major!histocompatibility!complex!(MHC)!class!I!expression!(Moretta,!Marcenaro!et!al.!2005,!Vivier,!Raulet!et!al.!2011).! It! is!therefore!logical!that!the!cytokineNproducing!CD56bright!subset!predominates!in!SLTs,!where!NK!cells!are!in!close! proximity! to! DCs! and! TNcells.! Many! other! proinflammatory! factors! are!secreted! by! NK! cells! including! tumour! necrosis! factorNα! (TNFNα),! granulocyte!colony! stimulating! factor! (GMNCSF),! interleukin! (IL)N3,! ILN8,! CCL2,! CCL3,! CCL4,!CCL5! and! CXCL1! (Walzer,! Dalod! et! al.! 2005).! NK! cells! can! also! play! an!immunoregulatory! role! through! secretion!of! ILN10!and! it! is! thought! that!direct!killing!of!target!cells!may!regulate!TNcell!responses!by!decreasing!antigenic!load!(Vivier,! Raulet! et! al.! 2011).! Furthermore,! the! influence! of! NK! cells! on! virus!specific! TNcell! responses! has! been! investigated! in! murine! lymphocytic!choriomeningitis! virus! (LCMV)! infection! (a!model! for! human! hepatitis! C! virus!(HCV)! and! human! immunodeficiency! virus! (HIV)! infections)! and! in! human!chronic! hepatitis! B! virus! (HBV)! infection! (Waggoner,! Cornberg! et! al.! 2012,!Peppa,! Gill! et! al.! 2013).! These! studies! provide! accumulating! evidence! that! NK!
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cells!can!negatively!regulate!antiviral! immunity!by!acting!as!rheostats! for!virus!specific!TNcell!responses.!!In!addition!to!production!of!factors!influencing!other!components!of!both!innate!and!adaptive!immunity,!NK!cells!in!turn!rely!on!stimulation!or!priming!by!other!cellular!constituents!of!the!immune!response.!For!example,!ILN12,!ILN15!and!ILN18! produced! by! macrophages! and! dendritic! cells,! are! required! for! NK! cell!activation,!proliferation!and!survival!(Lucas,!Schachterle!et!al.!2007,!Guia,!Cognet!et!al.!2008,!Mortier,!Advincula!et!al.!2009).!Thus!an!important!feature!of!NK!cell!functionality! is! “crossNtalk”! with! other! players! in! the! innate! and! adaptive!immune!response.!!!
1.1.4!NK!cell!receptors!NK!cells!do!not!exhibit!the!exquisite!antigen!specificity!that!dominates!T!and!B!cell! function.! Instead,!NK! cell! activation! is! controlled! by! signals! transduced! by!surface! activating! and! inhibitory! receptors.! The! balance! of! these! signals!determines! whether! an! NK! cell! remains! in! an! inhibitory! state,! or! becomes!activated.!In!health,!the!inhibitory!signals!dominate!so!that!NK!cells!are!tolerant!toward! self.! This! is! achieved! because! the! majority! of! NK! inhibitory! receptors!bind! to! MHC! class! I! ligands,! which! are! expressed! by! all! cells.! As! shall! be!explained! in! Section! 1.1.9,! the! NK! cell! maturation! process! ensures! that! the!majority!of!functional!NK!cells!express!an!inhibitory!receptor!for!self!MHC!class!I.!!The!importance!of!MHC!and!its!role!in!alloreactivity!is!discussed!in!Section!1.2.!!!
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A! useful! way! of! classifying! the! many! different! activating! and! inhibitory! NK!receptors!is!according!to!MHC!specificity,!which!is!a!key!determinant!of!influence!on!NK!cell!development!and!function!(tables!1.1!and!1.2)!!!!
1.1.4.1!MHC!specific!inhibitory!receptors!In! humans,! two!main! families! of! inhibitory! receptors! engage!MHC! ligands,! the!inhibitory!killer!immunoglobulin!(Ig)Nlike!receptors,!(KIR)!and!the!CNtype!lectin!like!receptor!CD94NNKG2A.!!
1.! KIR:! this! polymorphic! family! comprises! both! activating! and! inhibitory!members.! KIR! belong! to! the! IgNsuperfamily! and! nomenclature! has! been!standardized!based!on!structure!(Andre,!Biassoni!et!al.!2001),!which!consists!of!a!type! 1! transmembrane! glycoprotein! with! two! or! three! extraNcellular! IgNlike!domains! (2D!or!3D),!and!either!a! long! (L)!or! short! (S)! cytoplasmic! tail! (figure!
1.3).!Thus!KIR2DL*!refers!to!inhibitory!KIR!with!2!extracellular!IgNlike!domains!and!a!long!cytoplasmic!tail;!receptors!with!differing!amino!acid!sequences!in!key!positions! that! effect! ligand! binding! are! suffixed! with! 1,! 2,! etc.! (e.g.! KIR2DL1,!KIR2DL2,!KIR2DL3).!!!Inhibitory! receptors! have! long! cytoplasmic! tails! that! contain! immunoreceptor!tyrosineNbased! inhibitory!motifs! (ITIMs).! Receptor! engagement!with! its! ligand!leads! to! ITIM! phosphorylation! and! recruitment! of! Src! homologyNcontaining!tyrosine! phosphatases! (SHP)! with! resultant! downstream! negative! signaling.!KIR2DL4!is!an!exception! in!that,!although!its!cytoplasmic!tail!contains!an!ITIM,!crossNlinking! of! this! receptor! activates! NK! cells! (Faure! and! Long! 2002,! Yusa,!
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Catina! et! al.! 2002).! This! is! achieved! because! KIR2DL4! associates! with! a!membrane! bound! adaptor! protein! (FcεR1)! containing! activating! motifs! (see!activating!receptors!below)!(KikuchiNMaki,!Catina!et!al.!2005).!!!
!
Figure'1.3'KIR'nomenclature.'
KIR,are,named,according,to,structural,features,that,are,fundamental,to,their,function.,!The!MHC!class!I!ligands!for!inhibitory!KIR!have!largely!been!defined!(table!1.1),!but! KIRNligand! associations! are! by! no! means! straightforward.! Genetic! and!binding!studies!have!demonstrated!a!high!degree!of!polymorphism!in!both!KIR!and! their! ligands,! which! have! significant! effects! on! KIRNligand! interactions.!Furthermore,!it!has!been!demonstrated!that!the!peptide!bound!within!the!MHC!groove! influences! the! immune! synapse! and! receptor! signaling,! uncovering! a!
KIR! 2D! L! 1!!!!!!*001!
! ! 3D! S! 2!
! ! ! ! ! 3!
! ! ! ! ! 4!



















further! layer! of! complexity! within! the! system! (Malnati,! Peruzzi! et! al.! 1995,!Fadda,!Borhis!et!al.!2010).!Whilst!KIR!are!found!in!humans!and!other!primates,!they! are!not!present! in! other!mammals.! Interestingly,! in!mice! the!Ly49!CNtype!lectinNlike!receptors!(which!are!structurally!very!distinct!from!KIR)!serve!a!very!similar!purpose! to!KIR.!Like!KIR,! there!are!both!activating!and! inhibitory!Ly49!receptors,! which! exhibit! substantial! polymorphism! and! intracellular! signaling!pathways! between! KIR! and! Ly49! are! similar.! This! indicates! convergent!evolution,! supported! by! evidence! demonstrating! that! activating! KIR! and! Ly49!have! evolved! from! their! respective! ancestral! inhibitory! receptors! (AbiNRached!and!Parham!2005).!!Polymorphism!within! the! KIRNHLA! system! creates! variability! in! NK! responses!between! individuals! and! populations,! and! this! is! of! particular! importance! in!KIR2DL1/2/3! interactions!with!HLANC.!KIR2DL2!and!KIR2DL3!principally!bind!HLANC! molecules! with! an! asparagine! at! residue! 80! of! the! αN1! helix! (group! 1!alleles,!HLANC1),!whereas!KIR2DL1!binds!HLANC!molecules!that!have!a!lysine!at!residue! 80! (group! 2! alleles,! HLANC2) 1 .! Furthermore! binding! studies! have!demonstrated!differences! in! the!avidity!of! these! interactions!(Winter,!Gumperz!et! al.! 1998),! so! that,! for! example,! the! KIR2DL2NHLANC1! interaction! is! stronger!than! KIR2DL3NHLANC1.! This! has! significant! consequences,! as! KIRNHLA!combinations! have! been! associated! with! the! host! response! to! pathogens,!influencing! outcomes! in! diseases! such! as! HIV,! HCV! and! malaria.! For! example!individuals!homozygous!for!KIR2DL3NHLAC1!have!a!higher!rate!of!resolution!of!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!1!Recent!data!has!shown!that!some!allotypes!of!KIR2DL2/3!can!bind!HLANC2,!but!the!significance!of!these!interactions!is!unclear!(Moesta!and!Parham,!2012).!!
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2.! CD94\NKG2A:! The! other! main! MHCNspecific! inhibitory! receptor! is! formed!from!a!heterodimer!between!CD94!and!NKG2A.!CD94!is!a!70kD!disulfide!bonded!dimeric! protein! first! described! in! 1990! (Aramburu,! Balboa! et! al.! 1990),! that!covalently! associates! with! members! of! the! CNtype! lectinNlike! receptor! family!NKG2*!(Lazetic,!Chang!et!al.!1996,!Brooks,!Posch!et!al.!1997).!The!NKG2*!subunit!determines!whether!the!heterodimer!transduces!activating!or!inhibitory!signals.!Thus! CD94NNKG2A! is! an! inhibitory! receptor! because! it! utilizes! the! same!cytoplasmic!signaling!apparatus!as!KIR!(ie.!via! ITIMs!and!SHP)!to!transduce!an!inhibitory! signal.! Conversely! because! NKG2C! and! NKG2E! contain! activating!motifs! in! their! cytoplasmic! tails,! association! with! CD94! forms! activating!receptors! (Lazetic,! Chang! et! al.! 1996).! Human! CD94NNKG2*! bind! to! the! nonNclassical! MHC! class! I! molecule! HLANE,! which! is! ubiquitously! expressed! and!relatively! nonNpolymorphic! (the! ligand! for! CD94NNKG2*! in! mice! is! Qa1b).!Therefore! in! humans! the! CD94NNKG2A/HLANE! system! is! relatively! conserved!and,!compared!with!KIR,!does!not!contribute!significantly!to!variability!in!NK!cell!responses.!!Leukocyte! immunoglobulinNlike! receptors! (LILR,! also! known! as!immunoglobulinNlike!transcripts,!ILT)!are!inhibitory!receptors!that!bind!classical!and!nonNclassical!MHC!class!I.!However!their!role!in!NK!cell!regulation!is!unclear!as! inhibitory! KIR! and! NKG2A! transmit! much! stronger! inhibitory! signaling!(Navarro,!Llano!et!al.!1999).!LILR!have!been!shown!to!bind!UL18,!an!MHC!class!I!mimic!encoded!by! cytomegalovirus! (CMV),!which! can!actually! increase!NK!cell!induced!cytolysis!(Leong,!Chapman!et!al.!1998).!!
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1.1.4.2!Non\MHC!specific!inhibitory!receptors!The!MHCNspecific!inhibitory!receptors!described!above!are!important!in!NK!cell!development,! ‘education’! and! selfNtolerance.! Some!non–MHC!specific! inhibitory!receptors! have! also! been! described.! The! 2B4! receptor! is! present! on!approximately! 50%! of! NK! cells! and! has! dual! activating! and! inhibitory! roles!depending!upon!interactions!with!adaptor!proteins!(GarniNWagner,!Purohit!et!al.!1993,!McNerney,!Lee!et!al.!2005).!The! ligand! for!2B4! is!CD48,!and! in!mice! two!isoforms!exist!with!different!cytoplasmic!domains!that!signal!either!activation!or!inhibition! (Schatzle,! Sheu! et! al.! 1999).! In! humans! 2B4! has! been! shown! to! be!involved! in! the! immune! response! to! CD48Nexpressing! melanoma! cells,! but! its!role!in!other!pathology!is!not!known!(Vaidya,!Stepp!et!al.!2005).!!!Killer! cell! lectinNlike! receptor! G1! (KLRG1)! is! another! inhibitory! receptor! that!binds!cadherins!which!are!expressed!on!healthy!cells,!and!therefore!may!play!a!role!in!inhibiting!NK!activity!against!healthy!tissue!(Colonna!2006).!CD161!is!a!CNtype! lectinNlike! receptor! that! binds! lectinNlike! transcript! 1! (LLT1)! which! is!expressed!on!activated!plasmacytoid!cells,!DCs!and!activated!B!cells!(Rosen,!Cao!et!al.!2008).!CD161/LLT1!interaction!has!been!shown!to!inhibit!NK!cytotoxicity!and! IFNγ! production,! and! may! be! important! in! the! immune! response! to!pathogens!(Germain,!Meier!et!al.!2011).!!
1.1.4.3!MHC!specific!activating!receptors!Activating!receptors!are!key!to!NK!cell!functionality.!In!contrast!to!the!inhibitory!receptors,! most! NK! activating! receptors! transduce! signals! by! association! with!membrane! bound! adaptor! molecules,! including! DAP10! which! facilitates! PI3N
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kinase! activation! and! DAP12,! CD3ζ! and! FcεRIγ! which! contain! cytoplasmic!immunoreceptor!tyrosineNbased!activation!motifs!(ITAMs)!(Joyce!and!Sun!2011).!Ligation!of!the!ITAMs!leads!to!recruitment!and!activation!of!tyrosine!kinases!Syk!and!ZAP70!and!results!in!downstream!events!including!elevation!of!intracellular!Ca2+! levels,! and! activation! of! mitogen! activated! protein! kinase! (MAPK)! and!extracellular!signalNregulated!kinase!(ERK).!Ultimately!this!signal!cascade! leads!to! initiation! of! NK! cellNmediated! cytotoxicity! and! production! of! cytokines!including!IFNγ!(Lanier!2003).!!Like!the!inhibitory!receptors,!activating!receptors!may!be!categorized!according!to! MHC! specificity,! although! the! ligands! are! less! well! defined! than! for! the!inhibitory!NK!receptors!(table! 1.2).! In!contrast! to! the! inhibitory!NK!receptors,!the!MHC!specific!activating!receptors!play!a!less!prominent!role!in!NK!function.!!!Activating! KIR! possess! short! cytoplasmic! tails! and,! due! to! the! homology! with!inhibitory!KIR,!are!thought!to!bind!MHC!class!I!molecules.!However,!few!studies!have!been!able!to!demonstrate!this!binding,!and!the!ligands!for!several!activating!KIR! remain! elusive! (see! table! 1.2).! Direct! binding! of! KIR2DS1! to! HLANC2! has!been!demonstrated!(Biassoni,!Pessino!et!al.!1997,!Stewart,!LaugierNAnfossi!et!al.!2005),!but!the!strength!of!this!interaction!is!weak!compared!with!KIR2DL1:HLANC2.!More!recently!KIR2DS2!has!been!shown!to!recognize!HLANA11!(Liu,!Xiao!et!al.!2014),!but!the!significance!of!the!activating!KIR:HLA!interactions!is!uncertain,!and!the!function!of!activating!KIR!is!unresolved.!!
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NKG2C! and! NKG2E! form! heterodimers! with! CD94,! and! like! CD94NNKG2A,!recognize!HLANE.!Recent!studies!have!focused!particularly!on!NKG2C!expansion!as! a! marker! of! a! ‘memory’! NK! cell! phenotype! in! viral! infections! and! may! be!indicative! of! a! terminally! differentiated! or! more! mature/antigen! experienced!phenotype!(Guma,!Budt!et!al.!2006,!Bjorkstrom,!Lindgren!et!al.!2011,!Malmberg,!Beziat!et!al.!2012).!!






















PILR! CD99!HA:!haemagglutinin;!HS:! heparin! sulphate;!MLL5:!mixed! lineage! leukaemiaN5;!AICL:! activationNinduced!CNtype! lectin;!DNAMN1:! !DNAX!accessory!moleculeN1;!PVR:! !polio!virus! receptor;!PILR:!paired!IgNlike!type!2!receptor!!NKp30! and! NKp46! are! expressed! on! all! resting! and! activated! NK! cells,! but!NKp44!is!only!significantly!expressed!on!some!NK!cells!upon!stimulation!with!ILN2!(Fuchs,!Cella!et!al.!2005).!!A!ligand!for!NKp44!has!recently!been!characterized!
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as! an! unusual! isoform! of! the! mixed! lineage! leukaemiaN5! (MLL5)! protein!(Baychelier,! Sennepin! et! al.! 2013).! Deletion! of! any! one! NCR! reduces! NK! cell!killing! ability! against! tumour! targets,! highlighting! their! importance! in! NK! cell!effector! function! (Pegram,! Andrews! et! al.! 2011).! ! Furthermore,! it! has! been!demonstrated! that! NKp30! has! a! central! role! in! NKNdendritic! cell! interactions,!which!lead!to!DC!apoptosis!and!maturation!(Vitale,!Della!Chiesa!et!al.!2005).!!!NKG2D!is!an!activating!receptor!expressed!on!both!mouse!and!human!NK!cells.!This!receptor!is!related!to!the!NKG2A/C!family!and!is!expressed!as!a!homodimer,!rather! than! forming! a! heterodimer! with! CD94! (Bauer,! Groh! et! al.! 1999).! In!humans!several!ligands!for!NKG2D!have!been!characterized!including!MHC!class!I! chainNrelated!proteins!A!and!B!(MICA!and!MICB),!and!ULBP1,!2,!3!and!4.!The!expression! of! these! proteins! is! stressNinduced! and! therefore! upregulated! by!damage!or!malignant!transformation!(Cosman,!Mullberg!et!al.!2001,!Steinle,!Li!et!al.! 2001).! MIC! gene! expression! is! also! reported! to! be! related! to! heat! shock!response!pathways,!which! are! activated! in! tumours.!Mouse!data! demonstrates!that! NKG2D! deletion! is! associated! with! rapid! lymphoma! progression! (Guerra,!Tan! et! al.! 2008).! Therefore! NKG2D! plays! an! important! role! in! tumour!surveillance.!!DNAMN1!is!a!coNstimulatory!activating!receptor!expressed!on!around!50%!of!NK!cells.! It! is! an! IgNsuperfamily! member! and! ligands! include! CD155! and! CD112,!which! have! been! shown! to! be! upregulated! in! some! tumours! (eg! multiple!myeloma)!(Bottino,!Castriconi!et!al.!2003,!Soriani,!Zingoni!et!al.!2009).!DNAMN1!has!also!been!shown!to!be!involved!in!lysis!of!tumour!cells!not!expressing!other!
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NK! activating! receptor! ligands,! thus! providing! alternative!mechanisms! for! NK!activation.! It! is! thought! DNAMN1! plays! an! important! role! in! stabalising! the!immune! synapse! between! NK! cells! and! their! targets,! as! it! associates! with!lymphocyte! adhesion! moleculeN1! (LFAN1)! and! binds! intracellular! adhesion!molecule! (ICAM)! (Shibuya,! Campbell! et! al.! 1996,! Shibuya,! Lanier! et! al.! 1999).!Other!coNstimulatory!receptors!include!NKRNP1!which!can!contain!ITIMs!and!can!also!associate!with!ITAM!containing!adaptors!and!therefore!may!have!a!dual!role!depending!on!the!situation!(Arase,!Arase!et!al.!1997,!Carlyle,!Martin!et!al.!1999)!and! paired! IgNlike! 2! receptor! (PILβ),! an! activating! receptor! recognizing!carbohydrate! chains,! thus! potentially! broadening! NK! cell! recognition! of! target!cells!(Wang,!Shiratori!et!al.!2008).!!!
1.1.5!Diversity!of!receptor!repertoire!Not! all! NK! cells! are! the! same.! MHC! specific! receptor! genes! are! expressed!stochastically,! and! a! key! feature! of! NK! cells! is! the! variability! in! receptor!expression!between!clones.!Within!an!individual!each!NK!cell!clone!expresses!a!unique!repertoire!of!activating!and!inhibitory!receptors,!with!cognate!ligands!as!described!above!(Raulet,!Vance!et!al.!2001).!This!therefore!leads!to!differences!in!activation!threshold!and!reactivity!between!NK!cell!clones.!Additionally,!genetic!polymorphism!(particularly! in!KIR)!results! in!a! further! layer!of!diversity! in!NK!receptor! repertoire! between! individuals,! and! between! populations! (Shilling,!Guethlein!et!al.!2002,!Yawata,!Yawata!et!al.!2008).!!!
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1.1.6!NK!cell!development!NK!cells!arise!from!haematopoietic!stem!cells!(HSCs)!and!it!is!thought!that!early!NK! development! occurs! in! the! bone! marrow.! This! is! supported! by! murine!studies! demonstrating! abnormal! NK! cell! development! and! function! when! the!bone!marrow!was!ablated!or!disrupted!(Seaman,!Blackman!et!al.!1978,!Kumar,!BenNEzra! et! al.! 1979).! Although! the! thymus! is! not! required! for! NK! cell!development! (normal! NK! cell! development! is! observed! in! athymic! mice! (Su,!Ishikawa!et!al.!1993)),!NK!cell!populations!expressing!CD127!and!GATAN3!have!been! reported! in! the! thymus! (Vosshenrich,! GarciaNOjeda! et! al.! 2006).! NK! cell!precursors! can! also! be! found! in! lymph! nodes! and! the! liver,! but! it! is! unclear!whether! these! populations! represent! distinct! NK! cell! lineages! or! are! derived!from!circulating!immature!bone!marrow!cells!(Sun!and!Lanier!2011).!!Acquisition! of! NK! specific! markers! characterizes! NK! cell! differentiation! from!precursor!cells,!and!several!stages!of!NK!cell!development!have!been!described!(Colucci,! Caligiuri! et! al.! 2003).! The! common! lymphoid! progenitor! has! been!identified!as!the!precursor!cell!that!gives!rise!to!NK!cells!as!well!as!TN!and!BN!cells!(Kondo,!Weissman!et!al.!1997).!CD34+!HSCs!require!contact!with!stromal!cells!to!generate!NK!cells,!whilst!the!more!differentiated!CD7+CD34+!HSCs!can!give!rise!to! NK! cells! under! the! influence! of! ILN2! alone! (Miller,! Alley! et! al.! 1994).! ! Later!studies! have! shown! that! cytokines! such! as! cNKIT! ligand,! fetal! liver! kinase! 2!(FLK2)! ligand! and! ILN7! can! replace! the! stromal! cell! requirements! (Mrozek,!Anderson!et!al.!1996,!Williams,!Moore!et!al.!1997).!Furthermore,!in,vivo!studies!have! demonstrated! that! ILN15! is! crucial! for! the! development! of! NK! cells! from!early!HSCs!(Lodolce,!Boone!et!al.!1998,!Kennedy,!Glaccum!et!al.!2000).!!
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!In!mice!the!earliest!NK!precursor!is!a!nonNstromal!bone!marrow!cell!expressing!CD122!(β!chain!shared!by!the!ILN2!and!ILN15!receptors)!(Di!Santo!2006),!which!is!not! present! on! human! CD34+! cells.! In! humans! the! coNexpression! of! CD34! and!CD45RA!has!been!shown!to!characterize!preNNK!cells,!although!CD34+CD45RA+!cells!also!give!rise!to!nonNNK!lineage!cells!including!B!cells,!T!cells!and!DCs!(Blom!and!Spits!2006).!In,vitro!data!suggest!that!these!early!precursors!lose!expression!of!CD34,!and!develop!into!NK!intermediates!expressing!CD161.!These!cells!lack!the!ability!to!lyse!NK–sensitive!cell!lines,!but!when!incubated!with!Daudi!cells!in!ILN2! and! ILN12! can! differentiate! into! fully! functional! CD56+! NK! cells! (Bennett,!Zatsepina!et!al.!1996).!The!transition!from!CD34NCD161+CD56N!intermediates!to!CD3NCD56+! NK! cells! is! not! well! understood,! but, the! high! proportion! of!CD34dimCD45RA+!HPCs!found!in!SLTs!is!suggestive!that!these!sites!are!important!for! NK! cell! development.! Furthermore,! SLTs! are! enriched! with! CD56bright! NK!cells,!which!are!generally!understood! to!be!precursors!of!CD56dim! cells.!This! is!supported!by!the!following!observations:!(i)! in,vitro!culture!of!CD34+!cells!with!ILN2! or! ILN15! generates! CD56bright! cells! (Lotzova,! Savary! et! al.! 1993,! Mrozek,!Anderson! et! al.! 1996);! (ii)! after! CD34+! stem! cell! transplantation,! circulating!donor!derived!CD56bright!cells!appear!before!CD56dim!NK!cells!and!the!appearance!of! CD56dim! cells! coincides! with! a! relative! decrease! in! CD56bright! cells! (Shilling,!McQueen!et!al.!2003,!Vitale,!Chiossone!et!al.!2004).!Freud!and!Caligiuri! (2006)!have! described! 4! functionally! distinct! CD56bright!NK! cell! developmental! stages!using! CD34,! CD117! and! CD94! markers! with! cells! transitioning! from! stage! 1!CD34+CD117NCD94N! NK! cell! progenitors,! to! stage! 2! CD34+CD117+CD94N!pre! NK!cells,! followed! by! stage! 3! CD34NCD117+CD94N! immature! NK! cells! and! finally!
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CD34NCD117+/NCD94+!CD56bright!cells.! The! characteristics! of! each! developmental!stage! (including! capacities! for! cytokine! production,! cytotoxicity,! lineage!differentiation! potential,! and! gene! expression! profiles)! are! consistent! with!previous! predicted! characteristics! of! NK! intermediates.! As! immature! NK! cells!develop!into!stage!4!CD56bright!cells,!they!acquire!CD94NNKG2A!conferring!MHCNI!dependent! inhibition,! as! well! as! activating! receptors! NKp46! and! NKG2D.!Additionally,! this! stage! of! development! sees! the! acquisition! of! intracellular!perforin!and!the!capacity!to!produce!IFNγ.!!!!The! progression! of! CD56bright! cells! into! functionally! mature! CD56dim! cells! is!associated! with! the! acquisition! of! CD16! and! KIR! and! partial! loss! of! CD94!(Cooper,!Fehniger!et!al.!2001).!Recent!data!has!elucidated!CD57!as!a!marker!for!NK!cell!terminal!differentiation.!CD57!is!expressed!more!frequently!on!CD56dim!cells!that!lack!NKG2A!and!express!multiple!KIRs,!and!cells!expressing!CD57!show!no!evidence!of!recent!proliferation!(Bjorkstrom,!Riese!et!al.!2010,!LopezNVerges,!Milush!et!al.!2010).!!!
1.1.7!Natural!killer!cell!education!
1.1.7.1!Missing!self!Normal!NK!cell! function! is!dependent!on! the!ability!of!NK!cells! to!differentiate!between!healthy!cells!and!target!cells!(eg!nonNself,!transformed!or!infected!cells).!This! is!achieved! through! the! surface!expression!of! inhibitory! receptors! for! self!MHC!class!I!molecules,!which!maintain!NK!cells! in!an!inhibitory!state!when!the!receptors!and!ligands!interact.!This!is!essential!for!selfNtolerance,!as!healthy!cells!
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express!activating!ligands!for!NK!cells,!so!that!the!lack!of!inhibitory!ligands!alone!is!enough!to!activate!NK!cells.!This!was!demonstrated!in!studies!of!bone!marrow!transplantation!where!donor!cells! lacking!an!MHC!class! I!allele!of! the!recipient!were!frequently!rejected!by!NK!cells!(Ohlen,!Kling!et!al.!1989).!!!As! described! above,! the! two!main! families! of! inhibitory! receptors! are! the! KIR!(which!bind!HLANA,!B!and!C)!and!CD94NNKG2A!(which!bind!HLANE).!HLA!class!I!genes! are! encoded! within! the! HLA! cluster! on! chromosome! 6! separate! to! KIR!genes! located!within! the! leucocyte!receptor!complex!(LRC)!on!chromosome!19!(Yokoyama! and! Plougastel! 2003).! Therefore! inheritance! of! KIRs! and! HLA! is!unlinked,! so! that! genetic! mechanisms! cannot! ensure! that! NK! cells! within! an!individual!express!cognate! inhibitory!receptors! for!selfNHLA! ligands.!Yet!nearly!all!circulating!NK!cells!do!express!inhibitory!receptors!for!self,!and!those!that!do!not!are!hypofunctional!(Fernandez,!Treiner!et!al.!2005).!The!term!‘education’!has!been! coined! to! describe! the! broad! processes! during! NK! cell! development!resulting!in!selfNtolerance;!‘licensing‘!is!a!term!used!to!describe!the!acquisition!of!function,!which! in!NK! cells! is! thought! to!be! an!MHC!class! I! dependent!process!(Elliott!and!Yokoyama!2011).!The!mechanisms!underlying!these!processes!have!not! yet! been! fully! characterized,! but! several! credible! models! have! been!proposed,!supported!by!experimental!evidence.!!!
1.1.7.2!Models!for!the!generation!of!self\tolerance!The! ‘at,least,one’!model!proposes!that!during!development!the!initially!random!repertoire! of! NK! receptor! expression! is! modified! so! that! all! mature! NK! cells!express! one! or! more! inhibitory! receptors! for! a! self! MHC! class! I! molecule!
! 38!
(Valiante,! Uhrberg! et! al.! 1997).! This! could! involve! either! a! selection! process!where! only! NK! cells! expressing! inhibitory! receptors! for! self! MHC! class! I! are!allowed!to!expand,!or!deletion!of!cells!lacking!inhibitory!receptors!for!self!MHC!class! I.! ! The! fact! that! 10N20%!of! circulating!NK! cells! do!not! express! inhibitory!receptors! for! self!MHC!class! I! seems! to! contradict! this!model.!However,! as!has!been! mentioned,! these! cells! are! hyporesponsive,! and! may! actually! reflect!immature!cells,!or!those!that!have!undergone!altered!development!as!a!result!of!a!developmental! selection!mechanism.! Interestingly,! functionality!of! these!cells!can! be! restored! by! cytokine! stimulation! with! ILN2! (Fernandez,! Treiner! et! al.!2005,!Kim,!PoursineNLaurent!et!al.!2005).!Mouse!studies!have!demonstrated!that!MHC! class! I! specific! receptor! expression! is! acquired! sequentially! and! that! the!average!number!of!inhibitory!receptors!expressed!by!NK!cells!increases!in!hosts!that!lack!MHC!class!I!molecules!(Roth,!Carlyle!et!al.!2000).!This!suggests!that!an!‘auditioning’! process!may! take! place! during!NK! cell! development!whereby!NK!cells!continue!to!express!additional! inhibitory!receptors!until!a!selfNrecognising!one!is!expressed.!However!the!existence!of!NK!cells!without!inhibitory!receptors!does!imply!that!this!mechanism!has!a!limited!role!in!NK!development.!!Others!have!proposed!that!nonNMHC!class!I!specific!inhibitory!receptors!such!as!KLRG1!and!2B4!might!explain!how!cells! lacking!MHCNclass! I! specific! inhibitory!receptors! achieve! tolerance.! However! it! has! not! been! shown! that! their!expression!is!increased!in!cells!lacking!MHC!class!I!specific!inhibitory!receptors.!In! one! study! investigating! NK! cells! from! patients! with! transporter! associated!with!antigen!processing!(TAP)!deficiency!(who!do!not!express!normal! levels!of!MHC),! increased! NK! levels! of! carcinoembryonic! antigen–related! cell! adhesion!
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molecule! 1! (CEACAMN1)! were! shown! to! inhibit! NK! mediated! cytotoxicity!(Markel,!Mussaffi! et! al.! 2004).! ! Conversely,! a!more! recent! analysis! of! NK! cells!from!TAP!deficient!individuals!reported!a!significant!effect!of!MHC!class!I!on!KIR!repertoire,! NK! maturation! and! function! (Sleiman,! Brons! et! al.! 2014).!Furthermore,! cells! lacking! MHC! class! I! specific! inhibitory! receptors! are!hyporesponsive! to! target! cells! lacking! ligands! to! any! inhibitory! receptor! (Kim,!PoursineNLaurent! et! al.! 2005).! These! data! suggest! that! that! nonNMHC! class! I!specific!receptors!are!unlikely!to!play!a!major!role!in!NK!hyporesponsiveness.!!It!has!also!been!suggested!that!tolerance!in!NK!cells!lacking!inhibitory!receptors!specific!for!self!MHC!class!I!is!achieved!through!downregulated!expression!of!the!activating!receptors.!However,!the!activating!receptors!studied!to!date,!including!NKG2D,!NKRNP1C!and!Ly49D,!have!been!shown!to!be!expressed!at!normal!levels!in! the! hyporesponsive! cells! (Fernandez,! Treiner! et! al.! 2005,! Kim,! PoursineNLaurent!et!al.!2005).!However,!the!role!of!other!activating!receptors,!particularly!the!NCRs,!has!not!been!studied!in!this!context.!!!!!The! ‘arming’! and! ‘disarming’! models! provide! plausible! explanations! for! the!generation!of!selfNtolerance.!In!the!arming!model,!the!presence!of!self!MHC!class!I! specific! receptors! allows! precursor! NK! cells! to! become! functionally! mature!(armed),!whilst!those!lacking!the!self!MHC!class!I!specific!receptors!remain!in!an!immature! hyporesponsive! state! (similar! to! the! ‘at! least! one’! model)! (Wu! and!Raulet! 1997,!Raulet! 2004).! The!disarming!model! dictates! that!NK! cells! lacking!self!specific!MHC!class!I!receptors!are!induced!into!a!state!of!hyporesponsiveness!by!chronic!stimulating!encounters!with!self!cells!(equivalent!to!anergy!in!T!cells)!
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1.2.1!Overview!Transplantation!refers!to!the!engraftment!of!cells!from!one!individual!(donor)!to!another!(recipient).!Human!transplantation!was! first! recorded! in!500!BC!when!Chinese!doctor!Pien!Ch’iao! reputedly! swapped! the!hearts!of!warriors!Gong!Hu!and! Qi! Ying,! and! several! other! accounts! of! crude! limb,! organ! and! blood!transplantation! (transfusion)! have! been! documented! throughout! history!(http://www.wellcomecollection.org/whatsNon/events/inNorNout/transplantNtimeline.aspx! ,! Linden! 2009).! These! were! almost! always! unsuccessful! due! to!immunological!rejection.!In!the!modern!era,!Peter!Medawar’s!work!in!the!1940s!in! understanding! the! immunological! processes! involved! in! tissue! rejection!developed!the!field!of!transplantation!biology!(Medawar!1956).!Since!then,!our!understanding! of! transplantation! has! rapidly! evolved,! such! that! now! it! is!routinely! employed! with! relatively! success! in! treating! many! varied! medical!conditions.!!!
1.2.2!Immunological!response!to!transplantation!!The! immune! system!has! evolved! exquisite! and! highly! effective!mechanisms! to!recognize! and! eliminate! nonNself! tissue,! and!managing! graft! tolerance! remains!one!of!the!great!challenges!of!organ!transplantation.!Immunological!rejection!can!occur!in!several!forms!and!the!strategies!employed!to!reduce!the!risks!of!these!occurring! include! the! use! of! immunosuppressive! agents! and! genetic! donor!recipient!matching.!!
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Recipient!tolerance!toward!grafts!depends!upon!the!degree!of!genetic!disparity!between! the! donor! and! recipient.! For! example,! xenografts! (transplantation!between! different! species)! are! poorly! tolerated! and! often! result! in! rapid!immunological!rejection,!while!autografts!(transplantation!of!cells/organs!within!an!individual)!are!not!rejected!at!all!as!they!do!not!express!foreign!antigens.!!!Allografts!(grafts!between!members!of!the!same!species)!are!the!most!common!form! of! transplantation! in! humans! and! tolerance! varies! not! only! according! to!genetic!matching,!but!also!depending!on!the!type!of!graft.!For!example,!the!eye!and! placenta! are! considered! immunologically! privileged! sites! as! they! can! be!transplanted! without! eliciting! an! immune! response.! This! is! probably! an!evolutionary! adaptation! as! inflammation! in! these! sites! would! lead! to!catastrophic! consequences.! On! the! other! hand! hematopoietic! stem! cell!transplantation! requires! a! high!degree! of! genetic!matching! to! avoid! a! graft! vs.!host! effect! where! the! donor! immune! cells! attack! host! tissues.! In! solid! organ!transplantation! the! liver! is! considered! relatively! tolerogenic! (compared! to! the!kidney,! for! example)! and! therefore! genetic! matching! can! be! less! stringent!without!adversely!influencing!outcomes!in!liver!transplantation.!!!Rejection! of! transplanted! tissue! can! take! place! through! humoral! and! cell!mediated! mechanisms.! The! molecules! that! elicit! immune! responses! of!genetically! disparate! tissues! are! known! as! histocompatibility! antigens.! Whilst!there! are!many! loci! encoding! these! antigens,! the! loci! responsible! for! the!most!robust!immunological!reactions!are!encoded!within!the!major!histocompatibility!complex!(MHC).!Within!humans,!the!MHC!is!termed!the!human!leukocyte!antigen!
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(HLA)!system!and!is!encoded!on!the!short!arm!of!chromosome!6.!HLA!alleles!are!inherited! as! haplotypes,! so! that! an! individual! carries! one!haplotype! from!each!parent,!and!expresses!both!sets!of!alleles!on!the!cell!surface.!!
MHC! class! I! molecules! are! expressed! on! all! nucleated! cells.! Class! II! MHC!molecules!are!only!expressed!on!cells!within!the!immune!system!which!function!as! professional! APCs! such! as! dendritic! cells,! macrophages! and! B! cells.! The!function! of! the! MHC! molecules! is! to! present! antigenic! peptides! on! the! cell!surface,!and!this! is!reflected! in! their!3Ndimensional!structure.!Class! I!molecules!comprise! 3! alpha! domains! and! a! β2! microglobulin! domain! folded! to! form! a!peptideNbinding! groove.! Class! II!molecules! comprise! an! α! and! β! chain! forming!the!structure!around!the!peptide!groove.!The!two!classes!of!MHC!serve!distinct!purposes:! class! I! MHC! predominantly! present! peptides! from! within! the! cell,!whilst! class! II! MHC! are! responsible! for! presenting! extracellular! antigens.! The!ligands! for! class! I! and! class! II!MHC/peptide! complexes! are! largely! present! on!lymphocytes,!namely!T!cells!and!natural!killer!cells.!!!T!cells!are!classically!considered!to!be!the!main!effectors!in!the!adaptive!immune!response!and!whilst!a!detailed!account!of!T!cell!development!and! function!will!not! be! discussed! here,! a! brief! overview! of! T! cell! antigen! recognition! and!generation!of!selfNtolerance!follows.!!!T!cells!are!defined!by!the!T!cell!receptor!(TCR),!which!recognizes!MHC/peptide!complexes.! The! TCR! is! a! highly! evolved! molecule! comprising! two! chains,! the!constituents! of! which! determine! the! form! of! the! receptor:! either! a! αβ!
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heterodimer!or!a!γδ!heterodimer.!The!majority!of!peripheral!T!cells!express!the!αβ!receptor,!whilst!γδ!cells!make!up!higher!proportions!in!certain!tissues!(eg!gut!intraepithelial! lymphocytes).!All! the!chains!have!a!characteristic!structure!with!an!IgNlike!variable!(V)!region!at!the!N!terminus!and!an!IgNlike!constant!I!region!second! domain.! ! During! T! cell! development! rearrangement! of! hypervariable!complimentary! determining! regions! (CDRs)! in! the! genes! encoding! the! V!segments!of!the!α!and!β!chains!generates!the!extensive!diversity!in!TCRs,!so!that!a! vast! range!of!MHCNpeptide! complexes! can!be! recognized.!Tolerance! to! self! is!achieved! centrally! through! clonal! deletion! of! selfNrecognising! receptors! during!development! in! the! thymus!or!bone!marrow,!and!peripherally! through!chronic!stimulation! resulting! in! hyporesponsiveness! (anergy).! Importantly,! it! is!extremely! difficult! to! induce! tolerance! in! mature! T! cells,! so! that! lifelong!immunosuppression!is!required!following!transplantation!(see!Section!1.3)!!




Parents, homozygous, for, MHC, I, are, crossed, to, create, heterozygous, F1, offspring., A'
Autologous,cells,express,MHC,I,of,both,parents,,and,thus,are,recognised,as,self,by,all,NK,
clones, expressing, inhibitory, receptors, for, either, parental, MHC., B, Maternal, cells, only,
express,maternal,MHC, I,, and, therefore, are, only, recognised, as, self, by, F1, NK, cell, clones,
expressing, inhibitory, receptors, for, maternal, MHC, 1, (NK2)., NK, clones, expressing, only,
inhibitory, receptors, for, paternal, MHC, I, (NK1), do, not, receive, an, inhibitory, signal,, and,
reject,the,maternal,cells.,C,a,similar,situation,occurs,when,paternal,cells,are,transplanted,
as,they,are,rejected,by,NK2,cells,which,only,recognise,maternal,MHC,I.,!!This! cannot! occur! through! T! cell! mediated! mechanisms,! as! the! offspring! will!express!all!MHC!class!I!antigens!of!both!parents,!and!therefore!T!cells!reactive!to!these!will!have!been!deleted!during!development!as!described!above.!Rather!the!rejection! occurs! because! of! stochastic! clonal! expression! of! NK! receptors.! For!example,!NK! cell! clones! expressing! inhibitory! receptors! only! for!paternal!MHC!class! I! will! not! recognize! maternal! bone! marrow! cells! as! self,! and! therefore!become!activated!upon!interaction!with!these!cells.!Similarly,!NK!cell!clones!with!inhibitory! receptors! for! only! maternal! MHC! class! I! will! reject! paternal! bone!
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marrow.!This!has!important!implications!in!clinical!practice!in!that!alloreactivity!is! frequently! observed! in! HSC! transplantation! (HSCT).! Therefore! a! high!resolution!HLA!matching!strategy!is!employed!in!order!to!optimise!outcomes!in!HSCT! (Furst,! Muller! et! al.! 2013).! Hybrid! resistance! is! a! key! concept! in! NK!response! to! transplantation! and! its! relevance! to! liver! transplantation! and! this!thesis!is!expanded!upon!in!Section!1.4.!!! !
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1.3!Liver!Transplantation!The!process!of!liver!transplantation!is!complex,!expensive!and,!crucially,!limited!by!the!number!of!available!donor!organs.!Therefore!all!possible!strategies!aimed!at! maximizing! allograft! utility! should! be! employed.! Multiple! factors! must! be!considered! to! optimise! the! transplant! outcome.! These! may! broadly! be!categorized!into!four!groups:!
Recipient.! Comprehensive! evaluation! of! the! potential! recipient! is! necessary! to!ensure!that!a!liver!transplant!is!appropriate,!and!once!this!has!been!established,!that!the!patient!will!be!able!to!undergo!the!rigours!of!a!major!operation!(Leise,!Kim! et! al.! 2011,! MartinezNPalli! and! Cardenas! 2011).! Within! this! process,!treatments! aimed! at! optimising! the! patient’s! physical! state! are! employed,! and!transplantation! should! only! proceed! if! the! patient! is! deemed! medically! fit!enough!at!the!time!an!appropriate!organ!becomes!available!
Donor.! The! state! of! the! donor! graft! is! clearly! a! key! factor! in! determining! the!success!of! liver! transplantation.!The! ideal!graft!would!come! from!an! individual!with!no!medical!coNmorbidities,!and!would!be!surgically!dissected!(‘retrieved’),!whilst!the!donor’s!circulation!is!intact!(donation!after!brain!death,!DBD!donor).!This! minimizes! the! warm! ischaemia! time,! a! critical! period! during! which!irreversible!cellular!damage!can!occur!in!the!graft!(Kootstra,!Daemen!et!al.!1995,!JimenezNGalanes,!MeneuNDiaz!et!al.!2009).!The!limited!availability!of!donors!and!high!demand!for!grafts!means!that!most!often!these!ideal!conditions!are!not!met.!Increasingly! ‘marginal’! grafts! are! utilized! such! as! those!with! evidence! of! liver!disease! (eg! steatosis),! or! those! resected! after! the! heart! has! stopped! beating!
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(donation! after! circulatory! death,! DCD)! (Callaghan,! Charman! et! al.! 2013).! Our!ability!to!modify!these!factors!will!remain!limited!until!donation!rates!improve.!Providing! the! best! liver! for! engraftment! also! involves! meticulous! surgical!resection! such! that! the! liver! and! hilar! structures! (vessels,! bile! duct)! are!preserved!as! intact!as!possible.!Finally!the!length!of!time!the!between!retrieval!and!engraftment!(cold!ischemia!time)!must!be!minimized.!!
PeriNoperative! care.! Much! of! the! improvements! we! have! seen! in! liver!transplantation!outcomes!over!the!last!4!decades!have!resulted!from!advances!in!the! technical! management! around! the! operation.! ! As! well! as! optimising! the!recipient’s!health!and!donor!liver!as!described!above,!perioperative!monitoring!and! management! of! issues! such! as! circulatory! dysfunction,! coagulopathy! and!sepsis!are!vital!in!improving!outcomes!(Nandhakumar,!McCluskey!et!al.!2012).!!
Immunological!tolerance.!It! is!of!paramount!importance!to!ensure!the!recipient!immune! system! tolerates! the! allograft! to! avoid! rejection.! The! main! strategies!employed! to!maximize! immunological! tolerance! are! genetic!matching! to! avoid!alloreactivity! and! the! use! of! immunosuppressant! agents,! which! dampen! the!immune! response! to! alloantigens.! The! extreme! shortage! of! donor! organs! and!severity!of!illness!of!potential!recipients!means!that!it!is!not!practical!to!employ!exact!genetic!matching!strategies.!As!T!cells!are!considered!the!main!effectors!of!alloreactivity,! the! mainstay! of! immunosuppressive! agents! are! directed! at!reducing! T! cell! activation! and! proliferation.! These! agents! are! not! thought! to!directly!affect!NK!cell!function!(see!Section!1.4)!and!therefore,!theoretically,!NK!
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cells!could!play!a!major!role!in!organ!rejection.!!This!is!the!central!theme!in!this!thesis!and!is!explored!in!greater!detail!in!this!and!following!chapters.!!!
1.3.1!Indications,!selection!for!listing!and!survival!The!main! indications! for! adult! liver! transplantation!are!acute! liver! failure,! end!stage! chronic! liver! disease! and! hepatocellular! carcinoma! (HCC),! whilst! rare!indications! include! liver! based! metabolic! conditions! causing! systemic! disease!(O'Leary,!Lepe!et!al.!2008).!Whatever!the!aetiology!of! liver!disease,!the!process!involved!in!deciding!whether!an!individual!is!a!candidate!for!a!liver!transplant!is!complicated.! The! principles! of! utilitarianism! and! egalitarianism! necessarily!underpin! the! philosophy! of! transplant! selection,! where! the! precious! limited!resource!of!donor!grafts!must!be!employed!to!maximize!their!benefit.!Central!to!the! evaluation! process! is! determining! the! severity! of! liver! disease.! Several!scoring! systems! have! been! developed! to! address! this,!with! the! aim! of! reliably!predicting!prognosis!without!transplantation!so!that!potential!recipients!can!be!categorized! according! to! score.! The!Model! of! End! Stage! Liver! Disease! (MELD)!score! in! the!USA!and!UK!End!Stage!Liver!Disease! (UKELD)!score! in! the!UK!are!employed! for! this! purpose,! as! they! have! been! proven! to! reliably! predict!mortality.! Once! an! individual! is! determined! to! have! disease! severe! enough! to!consider!liver!transplantation,!extensive!physical!and!psychosocial!evaluation!is!carried!out,!in!order!to!assess!whether!transplantation!is!feasible!in!the!potential!recipient.!!!Many! factors! influence! post! transplant! survival,! not! least! the! physical!characteristics! of! the! individual! recipient.! Nonetheless,! despite! being! a! major!
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operation,! liver!transplantation!has!become!a!highly!successful!procedure,!with!post!transplant!survival!rates!currently!90%!at!1!year!and!70%!at!5!years.!This!reflects! extraordinary! progress! in! all! aspects! of! liver! transplantation,! from!patient! selection,! preNoperative! optimisation,! surgical! technique,! perioperative!care!and!management!of!immunosuppression.!However,!there!is!still!a!small!but!significant!rate!of!acute!and!chronic!rejection,!and!outcomes! in! transplantation!for!chronic!hepatitis!C!are!significantly!poorer!than!most!other!indications.!It!is!these!challenges!that!research!efforts!must!focus!on,!and!provide!the!background!to!the!studies!in!this!thesis.!! !
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Receptor, colours, represent, cognate, KIR/HLA, combinations, (eg, blue, KIR, on, NK, cell,
recognises,blue,HLA, ligand,on,donor, cell).,NK, cells, colours, represent,putative, inhibition,
(blue), or, activation, (red)., A,' B' in, matched, LT, match,, the, donor, cells, express, HLA,
recognised, by, recipient, inhibitory,KIRs,, and, therefore, an, inhibitory, signal, is, transduced,
(✔).,C,' D, in,mismatched, LT,, recipient,NK, cell, clones, express,KIRs, that, do, not, recognise,
donor, HLA, ligands,, and, these, clones, may, lose, their, inhibitory, status, (✗),, becoming,
activated.,,
,The! introduction! of! an! allograft! will! theoretically! challenge! the! recipient! NK!recognition!system!depending!on!degree!of!HLA!matching!and!I!will!focus!on!the!HLANC1/C2NKIR2DL1/2/3!system!to!illustrate!this.!!
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!In!HLANC!matched!transplantation,!recipient!NK!cells!are!educated!on!recipient!HLANC! alleles,! which! are! also! present! on! the! donor! cells.! Therefore! the! donor!cells! are! able! to! form! inhibitory! KIRNHLANC! interactions,! and! there! is! no! NK!alloreactivity.! This! will! occur! when! the! donor! is! either! homozygous! (figure!











t C1C1 Match MM"for"158a MM"for"158b 
C1C2 Match Match Match 
C2C2 MM"for"158a MM"for"158b Match 
Table'1.3'Donor:recipient'HLADC'matching.'




1.4.1!Genetic!studies!in!transplantation!The!effects!of!HLA!mismatching!between!donor!and!recipient!have!been!studied!most!extensively!in!HSCT.!In!this!setting,!mismatching!can!cause!alloreactivity!in!two!ways:!1)!recipient!NK!cells!can!reject!donor!cells!that!do!not!express!ligands!for! recipient!NK! inhibitory! receptors! (akin! to! hybrid! resistance);! 2)! donor!NK!cells!can! lyse!recipient!cells! that!do!not!express! ligands!to!donor! inhibitory!NK!receptors! (graft! versus! host! disease,! GvHD).! Indeed! in! bone! marrow!transplantation! NK! alloreactivity! in! KIR! epitope! mismatch! has! been! well!described!(Ciccone,!Viale!et!al.!1988,!Ciccone,!Pende!et!al.!1992,!Colonna,!Brooks!et! al.! 1993,!Ruggeri,!Capanni!et! al.! 2002).!Because!of! the!high!potential! for!NK!and! T! cell! driven! alloreactivity! in! HSCT,! high! resolution! HLA! matching! is!employed.!However,!over!the!last!15!years,!benefits!of!HLA!mismatch!have!been!demonstrated.! In! acute! myeloid! leukaemia! (AML)! KIRNligand! mismatch! in!haploidentical! allogeneic! BMT! has! been! associated! with! increased! survival,!decreased! relapse,! and! reduced! GvHD! (Ruggeri,! Capanni! et! al.! 2002,! Ruggeri,!Mancusi! et! al.! 2007).! It! is! thought! that! the! major! mechanism! for! these!
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advantages!is!a!graft!versus!leukaemia!effect,!where!donor!NK!cells!lyse!tumour!target!cells.!These!observations!have!led!to!NK!cell!based!immunotherapy!as!an!emerging! research! field! in! treatment! of! haematological! malignancies! (Miller,!Soignier!et!al.!2005,!Rubnitz,!Inaba!et!al.!2010,!Curti,!Ruggeri!et!al.!2011).!!!In! solid! organ! transplantation! only! a! few! studies! have! analyzed! the! effects! of!HLANKIR! mismatching,! and! these! have! been! performed! in! liver! and! kidney!transplantation.!In!renal!transplantation,!one!study!reported!a!beneficial!effect!of!donor!HLANC2!homozygosity,!and!associations!between!stable!renal!function!and!high! numbers! of! inhibitory! receptors! in! the! recipient! genotype,! matches! for!KIR2DL2/DS2,! and! mismatch! for! KIR2DL3! (Kunert,! Seiler! et! al.! 2007).! Other!influences! of! HLA! and! KIR! on! outcomes! reported! in! kidney! transplantation!include:! beneficial! effect! of! recipient! HLANC2! on! longNterm! graft! survival!(Hanvesakul,! Kubal! et! al.! 2011);! a! reduction! in! graft! survival! in! KIRNligand!mismatch! (van! Bergen,! Thompson! et! al.! 2011);! and! an! association! between!KIR2DS4! and! graft! rejection! (Nowak,! MagottNProcelewska! et! al.! 2012).! In!contrast!other!studies!have!demonstrated!no!effect!of!KIR!or!HLA!genotype!on!outcomes! in! kidney! transplantation! (Tran,! Mytilineos! et! al.! 2005,! Tran,!Unterrainer!et!al.!2013).!!Early!studies!in!liver!transplantation!have!variably!reported!a!negative!effect!of!HLA!matching! on! graft! survival! (Donaldson,! Underhill! et! al.! 1993,! Rasmussen,!Davies! et! al.! 1995,! Muro,! Marin! et! al.! 1999)! or! a! benefit! of! HLA!matching! on!reducing! acute! rejection! and! improving! graft! survival! (Nikaein,! Backman! et! al.!1995,!MoyaNQuiles,!Muro!et!al.!2003).!!
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,Bishara! et, al! (2005)! reported! HLANC! matching! was! associated! with! fewer!rejection! episodes! in! the! first! year! post! transplantation,! whilst! HLANBw!mismatching! had! no! effect! on! outcome.! In! an! analysis! of! 446! liver! transplant!recipients!MoyaNQuiles!et,al,(2007)!observed!a! significant! association!between!lower! recipient! HLANCw*07! (an! HLANC1! allele)! frequency! and! acute! rejection.!The! HLANC2/KIR2DL1! interaction! transduces! a! stronger! NK! inhibitory! signal!than! HLANC1/KIR2DL2/3! (Winter,! Gumperz! et! al.! 1998),! and! it! has! been!postulated! that! donor! HLANC2! might! therefore! protect! the! graft! from! NK!alloreactivity.!This!question!was!addressed!in!two!retrospective!studies!but!with!inconsistent! findings.! In! a! cohort!of!416! transplant! recipients!Hanvesakul!et,al!(2008)!reported!the!presence!of!HLANC2!in!the!donor!was!protective!in!terms!of!development! of! chronic! rejection,! cirrhosis! and! graft! loss! in! a! dose! related!manner.!This!was!not!corroborated!in!a!subsequent!study!of!913!genotyped!liver!donors,!which!found!no!effect!of!HLANC2!on!either!graft!or!patient!survival!(Tran,!Middleton!et!al.!2009).!More!recently,!the!effect!of!recipient!KIR!and!donor!HLANC!genotypes!have!been!explored,!again!with!disparate!findings.!!Whilst!Moroso!et,
al!(2011)!found!no!effect!of!KIR/ligand!mismatching!on!acute!rejection,!graft!or!patient!survival,!Legaz!et,al,(2013)!have!recently!reported!a!beneficial!effect!on!shortNterm!survival!of!recipient!KIR2DL3N!donor!HLANC1!matching.!!In!liver!transplantation,!there!is!a!paucity!of!data!assessing!the!effects!of!HLA!and!KIR!genotypes!and!matching!on!NK!cell!activation!or! function.! In!a!study!of!31!liver! transplant! recipients,! Oertel! et, al! (2001)! found! increased! cytotoxicity! in!recipient!NK!cells!in!the!first!3!weeks!post!transplant!in!cases!where!there!was!
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predicted!NK!cell!alloreactivity!(according!to!the!model!described!earlier!in!this!section).!!Thus!immunogenetic!studies!have!not!provided!sufficient!evidence!to!generate!a!consensus! view! of! the! effect! of! HLA! matching! on! clinical! outcomes! in! liver!transplantation,! and! there! is! little! data! on! the! effects! of! matching! on! NK! cell!function.!!!
1.4.2!Studies!of!NK!phenotyping!and!function!after!transplantation!Most! study! designs! into! NK! cell! alloreactivity! predicted! by! the! missing! self!model,! have! focused! on! clinical! outcomes! according! to! HLA! mismatching.! In!order! to! determine! that! NK! cells! are! the! effectors! of! alloreactivity! or! indeed!tolerance,! it! is! important! to! examine! the! effect! of! transplantation! on! the!activation!and!functionality!of!NK!cells.!An!early!study!of!NK!cell!reconstitution!after!HSCT!demonstrated!increased!numbers!of!CD56dim!NK!cells!in!the!first!few!months!post!transplant,!and!reduced!cytotoxicity!of!the!CD56bright!subset,!which!could!be!restored!with!ILN2!stimulation!(Jacobs,!Stoll!et!al.!1992).!A!subsequent!study! reported! that! early! after!HSCT!CD3NCD56+!NK! cells! initially! lacked!CD16,!and! that! all! NK! cells! initially! expressed! CD94/NKG2A,! acquiring! KIR! at! late!stages!post!transplant;!whilst!donor!NK!cells!retained!cytotoxicity!against!MHC!class! I! deficient! cell! lines,! they! did! not! lyse! recipient! target! cells,! even! in! the!setting!of!graft!versus!host!disease!(GvHD)!(Vitale,!Pitto!et!al.!2000).!In!another!study! of! NK! cells! after! bone! marrow! transplantation,! NK! cells! from! 5! of! 24!recipients!exhibited!an! immature!phenotype!at!engraftment,! lacking!KIR,!CD16!
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and!NKG2D,!and!expressing!low!levels!of!NKp30,!NKp46,!2B4!and!NKG2A.!These!cells!were!hypofunctional,!but!after!30!days!the!phenotype!and!functionality!had!recovered! (Shilling,! McQueen! et! al.! 2003).! These! studies! give! an! insight! into!
donor! NK! cell! development! and! maturation! in! the! setting! of! HSCT,! but! solid!organ!transplantation!represents!a!significantly!different!context,!as!developing!and!mature!recipient!NK!cells!encounter!donor!cells!in!peripheral!tissue.!!!NK!cells!were!conventionally!thought!not!to!participate!in!solid!organ!transplant!rejection.!This!was!based!on!observations!that!NK!cell!depletion!in!rat!recipients!of! liver,! cardiac! or! skin! allografts! did! not! alter! rejection! outcomes! (Markus,!Selvaggi! et! al.! 1993);! conversely,! in!RAGG/G!mice! (which! therefore! lack!T! and!B!cells,!but!have!normal!NK!cells),!allografts!survived!indefinitely!(Bingaman,!Ha!et!al.! 2000).! However! further! experimental! data! in! animals! has! challenged! this!view.!For!example!NK!cells!have!been!shown!to!infiltrate!rat!liver!allografts!and!produce! potent! chemokine! and! cytokine! mediators! of! acute! rejection! (Kondo,!Morita!et!al.!2000,!Obara,!Nagasaki!et!al.!2005).!In!CD28!knockout!mice!(in!which!there!is!blockade!of!the!TNcell!coNstimulatory!signal),!NK!cell!depletion!prolonged!cardiac!allograft!survival,!thus!implicating!NK!cells!in!rejection!(Maier,!Tertilt!et!al.!2001).!!!In! human! solid! organ! transplantation! few! studies! have! looked! into! NK! cell!phenotyping.! In!acute!antibody!mediated! rejection!of!human!renal! transplants,!NK!cells!have!been!found!within!the!allograft!(Hidalgo,!Sis!et!al.!2010).!In!a!study!of! NK! cells! in! bronchoalveolar! lavages! in! lung! transplant! recipients,! NK! cells!from! patients! experiencing! acute! rejection! episodes! were! found! to! be! more!
! 60!
activated,! expressing! higher! levels! of! NKp44,! CD107a,! HLANDR! and! CD25!(Meehan,! Sullivan! et! al.! 2010).! Another! lung! transplant! study! in! paediatric!recipients! reported! an! expansion! of! CD56bright! NK! cells,! with! preserved!functionality!(Wiesmayr,!Webber!et!al.!2012).!The!liver!is!of!particular!interest!in!NK! cell! alloreactivity! because! NK! cells! are! enriched! within! the! intrahepatic!lymphocyte! population! (Gao,! Radaeva! et! al.! 2009).! A! study! of! 36! transplant!recipients! reported! increased!recipient!NK!cytotoxicity!but!no!association!with!acute!rejection!was!demonstrated!(Oertel,!Kohlhaw!et!al.!2001).!A!more!recent!study! investigating! recipient!NK! cell! phenotyping! after! LT! found! a!decrease! in!NK! cell! number,! and! increased! NKp30! at! one! week! post! LT! but! this! did! not!persist!at!12!months!(Pham,!PiardNRuster!et!al.!2012).! In!the!specific!setting!of!recurrent!hepatitis!C!post!LT,!Varchetta!et!al!noted!a!decrease!in!the!proportion!of! NK! cells! at! 7! days,! and! an! increase! in! CD94/NKG2C! expression! which! was!associated!with! hepatitis! C! recurrence! (Varchetta,! Oliviero! et! al.! 2009).!Whilst!these! studies! have! provided! some! insight! into! the! recipient! NK! response! to!allograft,! detailed! characterization! of! NK! phenotyping! and! function! after!transplantation!has!not!been!performed.!!! !
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Immunity!! CysA!! Murine,!in,vitro,51Cr!release!assay!! ↓!NK!activity!!
1984! Nair!et!al!J,Immunol, Pred! In,vitro,!51Cr!release!assay,!ADCC! ↓!NK!activity!
1991!! Wasik!et!al!
Transplantation!! FK506,!CysA!! In,vitro,,ADCC!assay!! No!effect!on!activity!!
1994!! Alamartine!et!al!!
Nephrol,Dial,Trans,! CysA,!FK506,!Pred,!6MP!! In,vitro,,specific!killing!assay,! Cys!A/FK506!–!no!effect!Pred/6MP!N!↓!NK!activity!!
1995!! van!!Ierssel!et!al!!
APT,! Pred,!Budesonide!! CD!patients,!in,vivo,,51Cr!release!assay,! ↓!NK!activity!at!Wk!2/4!but!↑!at!wk!10!!
2006!! VacherNCoponat!et!al!Transplantation!! FK506,!MMF,!CysA,!Aza!! Renal!transplant!in,vivo!Europium!release!assay,! ↑!NK!activity!with!FK506/MMF!at!1!year!!
2007!! Wang!et!al!Blood!! CysA!! In,vitro,!FACS,!Western!blotting,!Ca!imaging,!51Cr,! No!effect!on!cytotoxicity.!Changes!in!receptors!!
2008!! Wai!et!al!
Transplantation,! Rapamycin,!FK506,!CysA!! Rat,!in,vivo,/vitro,,IFN!γ!release/!killing!!assay!! Rapamycin!↓!NK!activity,!but!not!FK506/CysA!!
2008!! Thum!et!al.!Am,J,
Reprod,Med!! Pred!! Recurrent!miscarriage!pts,!in,vivo,!killing!assay!! ↓!NK!activity!!
2010!! Morteau!et!al!PLoS,! CysA,!FK506!! Renal!transplant!pts!in,
vitro/in,vivo,,LAMP/IFN!γ! ↓!NK!activity!!






CysA,!FK506,!MMF,!Sir! In,vitro,CD107a,!IFN!γ!Elispot,!proliferation!assays, Altered!NK!subsets!Effects!varied!with!cytokines!used!CysA,! Cyclosporine! A;! FK506,! Tacrolimus;! Pred,! Prednisolone;! 6MP,! 6NMercaptopurine;! MMF,!Mycophenylate!Mofetil;!Sir,!Sirolimus;!51Cr,!51Chromium;!CD,!Crohn’s!disease!! !
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2.1!Subject!selection!and!sample!collection!Peripheral! venous! blood! was! taken! from! study! participants! in! EDTA! blood!bottles.!Between!10N20!ml!of!blood!was!taken!and!either!processed!immediately!or!stored!at!4oC!until!processing.!The!maximum!time!between!venesection!and!blood!processing!was!16!hours.!All!participants!were!given!a!patient!information!sheet! (appendix! 1),! and! gave! informed! consent! for! participation! in! the! study!(appendix!2).!!
2.1.1!Cross\Sectional!Study!Individuals! that! had! undergone! liver! transplantation! were! recruited! from!outpatient!clinics!at!the!Institute!of!Liver!Studies!(ILS)!at!Kings!College!London,!and! from!St!Mary’s!Hospital,! Imperial!College!Academic!Health!Science!Centre,!London.! Inclusion! criteria! were:! ! aged! over! 18! and! capacity! to! give! informed!consent.!Exclusion!criteria!were:!less!than!4!weeks!postNtransplant!and!refusal!to!consent.!A!total!of!109!patients!were!recruited.!Patient!characteristics!are!shown!in!table!2.1.!!!!
2.1.2!Longitudinal!Study!Patients! were! recruited! during! their! admission! for! workNup! for! liver!transplantation!at!the!ILS.!Inclusion!criteria!were:!age!greater!than!18.!Exclusion!criteria! were:! unable! to! give! informed! consent.! After! informed! consent,! blood!was!collected!from!each!patient!preNtransplant.!If!the!patients!went!on!to!receive!
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a! liver! transplant,!blood!samples!were! taken! in! the!12!months!post! transplant.!TwentyNeight! patients!were! recruited! from! transplant!workNup,! 21!were! listed!for! liver! transplantation! and! 13! received! an! allograft! during! the! followNup!period.!Of!these!post!transplant!samples!were!available!from!7!patients.!!
' '' !!!!!!!!!!!!Transplants' Healthy(Controls' p9value'
Total,'n! ! 109! ! 31! !! !!
Male,&n&(%)! ! 65! (59.6)! 18! (58.1)! NS!
Age,%years%(SD)! ! 55! (11.7)! 41! (13.4)! <0.0001!
Aetiology,*n*(%)! ! ! !! !! !!
! HCV! 25! (22.9)! !! !! !!
! ALD! 17! (15.6)! !! !! !!
! ALF! 11! (10.1)! !! !! !!
! PBC! 11! (10.1)! !! !! !!
! PSC! 11! (10.1)! !! !! !!
! Cryptogenic/NASH! 7! (6.4)! !! !! !!
! Subacute! 5! (4.6)! !! !! !!
! AIH! 5! (4.6)! !! !! !!
! Redo%Transplant! 3! (2.8)! !! !! !!
! Other! 14! (15.6)! !! !! !!
Time%since%T/P,%days%(range)! 2285! (73<9597)! !! !! !!
Immunosuppression,,n,(%)! (data%missing%from%2%patients)! !! !!
! Tacrolimus! 89! (83.2)! !! !! !!
! Sirolimus! 3! (2.8)! !! !! !!
! Cyclosporine! 9! (8.4)! !! !! !!
! Corticosteroid! 43! (40.2)! !! !! !!
! Mycophenylate! 29! (27.1)! !! !! !!
!! Unknown! 2! !! !! !! !!
Post%transplant%Biopsy%Available! 57! (53.3)! !! !! !!
Lab$Data$(range,$SD)! ! ! !! !! !!
! AST,%IU/L! 34#! (13<119,$21)! !! !! !!
! INR! 1.07! (0.85<2.71,&0.32)! !! !! !!
! Albumin,)g/L! 40.8%! (16<47,$4.8)! !! !! !!
! Bilirubin,)μmol/L! 10.8%! (3<50,$7.6)! !! !! !!
! Platelets,(x10
9
/L! 234$! (73<1042,&130)! !! !! !!
! Tacrolimus+level,+ng/ml! 4.7$! (0.5<14.9,&2.4)! !! !! !!
Table'2.1'Demographic'and'clinical'data'for'patients'recruited'into'crossDsectional'study.''
ALD:,alcoholGrelated,liver,disease;,ALF:,acute,liver,failure;,PBC:,primary,biliary,cirrhosis;,
PSC:, primary, sclerosing, cholangitis;, NASH:, nonGalcoholic, steatohepatitis;, AIH:,
autoimmune,hepatitis;,AST:,aspartate,transaminase;,INR:,international,normalised,ratio.!
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2.1.3!Healthy!controls!After!informed!consent!blood!samples!were!obtained!from!individuals!that!had!no! history! of! transplantation! or! immunosuppression.! For! all! of! the! assays!described,! each! experiment! comprised! a! healthy! control! sample! alongside! the!liver!transplant!samples,!in!order!to!control!for!assayNtoNassay!variation.!!




2.3.2!P815!The!P815!cell! line! is!a!mouse!mastocytoma!cell! line! that! is! resistant! to!NK!cell!killing,!and!expresses!the!Fcγ!receptor.!This!can!therefore!be!used!as!a!target!for!redirected! cytotoxicity! after! coating!with!murine! antibodies! to! specific! human!receptors!(Vadas,!Nicola!et!al.!1983).!




Target! Clone! Species! Isotype! Vendor! Cat.!No! Fluorophore! Dilution!
CD3! UCHT1! Mouse! IgG1! BioLegend! 300428! PerCP! 1:100!
CD3! OKT3! Mouse! IgG1! eBioscience! 57<0037<73! Pacific!Blue! 1:200!
CD56! MEM188! Mouse! IgG2a! BioLegend! 304604! FITC! 1:10!
CD56! HCD56! Mouse! IgG1! BioLegend! 318318! PE! 1:20!
CD56!! HCD56! Mouse! IgG1! BioLegend! 318317! PECy7! 1:100!
CD158a,h! EB6B! Mouse! IgG1! Beckman!
Coulter!
A09778! PE! 1:10!




















NKG2C! 134591! Mouse! IgG1! R&D!Systems! FAB138P! PE! 1:50!
CD16! 3G8! Mouse! IgG1! BioLegend! 302018! APC!Cy7! 1:20!
CD57! HCD57! Mouse! IgG1! BioLegend! 322216! Pacific!Blue! 1:100!
CD107a! H4A3! Mouse! IgG1! eBioscience! 51<1079<42! AF!647! 1:200!
TNFα! MAb11! Mouse! IgG1! BioLegend! 502906! PE! 1:50!
IFNγ! B27! Mouse! IgG1! BD!
Pharmingen!
554701! FITC! 1:100!





Table! 2.2! summarises! the! antibodies! used! in! the! flow! cytometry! experiments!describe!in!this!thesis.!!
2.5.1!Activation!panel!PBMCs! were! suspended! at! a! concentration! of! 1.5! x! 106! cells/ml! and! 200ul!aliquoted!into!a!96!well!plate!(3!x!105!cells/well).!The!cells!were!then!incubated!with! a! blocking! buffer! (10%! human! serum! (Cambrex,! U.K.)! in! FACS! buffer!(phosphate!buffered!saline!(PBS,!Invitrogen,!UK)!with!1%!bovine!serum!albumin!(BSA,!Sigma,!Poole,!UK)!and!0.1!%!sodium!azide))!on!ice!for!20!minutes,!washed!and!stained!with!Aqua!fixable!live/dead!stain!(Invitrogen,!U.K.)!and!then!stained!with! fluorochromeNconjugated!mouse!antihuman! IgG!monoclonal! antibodies! as!follows:! PerCPNCD3! (BioLegend,! U.K.)! and! FITCNCD56! (BioLegend,! U.K.);! half!were!stained!with!PENCD158a,h!(Beckman!Coulter,!U.K.),!staining!KIR2DL1,!and!half! with! PENCD158b! (Beckman! Coulter,! U.K.),! staining! KIR2DL2/3;! cells! from!each!half!were!stained!with!either!APCNCD337!(NKp30)!(Miltentyi!Biotec,!U.K.),!APCNCD335!(NKp46)!(Miltentyi!Biotec,!U.K.),!or!APCNCD314!(NKG2D)!(Miltentyi!Biotec,!U.K.).! Control!wells!were! stained!with! appropriate! IgG! isotype! controls!for!each!fluorochrome.!After!staining!the!cells!were!washed!twice!with!PBS!and!fixed!in!1%!paraformaldehyde!(PFA),!then!read!by!flow!cytometry.! !
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2.5.2!Differentiation!panel!PBMCs!were!prepared!and!plated!as!described!above.!After!blocking!the!PBMCs!were! incubated! with! the! following! antibodies:! PerCPNCD3! (Biolegend,! U.K.),!PECy7NCD56! (Biolegend,! U.K.),! PENNKG2C! (R&D! systems,! U.K.),! APC! Cy7NCD16!(Biolegend,!U.K.),!Pacific!BlueNCD57!(Biolegend,!U.K.).!Control!wells!were!stained!with! IgGN1! isotype!controls! for!each! fluorochrome,!and!after!washing,! the! cells!were!fixed!in!1%!PFA!and!analysed!by!flow!cytometry.!!!
2.6!NK!cell!functional!assays!
2.6.1!Cytotoxicity!assay!In! order! to! avoid! the! expense,! radiation! exposure! and! limitations! of! the!traditional! 51Chromium!based!cytotoxicity!assay,!a!more!novel! flowNcytometryNbased!method!for!measuring!NK!cell!specific!cytotoxicity!was!employed.!PBMCs!(effector!cells)!were!resuspended! in!R10!culture!medium!at!a! concentration!of!1.5!x!105!cells/ml!and!stimulated!with!1ng/ml!recombinant!human! interleukin!(IL)N15!(R&D!Systems,!U.K.).!The!cells!were! incubated!overnight!at!37oC! in!5%!carbon!dioxide!(CO2)!in!a!96Nwell!UNbottom!plate!with!a!volume!of!200ul/well.!!The!following!day!K562!(target!cells)!were!resuspended!in!R10!culture!medium!and! incubated! for!1!hour!at!37oC! in!5%!CO2!with! the!cell!marker!CellTracker™!Orange!CMTMR! (Invitrogen,!U.K.).! This! is! a! dye! that! passes! freely! through! cell!membranes.! Once! inside! the! cell,! the! reagent! reacts! with! thiol! groups! and! is!transformed!into!a!cell!impermeant!fluorescent!dye.!The!cells!were!washed!twice!
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in! PBS! and! resuspended! in! R10! culture!medium! at! a! concentration! of! 6! x! 105!cells/ml.!50ul!of! cell! suspension! (3!x!104! cells)!were! transferred! to!each!assay!well!of!a!96!well!U!bottom!plate.!The!ILN15!containing!media!was!then!removed!from! the! stimulated! PBMCs! and! these!were! resuspended! in! 50ul! of! fresh! R10!medium.! The! PBMCs!were! stimulated! by! incubation!with! the! K562! cells! at! an!effector:target!(E:T)!ratio!of!10:1!for!3!hours!at!37oC!in!5%!CO2,!with!no!effector!used!as!a!negative!control.!The!optimal!E:T!ratio!was!determined!by!titration!of!E:T! from!1:1! to!40:1.!After!4!hours! the!cells!were! transferred! to!a!VNbottomed!plate! and! the! media! removed.! The! cells! were! then! incubated! with! Live/Dead!fixable!Aqua!dead!cell!stain!(Invitrogen,!U.K.)!in!the!dark!on!ice!for!30!minutes,!washed! twice! in!PBS! and! resuspended! in! 1%!PFA.!Analysis! by! flow! cytometry!allowed!calculation!of!specific!cytotoxicity!as!follows:!! %!Dead!K562!in!test!wells!! N!! %!Dead!K562!in!control!well.!
!
2.6.2!CD107a!!PBMCs!were!prepared!and!stimulated!overnight!with!ILN15!as!described!for!the!cytotoxicity! assay.!The! following!day! the! ILN15! containing!media!was! removed!from!the!PBMCs,!which!were!resuspended! in!50ul!of! fresh!R10!containing!anti!AF647NCD107a!antibody!(eBioscience,!U.K.).!K562!target!cells!were!suspended!in!R10! medium! at! a! concentration! of! 1.2! x! 106! cells/ml! and! 50ul! added! to! the!PBMCs! resulting! in! an! E:T! ratio! of! 5:1.! This! optimal! ratio! was! determined! by!titration!of!E:T!from!1:1!to!40:1.!The!cells!were!incubated!at!37oC!in!5%!CO2!for!1!hour,!after!which!monensin!(Golgi!Stop,!BD!Biosciences,!U.K.)!was!added!to!the!
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mixture!at!a! final!concentration!of!3ug/ml.!Monensin!prevents!the!acidification!of! endocytic! vesicles,! blocking! protein! transport.! Therefore! this! prevents!degradation!of! reinternalised!CD107a,!and!allows!accumulation!of! intracellular!cytokines! in! the! Golgi! apparatus,! enhancing! visualisation! of! these! proteins! for!flow!cytometry.!After! a! further!3!hours! incubation!at!37oC! in!5%!CO2! the! cells!were! washed! and! incubated! with! blocking! buffer! for! 20! minutes.! The! PBMCs!were!then!stained!with!monoclonal!antibodies!to!identify!the!NK!cell!population!as! follows:!PerCPNCD3! (BioLegend,!U.K.)! and!FITCNCD56! (BioLegend,!U.K.).!The!cells! were! washed! twice! in! wash! buffer,! fixed! in! 1%! PFA! and! subsequently!analysed! by! flow! cytometry.! For! each! experiment,! spontaneous! degranulation!(CD107a!expression)!was!determined!for!PBMCs!in!the!absence!of!target!cells.!!!
2.6.3!Intracellular!cytokine!assay!PBMCs!were! prepared! and! stimulated! the! night! before! the! assay! as! described!above.!On!the!day!of!the!assay!the!PBMCs!were!incubated!at!37oC!in!5%!CO2!with!target!K562! cells! at! an!E:T! of! 5:1! (optimal! ratio! titrated! as! described).!After! 1!hour!Golgistop!was!added,!and!after!a!further!3!hours,!the!PBMCs!were!washed,!incubated! in!blocking!buffer,!washed,!and!surface!staining!was!performed!with!monoclonal! antibodies:! PerCPNCD3! (BioLegend,! U.K.)! and! FITCNCD56!(BioLegend,! U.K.).! The! cells! were! then! permeabilised! by! incubation! with!Cytofix/Cytoperm! reagent! (BD! Biosciences,! U.K.),! containing! formaldehyde! for!fixation!and!saponin!for!cell!permeabilisation.!Permeabilisation!was!maintained!by! using! Perm/Wash! (BD! Biosciences,! U.K.)! containing! saponin! for! all!subsequent!washing!and!staining!steps.!Intracellular!cytokine!staining!was!then!
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performed! by! incubating! the! PBMCs! for! 30! minutes! in! the! dark! at! 4oC! with!monoclonal! antibodies! as! follows:! FITCNIFNγ! (BD! Pharmingen,! U.K.)! and! PENTNFα!(Biolegend,!U.K.).!Cells!were!subsequently!washed!in!PBS!and!analysed!by!flow!cytometry.!!
2.7!Immunosuppression!assays!In!order!to!assess!the!effect!of!commonly!used!immunosuppressant!drugs!on!NK!cell!activation,!in,vitro!immunosuppression!assays!were!performed.!PBMCs!from!healthy!donors!were!incubated!at!37oC!in!5%!CO2!with!varying!concentrations!of!Prednisolone! (Pred,! Sigma,! U.K.),! Cyclosporine! A! (CysA,! Sigma,! U.K.)! or!Tacrolimus! (FK506,! Sigma,! U.K.).! PBMCs! incubated! with! R10! culture! medium!alone! were! used! as! a! control.! Phenotyping! and! functional! (cytotoxicity! and!CD107a)!assays!were!performed!as!described!above!at!baseline!and!at!16!and!96!hours! of! incubation.! Comparisons! were! made! between! the! drug! assays! and!control!(R10!medium!alone).!!
2.8!DNA!preparation!DNA!was!extracted! from!whole!blood!using! the!QIAmp!blood!kit! (Qiagen,!U.K.)!according! to! the! manufacturer’s! instructions.! Samples! were! lysed! using!proteinase! K! and! the! lysate!was! loaded! onto! the! DNeasy! spin! column.! During!centrifugation,! DNA! was! selectively! bound! to! the! silica! membrane! as!contaminants! passed! through.! Remaining! contaminants! and! enzyme! inhibitors!
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were!removed!in!two!wash!steps!and!DNA!was!then!eluted!in!water.!DNA!purity!and!quantification!was!assessed!by!spectrophotometry.!!
2.9!HLA!genotyping!Recipient! DNA! was! sent! for! HLA! genotyping! to! Dr! AnnNMargaret! Little’s!Histocompatibility!&!Immunogenetics!laboratory!in!Gartnavel!Hospital,!Glasgow.!The!methodology!utilized!the!Lifecodes!HLA!sequenceNspecific!oligonucleotides!(SSO)!Typing!kit!(GenNProbe,!U.S.A),!according!to!the!manufacturer’s!protocol.!!!Donor!HLA!genotyping!was!obtained!from!records!kindly!provided!by!NHS!Blood!and!Transplant!(www.nhsbt.nhs.uk)!!
2.10!KIR!genotyping!!KIR!copy!number!typing!was!performed!by!Dr!James!Traherne!at!Professor!John!Trowsdale’s!laboratory!in!Cambridge!using!a!recently!described!highNthroughput!technology!called!qKAT!(Jiang,!Johnson!et!al.!2012).!!!
2.11!NK!cell!purification!NK! cell! purification!was! performed!with! the! Invitrogen!Dynabeads! Untouched!Human! NK! cells! kit.! PBMCs! were! thawed! and! incubated! with! an! antibody!mixture!which!bound!to!all!the!nonNNK!cells.!The!cells!were!then!incubated!with!Dynabeads,! which! bound! to! all! the! antibody! bound! cells.! These! cells! were!
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separated! by! placing! the! mix! in! a! magnet! and! aspirating! the! supernatant!containing! purified! NK! cells.! The! purity! of! the! NK! cells! was! assessed! by! flow!cytometry,! staining! with! monoclonal! antibodies! as! follows:! PerCPNCD3!(BioLegend,!U.K.)!and!FITCNCD56!(BioLegend,!U.K.).!!!
2.12!Ribonucleic!acid!(RNA)!preparation!PhenolNchloroform! extraction! of! RNA! from! purified! NK! cells! was! performed!using!TRIzol! reagent! (Invitrogen,!U.K.).!The! standard!protocol!was!modified! to!obtain! maximum! yield! of! RNA! from! low! numbers! of! cells.! The! NK! cells! were!lysed!and!homogenized!in!TRIzol!(106!cells/ml)!by!vortexing!and!incubation!at!room!temperature!for!10!minutes.!Chloroform!was!then!added!(0.2!ml!per!1ml!of!TRIzol)! and! the!mixture! shaken! vigorously! by! hand! for! 15! seconds.! This! was!incubated!on!ice!for!5!minutes!and!then!centrifuged!at!4oC!for!15!minutes.!The!upper!aqueous!layer!was!aspirated!and!added!to!500ul!isopropranol/ml!TRIzol!used.! This! was! incubated! at! N20oC! for! 1! hour,! followed! by! 15! minutes!centrifugation! at! 4oC,! and! the! supernatant! was! discarded.! 75%! ethanol!(500ul/ml!TRIzol!used)!was!added!to!the!pellet,!and!this!was!incubated!at!N80oC!for! 1N24! hours.! The! mixture! was! centrifuged! 4oC! for! 15! minutes! and! the!supernatant!discarded.!The!pellet!was!left!for!10N15!minutes!to!allow!the!excess!ethanol! to! evaporate! and! then! resuspended! in! 20ul! of! DNaseN! and! RNaseNfree!water.!DNase!treatment!was!performed!with!the!Turbo!DNase!kit!(Ambion,!U.K.)!according! to! manufacturer’s! instructions.! The! RNA! was! then! quantified! by!spectrophotometry!and!aliquots!that!were!not!immediately!used!were!stored!at!N80!oC.!
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2.13!Microarray!!NK! cells! were! purified! from! freshly! processed! PBMCs! and! after! counting,! the!cells!were!lysed!and!homogenized!in!750ul!TRIzol.!The!lysed!cells!were!then!sent!on! dry! ice! to! Miltenyi! Biotec! in! Germany! for! RNA! extraction! and! microarray!analysis.!RNA!was!extracted!using!a!standard!TRIzol!protocol!and!quality!check!performed! via! the! Agilent! 2100! Bioanalyzer! platform! (Agilent! Technologies,!U.S.A.).!20ng!of!each! total!RNA!sample!was!used! for! the! linear!amplification!of!the! RNA.! Cy3Nlabelled! cRNA!was! produced! using! the! Agilent! Low! Input! Quick!Amp! Labelling! Kit! (Agilent! Technologies,! U.S.A.)! following! the! manufacturer’s!protocol.! Hybridization! was! performed! according! to! the! Agilent! 60Nmer! oligo!microarray!processing!protocol!using!the!Agilent!Gene!Expression!Hybridization!Kit! (Agilent!Technologies,!U.S.A.).!Briefly,!600ng!Cy3Nlabelled! fragmented!cRNA!in! hybridization! buffer! was! hybridized! overnight! at! 65oC! to! Agilent! Whole!Genome! Oligo! Microarrays! 8x60K! using! Agilent’s! recommended! hybridization!chamber!and!oven.!The!microarrays!were!washed!once!with!a!wash!buffer!for!1!minute! at! room! temperature! followed!by! a! second!wash!with! preheated!wash!buffer! for! 1! minute.! A! last! washing! step! was! performed! with! acetonitrile.!Fluorescence!signals!of!the!hybridized!Agilent!Microarrays!were!detected!using!Agilent’s!Microarray!Scanner!System!(Agilent!Technologies,!U.S.A.).!!With!the!aid!of!a!statistician,!the!Agilent!Feature!Extraction!Software!(FES)!was!used! to! read! out! and! process! the! microarray! image! files.! The! software!determines! feature! intensities! (including! background! subtraction),! rejects!outliers! and! calculates! statistical! confidences.! For! determination! of! differential!gene!expression!FES!derived!output!data! files!were! further! analysed!using! the!
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Rosetta! Resolver! gene! expression! data! analysis! system! (Rosetta! Biosoftware,!U.S.A.).! The! output! data! of! the! FES! included! gene! lists! with! signal! intensities!normalised! by! dividing! intensity! values! by! their! median.! Microarray! data! are!available! in! the! ArrayExpress! database! (www.ebi.ac.uk/arrayexpress)! under!accession!number!ENMTABN2132.!!Pathway! and! functional! analyses! were! performed! using! Ingenuity! Pathway!Analysis!6.0! (IPA;! Ingenuity®!Systems,!www.ingenuity.com).!An!Excel!data! set!containing!gene! identifiers!and!corresponding!expression!values!was!uploaded!into! the! IPA! programme,! and! each! gene! identifier! was! mapped! using! the!Ingenuity! Pathways! Knowledge! Base! (IPKB).! The! IPKB! analyses! identify! the!biological! functions!as!well!as! the!pathways! from!the! IPA! library!that!are!most!significant! to! the! data! set.! Fisher's! exact! test! was! used! to! calculate! a! pNvalue!determining! the! probability! that! each! biological! function! and/or! canonical!pathway!assigned!to!this!data!set!was!not!due!to!chance!alone.!!!
2.14!Quantitative!real!time!reverse!transcription!polymerase!
chain!reaction!(qRT\PCR)!In! order! to! validate! the!microarray! findings,! candidate! genes!were! chosen! for!gene!expression!analysis!in!a!further!cohort!of!samples.!RNA!was!extracted!from!purified!NK!cells!as!previously!described.!The!expression!of!11!candidate!genes!was! analysed! using! a! custom! array! plate! with! wells! preNloaded! with! primers!(RT2! profiler! PCR! array,! SABiosciences,! U.K.).! 200ng! of! RNA! was! used! as! a!template! to! make! complimentary! deoxyribonucleic! acid! (cDNA)! with! the! RT2!
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First! Strand! Kit! (SABiosciences,! U.K.)! according! to! the! manufacturer’s!instructions.!The!cDNA!was!stored!at!N20oC!until!required!for!the!PCR!assay.!!!For!the!realNtime!PCR!assay,!the!cDNA!was!thawed!and!added!to!RT2!SYBR!Green!Mastermix!and! RNaseNfree!water! according! to! the!manufacturer’s! instructions;!25ul!of!this!PCR!components!mix!was!loaded!into!each!well!of!the!array!plate.!As!well! as! the!genes!of! interest! (GOI),! expression!of! two!housekeeping!genes!was!assayed! for! comparative! quantitation.! Furthermore! the! array! plate! contained!three! control! wells! per! sample:! a)! positive! PCR! control! (PPC)! to! test! the!efficiency! of! the! PCR! using! a! preNdispensed! artificial! DNA! sequence! and! the!primer!set!that!detects!it;!b)!genomic!DNA!control!(GDC)!containing!a!primer!set!detecting!nonNtranscribed!genomic!DNA;!c)!reverse!transcription!control!(RTC)!to! test! the! efficiency! of! the! cDNA! synthesis! reaction,! containing! a! primer! set!detecting!template!synthesized!from!a!builtNin!external!RNA!control.!!The! array! plate!was! placed! into! the! StepOne! cycler! (Applied!Biosystems,!U.K.)!using!absolute!quantitation!settings.!After!amplification!the!threshold!cycle!(CT)!for!each!well!was!calculated!and!expression!of!each!GOI!was!calculated!using!the!comparative! CT! (deltaNdelta! CT,! ΔΔCT)! method.! Dissociation! (melting)! curve!analysis!was!performed!to!verify!the!PCR!specificity,!ensuring!one!PCR!product!per!well.!Quantitative!RT!PCR!was!also!performed!in!triplicate!on!NK!cells!from!3!healthy! donors! incubated! with! either! medium! alone,! or! immunosuppressive!drugs! at! mid! therapeutic! concentrations:! either! Prednisolone! 20ng/ml,!Tacrolimus!5ng/ml,!or!Cyclosporine!A!275ng/ml.!Gene!expression!was!analysed!between!NK!cells!incubated!with!the!drugs!and!control!(medium!alone).!
! 79!
MicroRNAN155! (miRN155)! quantitative! PCR! was! performed! with! the! miScript!PCR! system! (Qiagen,! U.K.)! according! to! the! manufacturer’s! instructions! as!follows.!Stored!RNA!extracted!by!the!Trizol!method!described!was!thawed,!and!200ng! was! added! to! the! reverse! transcription! mastermix! (containing! HiSpec!buffer,!nucleics!mix,!reverse!transcriptase!mix,!and!RNaseNfree!water)!in!a!final!volume!of!20!μl.! This!was!mixed!gently! and! incubated! for!60!minutes! at! 37oC,!then!5!minutes!at!95oC!to!inactivate!the!reverse!transcription!mix.!The!cDNA!was!then!diluted!in!RNaseNfree!water!and!2ng!was!used!for!the!PCR!reaction.!A!25!μl!reaction!mix! was! prepared! comprising! 2x! Quantitect! SYBR! Green! PCR!master!mix,! 10x! miScript! universal! Primer,! 10x! miScript! Primer! Assay! (miRN155),!template! cDNA,! and!RNaseNfree!water! at! room! temperature! (15–25oC).!Human!RNU6B!(RNU6N2)!miScript!primers!were!used!for!normalization!controls,!and!a!no! template! control! was! used! to! exclude! nonNspecific! amplification.! Reaction!mixes! were! prepared! in! triplicate! in! a! 96! well! plate,! which! was! sealed! and!centrifuged!at!1000g! for!1!minute.!The!plate!was! then!placed! into! the!StepOne!cycler! (Applied! Biosystems,! U.K.)! using! the! recommended! cycling! conditions.!After! amplification! the!CT! for! each!well!was! calculated! and! expression!of!miRN155!was!calculated!using!the!ΔΔCT!method.!!!
2.15!Intracellular!pSTAT!assay!As! STAT4! expression! was! significantly! downregulated! in! liver! transplantation!(see! chapter! 4),! an! assay! evaluating! phosphorylated! intracellular! STAT4!expression!was!performed.!The!Phosflow!kit!was!used! for! this!(BD!Biosciences!U.K.)!according!to!the!manufacturer’s!protocol.!PBMCs!were!resuspended!in!R10!
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culture!medium!and!stimulated!with!ILN12!at!a!concentration!of!10ng/ml.!After!60!minutes!surface!staining!was!performed!with!Pacific!BlueNCD3!(eBiosciences,!U.K.)! and! PECy7NCD56! (eBiosciences,! U.K.).! The! cells! were! then! fixed! by!incubation!with!preNwarmed!Cytofix!buffer!(BD!Biosciences!U.K.)!at!37oC!for!10N12!minutes.!This!was! followed!by! incubation! in!Perm!III!buffer! (1ml/106!cells)!on! ice! for! 30! minutes.! After! washing,! Phosflow! antibody! (AF647Nanti! STAT4!(pY693),!BD!Biosciences)!was!added!and!the!mixture!was!incubated!on!ice!in!the!dark!for!60!minutes.!The!cells!were!washed,!resuspended!in!PBS!and!analysed!by!flow! cytometry.! The! assay! was! also! performed! using! PBMCs! from! 3! healthy!donors! incubated! for! 72! hours! with! the! immunosuppressive! medications! as!previously!described.!!!
2.16!Clinical!data!Patient!information!was!recorded!from!clinical!notes!and!database!records.!Data!collected!included:!age,!sex,!date!of!transplant,!time!since!transplant,!aetiology!of!liver! disease,! immunosuppressive! therapy,! date! of! postNtransplant! biopsy! (if!done),!biopsy!details! (including! rejection!and! fibrosis! score),! episodes!of! acute!cellular! rejection! (ACR)! and! history! of! antiviral! treatment! (if! HCV! positive).!Laboratory!data!collected!included!serum!alanine!transaminase!(ALT),!aspartate!transaminase! (AST),! total!bilirubin! (TB),!albumin,! internationalised!normalised!ratio! (INR),! platelet! count,! serum! concentration! of! immunosuppressive! drugs!(Tacrolimus,!Cyclosporine,!Mycophenylate)!and!CMV!infection!status.!
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2.17!Statistical!analysis!Statistical! data! analysis! was! performed! using! GraphPad! Prism! version! 6.0b!software! (GraphPad! Software! Inc.,! U.S.A).! Descriptive! statistics! are! shown! as!mean±!standard!error!of!the!mean!(SEM)!as!appropriate.!Comparisons!between!groups!were!made!using! the! χ2! test!or!Fischer’s! exact! test! for!qualitative!data.!Comparisons!between! the!means!were!made!using! the!unpaired! tNtest! or! oneNway!analysis!of!variance!(ANOVA)!as!appropriate.!All!tests!were!twoNtailed!and!a!probability! value! (pNvalue)! of! less! than! 0.05! was! considered! significant.!Multivariate! analysis! and! logistic! regression! modelling! were! used! to! examine!associations!where!multiple! factors!were! involved.! A! pNvalue! of! less! than! 0.05!was!considered!significant.!!!Statistical!analyses!of!the!microarray!gene!expression!data!was!performed!with!the!statistical!analysis!software!environment!R!together!with!packages!available!as! part! of! the! Bioconductor! project! (http://www.bioconductor.org).! Data!generated! from! the! Agilent! Feature! Extraction! software! for! each! sample! was!imported! into! R.! Raw! data! was! quality! assessed! using! scatter! plot! matrices,!boxplots! and! principal! components! analysis.! Replicate! probes! were! mean!summarised!and!quantile!normalised!using!the!preNprocess!Core!R!package.!The!limma! R! package! (Smyth! 2004)!was! used! to! compute! empirical! Bayes!moderated!tNstatistics!to!identify!differentially!expressed!genes!between!groups.!A! corrected!pNvalue! cutNoff! of! less! than!0.05!was!used! to!determine! significant!differential!expression.!
! 82!
CHAPTER'3:!THE#EFFECT#OF#LIVER%TRANSPLANTATION*ON#NK!CELL$PHENOTYPE$AND$FUNCTION!
!In!health,!NK!cell!inhibitory!signaling!is!dominant!such!that!NK!cells!are!held!in!constitutive! inhibition,! and! therefore! do! not! attack! self! cells.! Release! from!inhibition! can! occur! through! loss! of! inhibitory! and/or! increase! in! activating!signals!so!that! the!balance!swings!towards!activation,!and!the!NK!cell!becomes!activated.! !NK! inhibitory! receptors! and! their! ligands! have! been!well! described!(see! Chapter! 1),! but! much! less! is! known! about! the! activating! receptors.! An!important! group! of! these! receptors! are! the! NCRs! NKp30! and! NKp46.! CrossNlinking!studies!have!shown!the!NCRs!to!play!a!key!role!in!NK!cell!activation,!and!conversely,!blocking!inhibits!NK!cell!cytotoxicity!(Sivori,!Vitale!et!al.!1997,!Pende,!Parolini! et! al.! 1999).! Additionally! the! activating! CNtype! lectin! receptor! NKG2D!binds!MICA!and!MIC!B.!The!density!of!the!activation!receptors!on!the!cell!surface!correlates!with!activation!status!and!it!has!been!shown!that!tumour!targets!are!resistant!to!NK!cells!expressing!reduced! levels!of!activating!receptors!(Pessino,!Sivori! et! al.! 1998,! Pende,! Parolini! et! al.! 1999,! Sivori,! Pende! et! al.! 1999,! Sivori,!Parolini!et!al.!2000).!!!Several! processes! are! associated! with! reduced! NCR! expression! including!malignant! transformation! (GarciaNIglesias,! Del! ToroNArreola! et! al.! 2009,! Pietra,!Manzini! et! al.! 2012),! HIV! infection! (De! Maria,! Fogli! et! al.! 2003)! and! drugs!(Fiegler,! Textor! et! al.! 2013).! Upregulation! of! NKp30! and! NKp46! have! been!
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NKG2D!!In! order! to! determine! the! activating! phenotype! of! recipient! NK! cells! in! liver!transplant! recipients,! the! surface! expression! of! the! NK! activating! receptors!NKp30,!NKp46!and!NKG2D!was!determined.!!













,HCV! infection! is! associated! with! NK! cell! activation,! and! therefore! the! LT!recipients! with! HCV! infection! (LT! HCV)! were! analysed! separately! from! LT!recipients! without! HCV! infection! (LT! nonNHCV).! This! demonstrated! highly!significant! down! regulation! of! the! natural! cytotoxicity! receptor! NKp30! in! LT!nonNHCV!compared!with!both!healthy!controls!and!LT!HCV!(p!<0.0001!for!both,!
figure!3.3).!Furthermore,! there!was!reduced!NKp46!expression!in!LT!nonNHCV!compared!with!healthy!controls!(p=0.05)!and!LT!HCV!(p=0.006).!There!were!no!differences!in!NKG2D!expression!between!any!of!the!groups!and!no!differences!were!found!between!LT!HCV!and!healthy!controls.!
All LT vs Healthy Controls














3.1.2!Expression!of!activating!receptors!on!NK!subsets!!NK!cells!undergo!several!stages!of!development!and!function!varies!accordingly.!CD56bright! cells! are! immature! and! are! precursors! of! CD56dim! NK! cells.!Furthermore,!only!fully!functional!‘licensed’!NK!cells!express!KIR.!Therefore!the!expression!of! the!activating! receptors!was!examined! in!CD56bright,! CD56dim!and!KIR2DL+!subsets.!!!Within!KIR+!NK!cells!there!was!highly!significant!downregulation!of!both!NKp30!and! NKp46! in! LT! nonNHCV! compared! with! healthy! controls! (p<0.0001! and!p=0.00015! respectively),! and! LT!HCV! (p<0.0001! for!NKp30! and! p=! 0.0028! for!NKp46)! as! shown! in! figure! 3.4.! The! expression! of! NKp30! was! significantly!higher! in! LT! HCV! compared! with! HC! (p=0.013).! In! order! to! assess! activating!expression! in!KIRN!NK!cells,!PBMCs!were! stained! for!KIR2DL1!and!KIR2DL2/3,!
Total NK cells




















,Compared! with! healthy! controls,! in! both! LT! groups! there! was! a! significant!increase! in! the! proportion! of! CD56bright! NK! cells! relative! to! total! NK! cells!(p=0.012! and! 0.0001! respectively,! figure! 3.5A).! In! LT! nonNHCV,! reduction! in!NKp30! expression!was! present! only! in! the! CD56dim! population! and! not! in! the!CD56bright!population!as! shown! in! figure! 3.5B,C.!Furthermore,! the! reduction! in!NKp46! expression! was! less! marked! in! CD56bright! NK! cells! in! comparison! with!CD56dim!NK!cells!(fold!change!in!MFI!vs!healthy!controls!was!N1.3!in!CD56bright!vs!N1.6!in!CD56dim).!Once!again,!no!reduction!in!any!activating!receptor!expression!was! observed! in! NK! cell! subsets! in! HCV! LT! recipients! compared!with! healthy!controls.!!
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3.2!Effect!of!liver!transplantation!on!NK!cell!function!!The!phenotyping! assays!demonstrated! significant!downregulation!of! activating!receptors!on! liver! transplant! recipient!NK!cells.!This! effect!was! largely! seen! in!the!mature!CD56dim! subset! and! less! so! in! the!CD56bright! population,!which!was!expanded!in!LT!recipients.!Furthermore,!the!changes!observed!were!not!present!in!LT!recipients!with!HCV!infection.!!!To! assess! NK! activation! further,! NK! cell! function! was! investigated.! NK! cell!effector! functions! include! cytokine! production,! crossNtalk! with! dendritic! cells!and!direct!and!indirect!cell!lysis.!Therefore!readouts!of!NK!cell!function!include!NK! cell! cytotoxicity,! degranulation,! and! cytokine! production.! Experimental!assays!were!designed! to!compare! these! functions! in!LT!recipient!NK!cells!with!healthy!controls!and!these!are!described!below.!!
3.2.1!Cytotoxicity!assay!!Once! released! from! inhibition,! natural! killer! cells! can! directly! lyse! target! cells!through! direct! contact! and! exocytosis! of! perforin/granzymes! containing!granules! (Shresta,! Pham! et! al.! 1998).! In! order! to! assess! NK! cell! specific!cytotoxicity!I!set!up!a!flow!cytometry!based!assay!as!described!in!the!methods.!Target!MHC!class!I!deficient!K562!cells!were!labeled!with!a!fluorescent!marker!before!coNculture!with!effector!cells!for!4!hours.!After!incubation,!the!cells!were!stained!with!a!liveNdead!stain,!so!that!the!proportion!of!target!cells!that!had!been!killed!was!a!measure!of!cytotoxicity!(Kim,!Donnenberg!et!al.!2007).!!
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by, flow, cytometry.,K562, cells,were, identified,as,CTO,positive,and,%,death, in, these, cells,
quantified,as,%,liveGdead,stain,positive.,Specific,cytotoxicity,was,calculated,by,subtracting,
%,death,in,the,control,well,(no,effector,cells),from,%,death,in,the,assay,well.,







ratio, for, cytotoxicity., Specific, cytotoxicity, was, calculated, relative, to, control, which,
contained,no,effector,cells.,,,
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Determination, of, optimal, incubation, time, and, E:T, ratio,was, performed, by, titrating, the,
ratio,of,PBMCs:K562,cells,and,the,length,of,coGincubation.,CD107a,expression,in,NK,cells,
was,quantified,by,flow,cytometry,as,described.,,
,To! determine! the! optimal! timing! and! E:T! ratio! for! the! assay,! NK! cells! were!incubated!with!K562!cells!at!E:T!ratios!from!40:1!to!1:1,!and!for!between!1!and!5!hours! (figure! 3.11).!The!plateau! for!CD107a!expression!was!between!3!and!5!hours,!and!for!the!E:T!ratio,!the!plateau!was!at!an!E:T!of!5:1.!Therefore!an!E:T!of!5:1!with!an!incubation!time!of!4!hours!was!used!for!all!further!CD107a!assays.!!
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3.2.3!Intracellular!cytokine!assay!As!well!as!cytolysis,!cytokine!production!is!a!key!function!of!NK!cells.!Early!in!the!immune!response!NK!cells!release!vast!quantities!of!cytokines,!particularly!IFNγ!and! TNFα.! These! are! important! in! the! recruitment! and! activation! of! multiple!other! cells! in! both! the! innate! and! adaptive! immune! response! (Moretta,!Marcenaro!et!al.!2008,!Fauriat,!Long!et!al.!2010).!As!our!data!has!demonstrated!hypofunctionality!of!NK!cell!cytotoxicity!in!LT,!cytokine!production!in!stimulated!NK!cells!was!assessed!with!a!flow!cytometry!based!assay.!!
All NK cells




























































E:T, ratios, and, for, varying, incubation, times, as, shown., The, PBMCs, were, then, surface,
stained, for, NK, cells, (CD3GCD56+), and, permeabilised, followed, by, intracellular, cytokine,
staining.,The,optimal,conditions,allowing,both,IFNγ,and,TNFα,quantification,in,the,same,
assay,were,determined.,
,Following! stimulation! with! K562! target! cells,! there! was! reduced! intracellular!expression! of! IFNγ! in! LT! nonNHCV! recipient! NK! cells! compared! with! healthy!controls! (p=0.020)! and! LT! HCV! recipients! (p=0.001,! figure! 3.14A).! The!difference!was!also!observed!in!the!CD56dim!NK!cell!subset!(p=0.008!for!both!LT!nonNHCV!vs.!healthy!control!and!LT!nonNHCV!vs.!LT!HCV).!In!CD56bright!NK!cells!IFNγ!expression!was!significantly! lower! in!LT!nonNHCV!compared!with!LT!HCV!
IFNγ time titration


































 E:T IFN γ

















































































































































3.3!NK!cell!differentiation!The! data! thus! far! provides! compelling! evidence! that! in! nonNHCV! liver!transplantation! recipient! NK! cells! exhibit! a! hypofunctional! phenotype.!Interestingly,! the! differences! in! activation! between! LT! recipients! and! healthy!controls!were!observed!in!CD56dim!but!not!in!less!mature!CD56bright!populations.!This!is!suggestive!of!an!altered!NK!differentiation!and!maturation!process!in!LT!recipients.! The! next! stage! of! experiments! was! designed! to! establish! whether!markers!of!NK!maturation!correlated!with!these!data.!!!CD16! (FCγRIII)! is! a! transmembrane! protein! present! on!most! CD56dim!NK! cells!but! expressed!by! very! few!peripheral! CD56bright! cells.! It! coNlocalises!with!CD3ζ!and!FcNεR1Nγ!and!binds!to!the!Fc!portion!of!IgG!antibodies!(Anegon,!Cuturi!et!al.!1988).! CD16! is! acquired! at! advanced! stages! of! NK! cell! differentiation,! and! the!expression! levels! of! CD16! correlates! with! the! level! of! NK! cell! maturation!(Moretta! 2010).! CD57! antigen! is! a! surface! marker! previously! associated! with!senescence!in!CD8+!T!cells,!and!more!recently!has!been!shown!to!be!a!marker!of!terminal!differentiation!in!NK!cells!(Bjorkstrom,!Riese!et!al.!2010,!LopezNVerges,!Milush! et! al.! 2010).! ! There! is! increasing! evidence! that! the! activating! receptor!NKG2C! is! a! marker! of! NK! cell! differentiation! and! adaptation! particularly! in!response! to! viral! infection! (LopezNVerges,!Milush! et! al.! 2011,! Beziat,! Liu! et! al.!2013).!!
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3.4!Effect!of!immunosuppression!on!NK!cells!!The! key! experimental! findings! support! a! hypothesis! that! liver! transplantation!results! in! defective! recipient! natural! killer! cell! maturation! leading! to! a!hypofunctional! phenotype.! Recipients! of! liver! allografts! necessarily! take!immunosuppressive! medication,! largely! based! around! calcineurin! inhibitors!(Cyclosporine! A! and! Tacrolimus).! In! the! phenotyped! cohort! 47/54! (87%)! LT!recipients! were! on! either! Tacrolimus! (43! patients)! or! Cyclosporine! A! (4!patients).! These! agents! target! the! adaptive! immune! response,! inhibiting! TNcell!activation! and! proliferation.! The! effect! of! immunosuppressive! medication! on!natural! killer! cell! activation! is! controversial.! Several! studies! investigating! this!have! reported! conflicting! findings! (as! discussed! in! Chapter! 1),! such! that! a!consensus! has! not! been! reached.! It! is! therefore! important! to! address! the!fundamental! question! of! whether! the! observed! changes! in! recipient! NK! cells!might! be! due! to! the! immunosuppressive! agents! taken! by! the! liver! transplant!recipients.!!!This!was!approached!by!performing!a!series!of!in,vitro!assays,!incubating!PBMCs!from! several! healthy! donors! with! commonly! used! immunosuppressants,!followed!by!assessment!of!NK!cell!phenotype!and!function.!The!results!of!these!experiments!are!described!below.!!PBMCs! from!healthy! donors!were! incubated!with! increasing! concentrations! of!the! immunosuppressive!medications!or!medium!alone!and!phenotyping!assays!were!performed!at!16!and!72!hours.!At! the!16!hour! time!point,! no!dose!effect!
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was!observed!on!the!expression!of!the!activating!receptors!over!the!therapeutic!ranges! of! any! of! the! immunosuppressive! agents! (figure! 3.17A\C).! At! the!midNtherapeutic! concentrations,! there! was! a! reduction! in! NKp30! (p=0.05)! and!NKG2D! (p<0.0001)! with! Prednisolone! figure! 3.17G.! At! 72! hours! there! was! a!trend!to!downregulation!of!NKp30!and!NKG2D!with!increasing!concentrations!of!Prednisolone,!but!no!other!dose!effects!were!observed!(figure!3.17D\F).!At!midNtherapeutic! concentrations,! no! significant! effects! of! the! immunosuppressive!agents!were!observed!on!the!expression!of!activating!receptors!(figure!3.17H).!!
!




Activating, receptor, expression, at, 16, hour, (ADC), and, 72, hour, (DDF), time, points., G,, H,
Summary,of,effect,of,immunosuppressive,agents,midGtherapeutic,concentrations,at,16,and,
72,hours.,*p<0.05,,****p<0.0001., ,



























































































































































































Figure'3.19'Activating'receptor'expression'and'acute'cellular'rejection.''!Of! the!54!LT!recipients!phenotyped,!47!(83%)!had!undergone!a! liver!biopsy!at!followNup.! Only! one! LT! nonNHCV! individual! had! advanced! fibrosis! at! biopsy,!therefore!it!was!not!possible!to!perform!an!analysis!of!NCR!and!development!of!advanced! fibrosis! in! the! LT! nonNHCV! group.! Within! the! LT! HCV! cohort,! 17!individuals!underwent!a!liver!biopsy:!6!(35%)!had!evidence!of!advanced!fibrosis!and! 11! (65%)! had! early! stage! fibrosis.! There! was! significantly! higher! NKp46!expression!in!LT!recipients!with!advanced!fibrosis!compared!with!those!who!had!early!stage!fibrosis!(figure!3.20).!However!the!time!to!biopsy!was!significantly!different!between!the!two!groups!(830!days!in!F0N3!group!vs!1659!days!in!F4N6!group,! p=0.04),! and! this! may! well! confound! the! results.! No! difference! in! NK!cytotoxicity!was!observed!between!the!two!fibrosis!groups!(figure!3.21).!
Figure'3.20'Activating'receptor'expression'and'fibrosis'score.''
*p<0.05!!






































































































3.6!Discussion!The! phenotype! and! function! of! recipient! natural! killer! cells! after! liver!transplantation!was!assessed!using!flow!cytometry!based!assays.!Compared!with!healthy! controls,! I! observed! a! significant! downregulation! in! the! expression! of!activating! natural! cytotoxicity! receptors! (NCRs)! and,! correlating! with! this,!reduced! functionality! including! cytotoxicity,! degranulation! and! cytokine!production.!!!These!data!challenge!the!conventional!paradigm!that!recipient!NK!cells!are!not!influenced!by!allografts.!Previous!animal!studies!have!also!provided!evidence!for!NK! cell! involvement! in! transplantation.! For! example! NK! cells! were! found! to!infiltrate!rodent!cardiac!allografts!a!few!days!after!transplantation!(Dresske,!Zhu!et!al.!1997),!and!in!mouse!models,!acute!rejection!of!cardiac!allografts!has!been!associated!with!NK!cells!expressing!NKG2D!(Feng,!Ke!et!al.!2009).!Furthermore!NK! cells! expressing! the! activation! marker! Ly49G2! have! been! shown! to! be!present! in! murine! cardiac! allograft! vasculopathy! lesions,! suggesting! a! role! in!chronic!rejection!(Russell,!Chase!et!al.!2001,!Uehara,!Chase!et!al.!2005,!Uehara,!Chase!et!al.!2005)!!However,! the! literature! concerning! NK! cell! activation! in! human! solid! organ!transplantation!is!sparse.!!The!expression!of!NKG2D!ligands!MICA/MICB!on!renal!and! pancreatic! transplants! has! been! associated! with! acute! rejection! (Hankey,!Drachenberg! et! al.! 2002,! SuarezNAlvarez,! AlonsoNArias! et! al.! 2009,! SuarezNAlvarez,! LopezNVazquez! et! al.! 2009).! Another! study! demonstrated! NK! cells!infiltrating! the! graft! in! acute! rejection! of! renal! transplants! (Hidalgo,! Sis! et! al.!
! 110!
2010).! In! liver! transplantation,!NK!cells! from!recipients!were! shown! to!exhibit!greater!cytotoxicity!in!HLA!mismatched!LT!compared!with!matched!LT!at!day!21,!but! no! association! with! acute! rejection! was! observed! (Oertel,! Kohlhaw! et! al.!2001).! Thus! studies! to! date! have! provided! very! limited! evidence! of! the! NK!response!to!allograft,!but!suggest!that!NK!cells!can!be!involved!in!acute!rejection.!My! data! set! is! the! first! to! describe! the! longNterm! effects! of! transplantation! on!recipient! NK! cells,! characterizing! the! peripheral! NK! cell! phenotype! in! LT!recipients.! In! demonstrating! that! NK! cells! do! indeed! exhibit! downregulated!activation,!the!results!may!explain!why!liver!allografts!are!well!tolerated.!!!One! possible!mechanism! underlying! this! NK! cell! tolerance! is! a! direct! effect! of!interaction! between! circulating! NK! cells! and! the! allograft;! this! could! result! in!downregulated! activation! in! mature! NK! cells,! or! altered!maturation/development!of!immature!cells.!In!order!to!address!whether!LT!has!similar!effect!on!NK!cells!at!different!stages!of!development,!phenotyping!assays!were!designed!to!identify!CD56bright!and!CD56dim!subsets!of!NK!cells,!which!differ!in! their! stage! of! maturation.! There! was! an! increase! in! CD56bright! cells! (as! a!proportion! of! total! NK! cells)! in! LT! recipients! and! the! reduction! of! NCR!expression!was!most!marked!in!the!CD56dim!cells.!CD56bright!NK!cells!generally!do!not!express!KIR,!and!consistent!with!this,!the!NCR!changes!were!most!striking!in!KIR+!NK!cells!whilst!no!downregulation!in!NCR!expression!was!seen!in!KIRN!cells.!!!These!data!provide!evidence!of!altered!development!of!recipient!NK!cells!in!liver!transplantation.! In! the! LT! recipient! cohort,! the! higher! relative! abundance! of!peripheral!CD56bright!NK!cells!is!suggestive!of!a!change!in!maturation!induced!by!
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the!allograft.!!The!observed!downregulation!of!activation!in!CD56dim!NK!cells,!but!not! in!the!CD56bright!subset!suggests!that!the!maturation!defect!occurs!between!the!two!stages!of!NK!development,!and!that!this!results!in!hypofunctionality.!!!The! in,vitro! immunosuppression!assays!were!performed!to!investigate!whether!the! findings! in! LT! recipient! NK! cells! could! be! a! direct! effect! of!immunosuppressive!therapy.!Nearly!90%!of! the!cohort!were!taking!calcineurin!inhibitor!based!immunosuppression,!and!thus!the!assays!were!representative!of!the!LT!recipient!cohort.!Whilst!there!are!limitations!to!the!in,vitro!experiments,!these! data! demonstrate! that! NK! cell! hypofunctionality! is! not! a! direct! effect! of!immunosuppressive!medication!on!mature!NK!cells.!However,!it!is!possible!that!the!immunosuppressants!have!upstream!effects!on!developing!NK!cells!prior!to!full!maturation.!A!previous!study!investigating!the!effects!of!Cyclosporine!on!NK!cells!reported!influences!on!development,!with!increased!CD56+CD16NKIRN!cells,!and!increased!IFNγ!production!(Wang,!Grzywacz!et!al.!2007).!!None!of!the!reduced!activation!phenomena!were!observed!in!NK!cells!from!liver!transplant!recipients!with!HCV!infection.! In!fact,!an! increase! in!NCR!expression!was! observed! in! HCV! LT! recipients! compared! with! nonNHCV.! In! the! nonNtransplant! setting,! NK! cells! are! thought! to! be! chronically! activated,! and! have!been! shown! to! express! higher! levels! of! activating! receptors! NKp30,! NKp44,!NKp46!and!NKG2D!(De!Maria,!Fogli!et!al.!2007,!Ahlenstiel,!Titerence!et!al.!2010,!Harrison,!Ettorre!et!al.!2010),!with!increased!cytotoxicity!(Duesberg,!Schneiders!et!al.!2001,!GoldenNMason,!MadrigalNEstebas!et!al.!2008,!Oliviero,!Varchetta!et!al.!2009,! Yoon,! Shiina! et! al.! 2009).! As! HCV! recurrence! is! universal! after! liver!
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!The! data! presented! in! the! previous! chapter! provides! evidence! that! recipient!natural!killer!cells!undergo!abnormal!maturation!following!liver!transplantation!with!associated!downregulation!of!activating!receptors!and!hypofunctionality!in!response!to!cytokine!stimulation.!This!was!not!observed!in!LT!recipients!infected!with!hepatitis!C!virus,!and!the!in,vitro!assays!demonstrated!that!the!changes!are!not!a!direct!effect!of!immunosuppressive!agents.!This!led!to!the!hypothesis!that!recipient!NK!cells!become!tolerised!by!the!donor!allograft,!an!effect!abrogated!by!the!presence!of!HCV!infection.!!!The!next!aim!of!the!study!was!investigation!into!the!mechanisms!through!which!the! observed! changes! in! recipient! NK! cells! occur.! As! there! seems! to! be! a!maturation! defect,! a! plausible! explanation! is! that! immature! NK! cells! undergo!altered! development! after! encountering! the! allograft.! Perhaps!hyporesponsiveness!is!a!result!of!chronic!stimulation!and!exhaustion.!!!Gene!expression! in! recipient!NK!cells! could!provide!a!valuable! insight! into! the!pathways!involved!in!NK!tolerance.!In!particular,!comparison!of!gene!expression!between! NK! cells! from! healthy! controls,! and! those! from! LT! recipients! could!provide! insight! into! the! mechanisms! underlying! tolerance.! Furthermore!comparison! between! HCV! and! nonNHCV! recipient! NK! cells! may! provide! an!answer!as!to!how!HCV!infection!counteracts!the!tolerising!effect!of!LT.!!
!!
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Gel, image, (A), and,
electropherogram,(B),of,total,
RNA, samples., As, a, reference,
the, molecular, weight, ladder,
(in, nucleotides,, nt), is, shown,
in, the, first, lane., The, lowest,
migrating, green, band,
represents, internal, standard.,
The, two, prominent, peaks,
within,the,electropherograms,
represent,ribosomal,RNA:,left,
18S,, right,28S., Scaling,of, the,
yGaxis, is, done, automatically,,






! RNA!was!extracted! from!15!LT!recipients!and! the!quality!was!assessed!via! the!Agilent!2100!Bioanalyzer!platform.!The!results!are!visualized!in!gel!images!and!electropherograms!(Figure!4.1).!The!software!also!allows!generation!of!an!RNA!Integrity! Number! (RIN)! to! check! integrity! and! overall! quality! of! total! RNA!samples!(Fleige!and!Pfaffl!2006).!Originally,!RNA!was!extracted!from!15!samples,!but!3!were!excluded!due!to!poor!quality!as!determined!by!RIN.!!!











signal, intensities, of, each, feature, represented, by, a, dot, are, shown, in, double, logarithmic,
scale.,xGaxis:,controlGlog,signal, intensity;,yGaxis:,sampleGlog,signal, intensity.,Red,diagonal,
lines,define,the,areas,of,2Gfold,differential,signal,intensities.,Blue,cross:,unchanged,genes.,








probe, signal, intensity,, with, similar, medians, and, distributions., Either, end, of, the, box,
represents, the,upper,and, lower,quartile,,and,the, line, in, the,middle,of, the,box,represents,
the,median.,Horizontal, lines,,connected,to,the,whiskers,represent,the, limits,of,values,not,
considered, to,be,outliers.,Outliers, (circles),are, values, lying,more, that,1.5, x, interquartile,
range.,,This,quality,control,tool,indicates,that,no,single,sample,had,significantly,different,
















groups, on, microarray., Figures, in, black, indicate, the, number, of, genes, differentially,
expressed,between,2,groups,only,,and, figures, in,white,(within,the, intersections), indicate,




,Appendix!3!shows!the!full!gene!lists!for!differentially!expressed!genes.!As!there!are! multiple! analyses! performed! in! microarray,! a! false! discovery! rate! (FDR)!correction! was! performed.! With! such! correction,! there! was! no! significant!differential!expression!of!any!gene!between!the!3!groups.!The!likely!explanation!for!this!is!the!low!number!of!samples!used!in!this!experiment.!!!
4.1.3!Pathway!analysis!!The!gene!lists!and!corresponding!expression!values!derived!from!the!microarray!analysis!were!input!into!the!Ingenuity®!Pathway!Analysis!Software!which!uses!the!Ingenuity®!Pathways!Knowledge!Base!(IPKB)!to!identify!biological!functions!as!well!as!pathways!that!are!most!significantly!effected!by!the!genes.!The!results!of!these!analyses!generate!biological!pathway!diagrams!as!shown!in!figures!4.6!\!


















































































































4.1.2%Systems%analysis%The!IPA!software!also!analyses!associated!network!functions!most!significantly!affected!by!differential!expression,!and!the!highest!scoring!were:!1. DNA! replication,! recombination! and! repair,! post! translational!modification!,!cell!cycle!2. Drug!metabolism,!cell!cycle,!cell!morphology!3. Antigen!presentation,!haematologival! system!development!and! function,!inflammatory!response.!!
%Biological!functions!most!affected!between!the!study!groups!were:!1. Haematological!disease!(p=2.58x10M4!to!3.16x10M2)!2. Immunological!disease!(p=2.58x10M4!to!3.16x10M2)!3. Inflammatory!response!(p=1.33x10M3!to!3.16x10M2)!!The!most!significantly!affected!molecular!and!cellular!functions!were:!1. Cellular!development!(p=1.57x10M6!to!3.16x10M2)!2. Cellular!growth!and!proliferation!(p=1.57x10M6!to!3.16x10M2)!3. Cellular!function!and!maintenance!(p=4.38x10M5!to!3.16x10M2)!! !
! 125!
4.2%Quantitative%RT5PCR%Microarray! is! a! powerful! tool! for! investigating! gene! profiling,! interrogating! the!expression!of!thousands!of!genes!on!one!experiment.!However!the!very!nature!of!this!technique!means! that! vast! numbers! of! comparisons! between! groups! are!made! and!can! result! in! false! positives;! this! is! accounted! for! by! FDR! correction.! In! order! to!achieve!statistical!significance,!many!more!microarrays!would!have!to!be!performed;!this!would!have!proved!prohibitively!expensive!and!was!certainly!beyond!the!budget!of! this! project.! However,! the! utility! of! the! data! provided! is! in! the! generation! of!possible! candidate! genes! to! explore! further.! Further! investigation!of! these!genes!of!interest!(GOI)!can!then!be!performed!by!measuring!expression!in!more!samples!with!qPCR.! This! then! enables! determination! of! whether! differential! gene! expression! is!indeed!significant.!!!Based!on!the!preMFDR!significant!pMvalues,!the!gene!lists!were!studied!and!candidate!genes!were!selected!for!further!analysis.!We!used!our!previous!data!to!generate!our!hypothesis! that! NK! cells! develop! tolerance! through! decreased! activation! related! to!altered!development!to!select!candidate!genes.!!Thus!genes!that!were!likely!to!effect!NK!cell!maturation!or!activation,!or!involved!in!the!response!to!HCV!infection!were!of!interest.!Table% 4.1% shows! the! genes! chosen! for! further! analysis! by! qPCR! and! the!functions!of!the!genes.!Eight!genes!were!selected!from!the!microarray!data!because!of!significant! differential! expression! between! groups.! IFI44L! and! KIR2DS3! were! also!selected! as,! although! not! reaching! statistical! significance,! there! were! high! fold!difference!expression!values!(3.09!and!6.99!respectively)!in!LT!HCV!vs!LT!nonMHCV.!One! further!gene!(IKZF2)!was!selected!because!of!recent!publications!suggesting!an!important!role!in!NKp46!expression!(NarniMMancinelli,!Jaeger!et!al.!2012).!
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The! method! of! extracting! RNA! for! the! qPCR! experiments! required! significant!adaptation!for!optimisation.!This!was!largely!due!to!the!problem!of!low!starting!number!of!cells!(a!few!as!1x105!NK!cells!after!purification!from!PBMCs).!Column!based!RNA!extraction!tended!to!yield!very!limited!levels!of!RNA,!as!much!of!the!RNA! was! lost! on! the! columns.! Thus! the! TRIzol! phenolMchloroform! extraction!method! was! employed! and! optimised! to! maximize! RNA! yield.! Modifications!found! to! have! a! significant! effect! on! yield!were! incubation! at! M80oC! for! 1! hour!after! the! isopropanol! precipitation! step,! and! using! inMsolution! DNase! (rather!than!a!column!based!method).!!!The!qPCR!reactions!were!performed!on!an!array!plate!preMloaded!with!primers!for!the!11!genes!of!interest!as!well!as!2!housekeeping!genes!(SMA!and!GAPDH)!(SABSciences,!U.K).!There!were!also!3!control!wells!per!sample:!a)!positive!PCR!control! (PPC);! b)! genomic!DNA! control! (GDC);! c)! reverse! transcription! control!(RTC)!and!the!purpose!of!these!is!described!in!the!Methods!chapter.!!!
4.2.1,STAT4,expression,reduced,in,LT,Quantitative!RTMPCR!was!performed!on!samples!from!13!healthy!controls,!12!LT!HCV!patients!and!17!LT!nonMHCV!patients.!The!experiments!were!validated!using!the! controls! described! and! the! housekeeping! genes! were! used! to! determine!relative!gene!expression!between!groups!ΔΔCT!method.!Figure,4.9, is!a!heatmap!representation! of! the! qPCR! data! for! all! the! genes! of! interest! quantified.! The!results! are! summarised! in! table, 4.2,! which! includes! the! fold! changes! and! p"values!for!the!genes!where!the!differential!gene!expression!was!either!significant!(p<0.05)!or!nearly!significant!(p=0.05M0.07).!
!!
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!The! most! consistent! difference! between! LT! and! healthy! controls! was!downregulation! of! STAT4! gene! expression.! This! occurred! in! both! LT! groups!compared!with!healthy!controls!(p=0.0001,!M10.73!fold!change,!and!p=0.01,!M3.78!fold!change!in!LT!nonMHCV!and!LT!HCV!respectively).!Compared!with!controls,!in!LT!nonMHCV!there!was!also!upregulation!of!ZNF683! (Hobit,! a! repressor!of! IFNγ!expression! (van!Gisbergen,!Kragten!et! al.! 2012),!p=0.06,!2.03! fold! change)! and!downregulation!of!KIR2DS3!(p=0.05,!M2.14!fold!change).!!
Figure'4.9'Heat'map'representation'of'gene'expression'between'the'3'groups.'
All8the8candidate8genes8selected8for8qPCR8are8represented.8The8black8and8red8colouration8
reflects8higher8gene8 expression;8 this8 can8be8 seen8 in8 STAT48expression,8where8 the8healthy8





genes!(ISGs)!as!found!in!chronic!HCV!infection).!When!comparing!all!LT!(ie.!HCV!and! nonMHCV)! with! controls,! downregulation! of! STAT4! (p=0.0001,! M6.97! fold!change)!and! IKZF2! (Helios,! a! transcription! factor!controlling!NKp46!expression!(NarniMMancinelli,! Jaeger! et! al.! 2012))! (p=0.06,! M2.26! fold! change)! and!upregulation!of!ZNF683!(p=0.07,!2.10!fold!change)!were!found.!
8
!
All!LT!vs!HC! LT!non,HCV!vs!HC! LT!HCV!vs!HC! LT!HCV!vs!LT!non,HCV!
Symbol! Fold!Change! p!value! Fold!Change! p!value! Fold!Change! p!value! Fold!Change! p!value!
!STAT4! "6.97! 0.0001! "10.73! 0.0004! "3.78! 0.01! 2.84! ns!
!IKZF2! "2.26! 0.06! "2.88! ns! "1.61! ns! 1.79! ns!
!ZNF683! 2.10! 0.07! 2.03! 0.06! 2.20! ns! 1.08! ns!
!IF144L! 1.99! ns! 1.14! ns! 4.38! ns! 3.85! 0.07!
!KIR2DS3! "2.47! ns! "2.14! 0.05! "3.01! ns! 0.71! ns!
Table'4.2'qRT'PCR'analysis'for'the'candidate'genes'identified'by'microarray'analysis.'
Expression8of8the8genes8of8interest8was8quantified8in8138healthy8controls8(HC),8178LT8non"HCV8and8128LT8HCV8
patients.8 Using8 housekeeping8 genes,8 the8ΔΔCT8 8method8was8 employed8 to8 determine8 relative8 expression.8 The8
fold"change8refers8to8expression8in8the8first8group8compared8to8the8second8in8the8header8column.8Negative8fold8







4.2.2,Immunosuppression,and,gene,expression,The! effects! of! immunosuppressive! medication! on! expression! of! the! candidate!genes!in!NK!cells!were!assessed!by!qRT!PCR!on!NK!cells!from!3!healthy!donors!incubated! with! Tacrolimus,! Cyclosporine! A,! Prednisolone,! or! medium! alone.!None!of!the!gene!expression!changes!observed!in!LT!were!replicated!in!these!in8
vitro! assays! (Table, 4.3)! and! in! general,! aside! from! KIR2DS3,! differences!observed!in8vitro!were!in!the!opposite!direction!to!those!observed!in8vivo.!!!
!
Fold!Regulation!compared!with!no!drug!
Symbol! Tacrolimus! Cyclosporin!A! Prednisolone!
STAT4! 8.0463! "1.0952! 10.3711!
IKZF2! 2.5727! 6.1457! 5.6047!
ZNF683! "3.5245! "4.9738! "28.0862!
IF144L! "5.5939! "36.9022! "15.4974!
KIR2DS3! "17.0462! "25.5979! "17.6655!
Table'4.3'Effects'of'immunosuppressants'on'gene'expression.''
Levels8 of8 candidate8 gene8 expression8 were8 quantified8 by8 qPCR8 in8 healthy8 NK8 cells8 after8
incubation8with8immunosuppressant8drugs8and8relative8expression8compare8to8incubation8
in8medium8alone8is8shown!!
4.2.3,Reduced,ILB12,induced,STAT4,phosphorylation,in,LT,STAT4! is! transcriptional! activator! that! is!phosphorylated! following! stimulation!of!lymphocytes!by!ILM12.!!In!order!to!determine!if!the!low!mRNA!levels!observed!had! functional! consequences,! STAT4! phosphorylation! in! response! to! ILM12!stimulation! was! measured.! There! was! significantly! reduced! STAT4!
!!
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method.8 A8 representative8 FACS8 plots8 demonstrating8 little8 pSTAT48 expression8 in8
unstimulated8NK8cells;8after8 IL"128stimulation,8 there8 is8 increased8pSTAT4,8with8a8 smaller8
increase8seen8in8LT8versus8HC.8The8results8of8experiments8in888LT8recipients8and888healthy8
donors8are8summarized8in8B.8***p<0.001.8!In! order! to! exclude! this! effect! as! being! directly! due! to! immunosuppressive!medication!the!effects!of!Tacrolimus,!Cyclosporine!A!and!Prednisolone!on!ILM12!induced! STAT4! phosphorylation! were! analysed.! No! change! was! observed! in!STAT4! phosphorylation! following! incubation!with! any! of! these! agents! (figure,



































PBMCs8 from8 healthy8 donors8 incubated8
with8 the8 immunosuppressive8 agents8
demonstrated8 no8 difference8 in8 pSTAT48
levels8 compare8with8medium8 alone.8 N=3.8
FK506=8 Tacrolimus,8 CysA=8 Cyclosporine8
A,8Pred8=8Prednisolone.88!
,
4.2.4,MicroRNAB155,expression,in,LT,STAT4!has!many!important!downstream!cellular!effects,!and!downregulation!of!STAT4!expression!and!activation!may!have!broad! functional!consequences.! !To!investigate!if!the!effects!of!STAT4!down!modulation!had!significant!effects!on!NK!cells! in8 vivo,! we! studied! the! expression! of! microRNAM155! (miRM155),! a! key!regulator! of! NK! cell! differentiation! and! activation,! that! is! a! target! of! STAT4!(Trotta,! Chen! et! al.! 2012,! Zawislak,! Beaulieu! et! al.! 2013).! Quantitative! RTMPCR!performed! on! isolated! NK! cells! from! postMLT! patients! and! healthy! controls!demonstrated!a!4.9!fold!downMregulation!of!miRM155!in!LT!(p=0.04,!figure,4.12),!which!is!consistent!with!the!observed!defect! in!STAT4!signaling.! !This!suggests!that!effects!of!STAT4!downregulation!have!an!onMgoing!effect!on!NK!cells!in!post!transplant!patients.!!!







































4.3,Discussion,In! this! chapter! gene! expression! profiling! was! utilized! to! explore! mechanisms!underlying! the! observed! differences! in!NK! cell! phenotype! and! function! in! liver!transplant!recipients.!The!initial!approach!employed!was!DNA!microarray,!which!has!the!advantage!of!assessing!the!expression!of!tens!of!thousands!of!genes!in!one!experiment.! This! technique! allows! for! a! global! comparison! of! gene! expression!between! groups! in! biologically! distinct! conditions,! and! therefore! provides!hypothesisMgenerating! data! that! may! help! explain! the! differences! between! the!groups.!As!such,!hitherto!unthoughtMof!mechanisms!can!be!elucidated,!and! then!explored!in!further!experimental!analysis.!!!Interestingly,!when!all!the!differentially!expressed!genes!were!analysed!through!the! pathways! analysis! software,! the! biological! networks! and! functions! most!affected!were!related!to! the! immunological!and! inflammatory!response,!cellular!development,! growth! and! proliferation.! This! is! consistent! with! the! previous!observation!that!NK!cells!in!LT!exhibit!a!hypofunctional!phenotype!and!that!this!is! related! to! altered! maturation! and! differentiation.! The! pathway! analysis!demonstrated! that! a! number! of! genes! involved! in! key! immunological! signaling!pathways!were!differentially!expressed!between!the!groups.!!!Protein!Kinase!CMθ!(PKCθ)!is!known!to!be!a!key!regulator!of!signal!transduction!in!activated! T! cells! (Isakov! and! Altman! 2012),! but! has! also! been! shown! to! be!important! in!NK! cell! activating! signal! transduction,! and! deficiency! in! PKCθ! has!been! shown! to! result! in! defects! in! NK! transcriptional! activation! and! IFNγ!
!!
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secretion! (Tassi,! Cella! et! al.! 2008).! Therefore! alterations! in! the! PKCθ! pathway!may! be! one! mechanism! through! which! the! altered! phenotype! in! recipient! NK!cells!arises.!!!The!pathway!analysis!also!found!Janus!kinase/signal!transducers!and!activators!of! transcription! (JAK/STAT)! signaling! to! be! significantly! altered! between! the!study! groups.! The! canonical! JAK/STAT! pathways! are! the! principal! signaling!mechanism! for! many! cytokines! and! growth! factors,! which! are! crucial! to! cell!proliferation,! differentiation,! apoptosis! and! migration! (Rawlings,! Rosler! et! al.!2004).! Therefore! alterations! in! JAK/STAT! signaling! would! have! significant!consequences! for! NK! cell! biology! from! activation,! to! differentiation! and!maturation.! The! confirmation! by! qRTMPCR! of! downregulation! in! STAT4!expression!provides!more!compelling!evidence!that!JAK/STAT!signaling!is!indeed!involved!in!the!alteration!in!recipient!NK!cell!function!after!LT.!!!The!STAT4!gene!is!located!on!chromosome!2q32!and!encodes!the!STAT4!protein.!This! is! an! important! transcription! factor! whose! expression! is! restricted! to!myeloid!cells,!thymus!and!testis!(Yamamoto,!Quelle!et!al.!1994),!and!is!known!to!be! required! in! the! development! of! Th1! cells! from! naïve! CD4+! T! cells! (Kaplan!2005).!STAT4!is!expressed!at!very!low!levels!in!resting!cells,!but!T!cell!production!of!STAT4!can!be!stimulated!by!phytohaemagglutinin!!(PHA)!(Bacon,!Petricoin!et!al.! 1995).! STAT4! is! activated! by! binding! of! ILM12! to! its! receptor! (ILM12R);! this!results! in! dimerization! of! the! ILM12R,! phosphorylation! of! JAK2,! which! in! turn!phosphorylates! STAT4.! PhosphoMSTAT4! (pSTAT4)! homodimerizes! and!translocates!into!the!nucleus!where!it!has!multiple!effects!on!gene!transcription,!
!!
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with! resultant! promotion! of! key! activating! cytokines! including! IFNγ! and! TNFα!(Wurster,!Tanaka!et!al.!2000).!!STAT4!has!been!shown!to!be!important!in!NK!cell!activation,!and!PBMC!production!of!IFNγ!is!impaired!after!HSCT!as!a!consequence!of! STAT4! deficiency,! with! significantly! reduced! STAT4! gene! expression!(Robertson,! Chang! et! al.! 2005).! In! the! present! study,! not! only!was!STAT4! gene!expression!downregulated,!but!STAT4!phosphorylation!in!response!to!ILM12!was!also! reduced.! Our! data! therefore! suggests! that! the! tolerant! NK! cell! phenotype!observed!in!LT!recipients!may!be!associated!with!defective!STAT4!signaling!and!is! consistent! with! the! observed! reduction! in! NK! cell! production! of! IFNγ! as!described!in!Chapter,3.!!!MicroRNAM155! has! been! shown! to! be! an! important! target! of! STAT4,! with!consensus! STAT4! binding! motifs! present! in! the! promotor! of! the! bic! gene! that!encodes! miRM155.! In! mice! miRM155! is! associated! with! accelerated! NK! cell!maturation,!and!deletion!of!this!miRNA!has!been!shown!to!result!in!defects!in!NK!cell! maintenance! and! homeostasis! (Zawislak,! Beaulieu! et! al.! 2013).! In! the! LT!cohort! a! 4.9Mfold! downregulation! of! miRM155! compared! with! healthy! controls!provides! further! evidence! of! downstream! consequences! of! defective! STAT4!signaling.! It! is! plausible! that! this! deficit! in! miRM155! may! cause! a! similar!maturation!defect!in!humans!as!is!observed!in!mice.!In!chapter,3,!NK!cells!from!LT! recipients!expressed! increased!NKG2C,! a!marker! that!has!been!shown! to!be!associated!with! terminal! differentiation! of! NK! cells! and! a! ‘memory’! phenotype!(LopezMVerges,! Milush! et! al.! 2010,! Moretta! 2010,! LopezMVerges,! Milush! et! al.!2011).! Thus! the! data! presented! in! this! study! suggests! that,! as! is! seen! in!mice,!miRM155!may!also!be!associated!with!NK!maturation!in!humans,!with!decreased!
!!
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levels! found! in! LT! associated! with! altered! differentiation! and! ultimately!hypofunctionality.!!!The! downregulation! in! STAT4! expression!was! present! in! LT! regardless! of! HCV!status,! suggesting! that! this! is! a! phenomenon! related! to! transplantation! itself.!However,! as! described! in! Chapter, 3,! NK! cells! in! HCV! LT! recipients! have!preserved!functionality.!Interestingly,!in!the!analysis!comparing!LT!HCV!with!LT!nonMHCV! increased!expression!of! IFI44L!was!observed.!As! this! is!an! interferonMinduced!protein,!known!to!be!activated!in!HCV!infection,!these!data!support!our!hypothesis! that! HCV! infection! counteracts! (rather! than! prevents)! the! tolerance!induced!by!LT.!!The! effects! of! immunosuppressive! agents! on! NK! gene! expression! have! not!previously!been!reported.!Tacrolimus!inhibits!calcineurin!phosphatase,!and!in!T!cells! has! been! shown! to! result! in! inhibition! of! calciumMdependent! events!including! ILM2! gene! transcription,! nitric! oxide! synthase! activation,! cell!degranulation,! and! apoptosis! (Thomson,! Bonham! et! al.! 1995).! Tacrolimus!may!also!enhance!expression!of!the!transforming!growth!factor!betaM1.!Thus!it!might!be!expected!that!gene!expression!involving!these!pathways!would!be!affected!in!NK! cells! from! LT! recipients! receiving! Tacrolimus.! Whilst! none! of! the! selected!candidate! genes! are! directly! involved! in! these! pathways,! the! analysis! of! the!microarray!data!set!suggested!that!ILM4!signalling!is!significantly!affected!in!LT.!In!murine!NK!cells! ILM4!and! ILM2! synergistically! enhance! IFNγ!production! (Bream,!Curiel!et!al.!2003),!thus!it!is!possible!that!the!observed!!effects!on!ILM4!signaling!in!our!LT!recipient!cohort!is!a!consequence!of!immunosuppression.!!
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!Since!I!found!that!the!CD56bright!population!is!expanded!after!LT,!some!of!the!gene!expression!differences!might!be!related! to! this.!Previous!studies!analysing!gene!expression! in!CD56bright! and!CD56dim!NK! subsets! and!have! reported!differential!gene! expression! profiles! between! the! two! populations! which! reflect! their!functional! diversity! (Hanna,! Bechtel! et! al.! 2004,!Wendt,!Wilk! et! al.! 2006,!Wilk,!Kalippke!et!al.!2008).!!For!example,!in!CD56dim!NK!cells!mRNA!expression!of!KIR!genes,! CD16,! and! granzyme! were! much! greater! than! in! CD56bright! NK! cells.!However!no!study!has!reported!differences!in!STAT!gene!expression,!or!of!ILM12!or! ILM4! between! the! NK! subsets.! Therefore! the! differences! in! STAT48 gene!expression!and!signaling!found!in!our!LT!cohort!are!not!likely!to!be!related!to!the!observed!changes! in!NK!subsets.! Instead,!we!propose!that! interactions!between!the! allograft! and! recipient! NK! cells! lead! to! the! observed! alterations! in! STAT4!signaling,!contributing!to!the!reduced!activation!and!resulting!NK!tolerance.!!
!The!microarray!dataset!clearly!has!its!limitations,!most!obviously!being!the!small!sample!size.!This!was!addressed!by!performing!qPCR!on!a!few!genes!of! interest!selected!from!the!microarray!in!samples!from!a!further!cohort.!However,!if!time!and!budget!allowed,!it!would!be!interesting!to!perform!microarray!on!many!more!samples.! This! would! enhance! the! statistical! power! of! the! results,! and! without!doubt!provide!many!more!genes!and!pathways!to!explore!further.!I!chose!to!focus!on!a!small!set!of!genes!for!further!analysis!by!qPCR,!and!explored!STAT4!in!detail.!There!were!many!other!genes! that!were!differentially!expressed,!and!pathways!(such! as! PKCθ! signaling)! that! could! equally! have! been! investigated.! Future!
!!
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!As!NK!cell!tolerance!of!self!involves!inhibitory!interactions!with!self!HLA!class!I!molecules,! and! liver!allografts!are!not!HLA!matched! to! the! recipient,! there! is!a!theoretical! opportunity! for! NK! cell! alloreactivity! in! HLA! mismatched!transplantation.!As!described!in!the!Chapter!1,!NK!cell!receptors!are!expressed!in!a!clonal!and!variegated!manner!so! that!within!an! individual,! clones!of!NK!cells!express!different!repertoires!of!receptors.!For!example,!some!clones!will!express!KIR2DL1!(HLAMC2!specific)!but!not!KIR2DL2/3!(HLAMC1!specific!but!with!some!cross!reactivity!with!HLAMC2),!and!vice!versa.!HLA!and!KIR!genes!are!encoded!on!different!chromosomes!and!are! therefore!not! linked,! so! that!an! individual!may!not! express! the! inhibitory! HLA! ligand! for! all! the! KIR! encoded! within! his!genotype.!Therefore!NK!clones!expressing!KIR2DL2!(and!not!KIR2DL1)!would!be!self!reactive!in!an!individual!homozygous!for!HLAMC2.!This!does!not!occur,!and!it!has! been! shown! that! NK! cells! that! do! not! express! inhibitory! receptors! to! self!ligands! are! hyporesponsive! (Fernandez,! Treiner! et! al.! 2005).! The!mechanisms!for! this! are! uncertain,! but! it! is! thought! that! NK! cells! undergo! an! educational!process! during! maturation! that! allows! full! maturation! of! only! those! clones!expressing!inhibitory!receptors!recognizing!self.!The!various!theories!for!this!are!discussed!in!Chapter!1.!!!Immunogenetic! studies! have! not! provided! sufficient! evidence! to! generate! a!consensus! view! of! the! effect! of! HLA! matching! on! clinical! outcomes! of! liver!
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5.1.1,Recipient,KIR,genotype,DNA!was! extracted! from!whole! blood! from!all! study! recruits! using! the!Qiagen!DNeasy!kit!and!quantified!by!spectrophotometry.!Aliquots!were!sent!to!the!KIR!genotyping! laboratory! in! Cambridge! for! full! KIR! allelic! typing! including! copy!number! (James! Traherne,! Trowsdale! laboratory,! Cambridge).! Of! the! 109! LT!recipients!recruited,!KIR!typing!was!possible!in!106!(97%).!Figure,5.1!shows!the!distribution!of!the!KIR!alleles!amongst!the!LT!recipients!and!the!copy!number!of!the!KIR!alleles!present!within!individuals!is!depicted!figure,5.2.!!
! !
Figure'5.1'The'distribution'of'KIR'alleles'amongst'LT'patients.''




































































































Association8 between8 KIR8 haplotype8 and8 the8 expression8 of8 the8 activating8 receptors8 was8
analysed8(haplotype8A:8All8n=33,8non"HCV8n=20,8HCV8n=13;8haplotype8B:8All8n=18,8non"HCV8






































































HLAMB"and" MC" interactions"with"KIR"dominate"NK" inhibitory" receptor" signaling"(Young,' Rust' et' al.' 1998," Yawata,& Yawata& et& al.& 2006)! and$ therefore$ genes$encoding( these( epitopes( were( analysed.( Donor( HLA( typing( data( was( obtained(from% the% UK% blood% and% transplant% (UKBT)% database,%with% 2% digit% allelic% typing%information)available.)Recipient)HLA)typing)was)performed)using)DNA)extracted)from% recipient% PBMCs% in% collaboration% with" the" Histocompatibility" and"Immunogenetics+ laboratory+ at+ Gartnavel+ General+ Hospital,+ Glasgow+ (Helen+McFarlane,#AnnMMargaret'Little,'Glasgow).'!
' '
Locus' Motif' Position'77' Position'80' Alleles'
HLABB, Bw4! N!(asparagine)! I!(isoleucine)! B*51,!B*52,!B*53,!B*57,!B*58,!!
HLABB, Bw4! N!(asparagine)! T!(threonine)! B*13,!B*27,!B*37,!B*44!HLABB, Bw4! D!(aspartic!acid)! T!(threonine)!
HLABB, Bw4! S!(serine)! T!(threonine)!
HLABB, Bw6! G!(glycine)! N!(asparagine)! B*7,!B*8,!B*14,!B*18,!B22,!B*35,!B*39,!B*45,!B*55,!B*56,!B*62,!B*64!HLABB, Bw6! S!(serine)! N!(asparagine)!
HLABC, C1! ! N!(asparagine)! Cw1,!Cw7,!Cw8,!Cw9,!Cw10,!Cw12,!Cw13,!Cw14,!Cw16!




positions' 77' and' 80' as' shown' in' table& 5.1! (Gumperz,) Barber) et) al.) 1997,"Kulkarni,*Martin*et*al.*2008)."'












5.1.3,KIR2DS3,The!microarray!and!qPCR!gene!expression!experiments!described! in!Chapter!4!suggested! a! role! for! the! activating! receptor! KIR2DS3! in! LT! HCV.! There! was!higher!gene!expression!of!KIR2DS3!in!LT!HCV!compared!with!both!LT!nonMHCV!and!healthy!controls.!Therefore! I! sought! to!assess!whether! the!presence!of! the!KIR2DS3! allele! was! associated! with! NK! activation.! There! was! no! statistical!difference! in! the!presence!of!KIR2DS3!between!LT!nonMHCV!and!LT!HCV!(26%!vs.! 32%! respectively,! p=0.61).! However,!within! the! LT! cohort,! the! presence! of!the!KIR2DS3!allele!was!associated!with!higher!expression!of!NCRs!(figure,5.5).!In!all!patients! there!was!higher!NKp46!expression! in! the!presence!of!KIR2DS3!(p=0.004),!and!within!the!LT!HCV!subgroup!increased!expression!of!both!NKp30!(p=0.04)!and!NKp46!(p=0.02)!were!associated!with!KIR2DS3.!!
!
Figure'5.5'NK'activation'and'KIR2DS3.'











































5.1.4,HLA,matching,,The!key!question!of!whether!HLA!mismatching!influences!NK!alloreactivity!was!addressed!by!comparison!of!NK!activation!between!HLAMB!and!MC!matched!and!mismatched!LT!recipients.!The!analysis!of!NK!activating!receptor!expression!in!CD56dim! NK! cells! is! summarised! in! figure, 5.6.! There! was! no! difference! in!expression!of!NKp30,!NKp46!or!NKG2D!in!either!HLAMC!of!HLAMB!mismatched!LT!compared!to!matched!LT.!Consistent!with!these!phenotyping!data,!no!differences!in! cytotoxicity! were! found! between! HLA! matched! and! mismatched! groups!(figure,5.7).'
'
Figure'5.6'HLAJB'and'JC'matching'and'NK'activation. 


















































HLA B matched vs mismatched All

























HLA B matched vs mismatched All























C:8 All8 n=17,8 non"HCV8 n=10,8 HCV8


















































































































































(mismatched), LT)., In, the, HCV, LT, subgroup, NKp30, expression, was, higher, in,Bw4Bw6:Bw4Bw6& (matched)& LT& compared& with& Bw6Bw6:Bw4Bw4& LT&(mismatched).- In- LT- nonMHCV$ no$ donor:recipient$ HLAMC" combinations" were"associated)with)NKp46)expression.)Nkp46)expression)was)significantly)higher)in)Bw4Bw6:Bw4Bw6&(matched)&LT&compared&with&Bw4Bw6:Bw6Bw6&(matched&LT&in# all# patients# and# this# remained# the# case# in# both# the# HCV# and# nonMHCV$subgroups.)NKp46)was#also#higher#in#Bw4Bw6:Bw4Bw6#(matched)#LT#compared#with% Bw6Bw6:Bw6Bw6% (matched)% LT% in% the% whole% cohort% and% nonMHCV$subgroup.) Finally,) in) the) whole) cohort,) Bw4Bw6:Bw4Bw6) (matched)) LT) was)associated)with)higher)NKp46)expression)than)Bw6Bw6:Bw4Bw6)(mismatched))LT.!
'
Figure'5.8'HLAJC'matching'subtypes'and'NCR'expression.'
Comparisons8were8made8 between8 each8 donor/recipient8HLA"C8 pairing8 subtype.8One"way8


















































































































ANOVA8was8 used8 to8 determine8 if8 there8 was8 a8 significant8 difference8 between8 the8means,8
with8Tukey’s8correction8for8multiple8comparisons.888The8donor8and8recipient8genotypes8and8
the8 number8 of8 patients8 in8 each8 subgroup8 are8 indicated8 below8 each8 graph.8 *p<0.05;8

























































































































































Donor C2 missing All























Donor C2 missing HCV
















5.1.5,HLABC/KIR,matching,,Inhibitory!signaling!in!the!HLAMC/KIR2DM!system!is!determined!by!the!strength!of! the! signal! transduced! by! the! KIRMligand! interaction.! Binding! and! functional!studies! have! established! that! the! binding! of! KIR2DL1! with! HLAMC2! is! the!strongest! inhibitory! combination,! followed! by! KIR2DL2/HLAMC1,! with!KIR2DL3/HLAMC1! conferring! the! weakest! inhibition! (Winter,! Gumperz! et! al.!1998,! Moesta,! Norman! et! al.! 2008).! It! has! been! hypothesized! that! these!differences! in! inhibitory! signaling! result! in! variable! susceptibility! to! disease.!Khakoo! et8 al8 (2004)! found! KIR2DL3/HLAMC1! was! associated! with! greater!resolution! of! acute!Hepatitis! C! infection!was! compared!with!KIR2DL2/HLAMC1!and! KIR2DL1/HLAMC2.! The! authors! postulated! that! the! weaker! inhibitory!signaling! conferred! by! KIR2DL3/HLAMC1! is!more! easily! overcome,! resulting! in!stronger!NK!antiviral!responses.!These!data!were!independently!corroborated!in!a!subsequent!study!(Romero,!Azocar!et!al.!2008).!Furthermore!in!pregnancy,!the!combination! of!maternal! KIR2DL1! and! fetal! HLAMC2! has! been! associated!with!recurrent!miscarriage,!growth!retardation!and!preMeclampsia!(Hiby,!Walker!et!al.!2004).!This!is!thought!to!be!because!the!stronger!inhibitory!combination!renders!uterine!NK!cells!hypofunctional,!providing!susceptibility!to!the!disorders.!!!I! sought! to! investigate!whether! the!variability!of! inhibitory!signaling!conferred!by! the! HLAMC/KIR2DM! combinations! had! significant! influence! on! NK! activating!receptor!expression!within!our!study!cohort!of!LT!recipients.!As!all! individuals!carry! KIR2DL1,! the! analysis! focused! on! KIR2DL2! and! KIR2DL3! alleles! in!combination! with! donor! HLAMC1C1! homozygous! and! HLAMC1C2! heterozygous!genotypes.!Activating!receptor!expression!was!compared!between!each!possible!
!!
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5.2,Association,of,HLA,and,KIR,genotypes,with,clinical,outcomes,!Thus!far!the!cellular!assays!have!demonstrated!that!HLA!and!KIR!genotypes!have!little!bearing!on!NK!cell! activation.!Few!previous! studies!have! investigated! the!influence!of!genetics!and!recipient!NK!cell!function,!but!have!focused!on!clinical!outcomes!such!as!rejection,!or!graft!and!patient!survival.!As!the!studied!cohort!was!taken!from!allograft!recipients!attending! liver!outpatient!clinics!and!donor!genotyping! was! only! available! for! the! current! graft,! assessment! of! graft! and!patient! survival! were! not! applicable! readouts! of! relevant! clinical! outcomes.!Instead,!episodes!of!acute!cellular!rejection,!and!degree!of!fibrosis!at!liver!biopsy!were!considered!more!appropriate!markers!of!clinical!outcome.!This!information!was! obtained! through! patient! clinical! records! and! departmental! databases.!
Table, 5.2, shows! the!number!of!patients! in!whom!genotyping!and!biopsy!data!were! available,! as!well! as! the! number! of! patients! diagnosed!with! at! least! one!episode! of! acute! cellular! rejection! (ACR).! For! the! purposes! of! this! analysis,! an!episode!of!ACR!was!attributed!if!there!was!a!diagnosis!of!ACR!made!on!the!basis!of!clinical,!biochemical!and/or!(but!not!necessarily)!biopsy!information.!! !
!!
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,, Number, , ,
Recruited, 109! ! !
HLABC,, ! ! !
,,,,Donor, 97! ! !
,,,,Recipient, 98! ! !
,,,,Both, 87! ! !
,HLABB, ! ! !
,,,,Donor, 102! ! !
,,,,Recipient,, 79! ! !
,,,,Both, 72! ! !




, Non"HCV8 HCV8 8
Episode,of,ACR, 12! 1! p=0.298
Fibrosis,score,0B3, 33! 16! 8
Fibrosis,Score,4B6, 1! 8! p=0.00258
Table'5.2'Genotyping'and'clinical'outcome'data.'
The8 number8 of8 patients8 in8 whom8 donor8 and/or8 recipient8 HLA/KIR8 genotyping8 was8
available8is8shown,8as8well8as8the8number8with8each8of8the8analysed8clinical8outcomes.8HCV8
was8 significantly8 associated8 with8 advanced8 fibrosis8 (but8 not8 ACR),8 and8 thus8 fibrosis8
analysis8was8performed8only8within8the8HCV8subgroup.88
8Fibrosis! stages! were! divided! into! early! stage! fibrosis! (fibrosis! score! 0M3)! or!advanced! fibrosis! (fibrosis! score! 4M6)! according! to! the! Ishak! scoring! system!(Ishak,!Baptista!et!al.!1995).!Of!the!total!cohort!of!109!liver!transplant!recipients,!both! donor! and! recipient! HLAMC! and! HLAMB! genotyping! was! available! in! 87!(80%)!and!72!(66%)!patients!respectively.!Both!donor!HLAMC!and!recipient!KIR!typing!were!available!in!94!(86%)!of!cases.!ACR!occurred!in!13!(12%)!patients!and!a!biopsy!was!available! in!58!(53%).!Of! the!patients!with! liver!biopsy!data,!only!1!of!34!!(3%)!nonMHCV!recipients!had!advanced!fibrosis,!compared!with!8!of!24!(33%)!HCV!recipients! (p=0.0025).! In!contrast,!ACR!was!not!associated!with!HCV!infection!status!(p=0.29),!with!only!one!HCV!LT!recipient!experiencing!ACR.!!
!!
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7/64      5/42ACR/TOTAL
Non HCV






6/48      5/33
HCV








1/15        0/9
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6/43               2/30ACR/TOTAL










6/31               2/25











































































5.2.2,Fibrosis,,Acute! cellular! rejection! may! be! a! shortMterm! marker! of! alloreactivity! in! liver!transplantation,! as! it! occurs! most! commonly! within! three! months! of! the!operation.! Practical! longerMterm! assessment! of! allograft! damage! is! a! more!challenging!task!as!differentiating!between!chronic!rejection,!disease!recurrence!or!de!novo! liver! disease! is! often! not! possible! on! the! basis! of! clinical! signs! and!biochemical!investigations.!The!gold!standard!for!assessing!the!state!of!the!graft!is!histological!assessment!of!a!liver!biopsy.!However,!this!is!not!routinely!carried!out! post! transplant,! and! only! performed! if! clinically! required.! In! the! recruited!cohort!of!patients,!34!nonMHCV! transplant! recipients!underwent!a! liver!biopsy,!but!the!majority!of!these!were!early!postMtransplant!(median!time!to!biopsy!11!months!post!transplantation)!for!assessment!of!acute!cellular!rejection.!Only!1!of!the! LT! nonMHCV! recipients! had! advanced! fibrosis,! and! none! had! chronic!rejection,!and!thus!within! this!cohort! it!was!not!possible! to!assess! the!effect!of!genotype!on!longMterm!outcomes.!!!However!the!hepatitis!C!cohort!did!provide!an!opportunity!to!study!the!influence!of!genetics!with!longerMterm!outcomes,!as!liver!biopsies!are!routinely!carried!out!on! a! yearly! basis.! This! is! because! hepatitis! C! recurrence! is! universal,! and!reinfection! of! the! graft! very! often! leads! to! accelerated! liver! fibrosis,! with!cirrhosis!occurring!in!up!to!30%!of!grafts!at!5!years!(Gane,!Naoumov!et!al.!1996,!Forman,! Lewis! et! al.! 2002).! This! can! lead! to! graft! failure! and! need! for! reMtransplantation.!For!this!reason,!regular!histological!assessment!of!liver!damage!is! carried!out!with! liver!biopsy.! It! is! known! that!NK! cells! are! important! in! the!immune! response! to! hepatitis! C,! and! in! the! nonMtransplant! setting,! HLAMKIR!
!!
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B!matched!patients,!although!this!did!not!reach!statistical!significance!(p=0.110,!Fisher’s! exact! test).! No! other! associations! were! observed! between! matching!(including!subtypes)!and!advanced!fibrosis!in!post!LT!HCV.!
!
Figure'5.20'HLA'matching'and'fibrosis.''
Associations8 between8HLA"B8 or8 "C8matching8 and8 fibrosis8 stage8 at8 biopsy8were8 analysed.8
The8numbers8in8each8group8are8indicated8below8the8bars.8
















































































5.3,Discussion,,!The!data!presented!in!this!chapter!describe!a!detailed!analysis!of!the!influence!of!KIR! and! HLA! genotyping! on! NK! activation! in! liver! transplantation.! The!associations!between!genotyping!and!clinical!outcomes!are!also!presented.!!!When! assessing! the! effects! of! KIR! genotype,! individuals! were! divided! into!haplotypes!A!and!B!according!to!KIR!gene!content.!As!haplotype!B!contains!more!activating! receptors,! one! might! hypothesise! that! NK! cells! from! haplotype! B!individuals! would! have! a! more! activating! phenotype.! However,! the! functional!assays!did!not!demonstrate!any!effect!of!haplotype!on!activation.!The!function!of!the!activating!KIR!is!poorly!understood!and!the!lack!of!association!between!KIR!haplotype! and! function! implies! that,! in! LT! at! least,! the! KIR! do! not! influence!recipient! NK! cell! alloreactivity! or! tolerance.! This! is! consistent! with! the!phenotyping! and! functional! data! presented! in! Chapter! 3,! which! demonstrated!that! the! tolerised! phenotype! of! NK! cells! was! independent! of! inhibitory! KIR!expression.!!!More! detailed! analyses! of! NCR! expression,! NK! function,! and! clinical! outcomes!according! to! donor! HLA,! recipient! HLA,! and! recipient! KIR! typing! were!performed.!Previous!studies!have!explored!a!possible!protective!role!in!LT!of!the!presence!of!HLAMC2!alleles!in!the!donor,!due!to!the!relatively!stronger!inhibitory!interaction! between! HLAMC2! and! KIR2DL1! (Hanvesakul,! Spencer! et! al.! 2008,!Tran,!Middleton!et!al.!2009).!I!found!no!associations!between!NK!cell!phenotype!or! function! and! the! presence! of! any! HLAMC1,! HLAMC2,! HLAMBw4,! or! HLAMBw6!
!!
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alleles! in!either!donor!or! recipient.! In!addition! the! lack!of!association!between!KIRMHLA!matching!and!NK!phenotype!is!an!important!finding,!further!supporting!the!emerging!theme!that!recipient!NK!cells!do!not!become!tolerised!through!KIRMligand!interactions.!!!The! analysis! of! the! KIR2DS3! allele! provided! interesting! results.! The! trend!towards!increased!carriage!of!the!KIR2DS3!allele!in!HCV!recipients!is!consistent!with! the! gene! expression! data,! and! with! previous! studies! reporting! an!association!between!KIR2DS3!and!chronic!HCV!infection!(Dring,!Morrison!et!al.!2011,! Fitzmaurice,! Hurst! et! al.! 2014).! In! our! cohort,! within! KIR2DS3! carriers!transplanted! for! HCV! infection,! there! was! higher! NCR! expression! and! a! trend!toward!increased!fibrosis.!At!present!little!is!known!about!the!functional!role!of!KIR2DS3! especially! since! transfection! experiments! demonstrate! that! there! is!little!or!no!surface!expression!of! the!protein! (VandenBussche,!Mulrooney!et!al.!2009).! Furthermore! the! ligand! for! KIR2DS3! remains! unknown.! One! possible!explanation!for!our!findings!is!that!KIR2DS3!is! in! linkage!disequilibrium!with!a!gene!(within!the!LRC)!that!has!a!functional!role!in!the!immune!response!to!HCV.!!!The!analysis!of!genetics!and!clinical!outcome!demonstrated!similar! findings,! in!that! there!was! no! association! between!HLAMB! or! –C!matching! and! episodes! of!ACR! or! development! of! fibrosis.! ! The! lack! of! genetic! influence! on! clinical!outcomes!supports! the!current! clinical! strategy!of!not!matching! for!HLA! in!LT.!That! genetics! do! not! seem! to! affect! outcomes,! even! when! specific! KIR/HLA!combinations!are!analysed,!leads!to!the!question!of!why!predicted!‘missingMself’!allospecificity!is!not!observed.!Recipient!NK!cells!lacking!inhibitory!KIR!specific!
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for! donor! HLA! must! have! overMriding! mechanisms! preventing! activation.! One!possible! explanation! is! that! the! presence! of! other! nonMHLA! specific! inhibitory!receptors! such! as! 2B4,! LIR,! and!KLRG1! (described! in! section! 1.1.4.4)! prevents!activation.! Other! KIR! independent! factors! affecting! recipient! NK! functionality!might! include!the! influence!of!cytokines!and!other!cellular! factors!generated! in!the!context!of!LT,!and!interactions!with!other!immune!cells!that!might!regulate!NK!cell!function.!!!In! the! Introduction! chapter! NK! development! and! education!was! discussed! in!detail.! The!maturation! and! education! processes! leading! to! functional! NK! cells!take!place!in!stages!across!different!sites,!including!secondary!lymphoid!tissues.!The! acquisition! of! surface! KIR! is! a! key! stage! in! this! process,! and! as! our! data!shows! that! neither! KIR! genotype! nor! expression! have! an! effect! on! the!development! of! tolerance,! I! propose! that! the! mechanism! leading! to! tolerance!occurs! at! a! stage! of! NK! cell! development! prior! to,! and! independent! of! KIR!expression.!As!such! interactions!between! the! liver!allograft!and!developing!NK!cells!resulting!in!downregulated!activation!are!not!due!to!direct!interference!to!the!licensing!process.!!!The!analysis!presented!in!this!chapter!is!limited!by!several!complicating!factors.!The! heterogeneity! of! underlying! liver! disease! is! one! such! factor,! as! this! may!affect!NK!cell!activity.!Separating!HCV!from!nonMHCV!was!an!attempt!to!control!for!this,!but!I!was!unable!to!further!sub–divide!the!recipient!group!into!specific!aetiologies!because!of! low!numbers.!Viral! infections!other!than!HCV!are!known!to!influence!the!function!of!NK!cells,!which!could!mask!the!effects!of!HLA!and!KIR!
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!The!data!presented!in!the!previous!chapters!provide!evidence!of!functional!and!maturation! alterations! in!NK! cells! taken! from!a! cohort! of! liver! transplantation!recipients!with!comparisons!made!with!a!cohort!of!healthy!control! individuals.!This! crossMsectional! analysis!demonstrates! significant! tolerance! in!LT! recipient!NK!cells.!But!how!do!these!recipient!NK!cell!changes!evolve!with!time!after!liver!transplantation?! To! date! there! have! been! few! studies! assessing! longitudinal!changes! in! recipient! NK! cells! after! transplantation.! In! HSCT,! previous! studies!have!reported!changes!in!frequency!of!NK!subsets!and!impairment!in!reactivity!to!target!cells!in!the!early!post!transplant!period!(Jacobs,!Stoll!et!al.!1992,!Vitale,!Pitto! et! al.! 2000).! The! timing! of! acquisition! of! receptors! and! functionality! by!donor! NK! cells! after! HSCT! has! also! been! described! (Shilling,! McQueen! et! al.!2003).! !An!early! liver! transplantation!study!reported! increased!NK!cytotoxicity!in! HLA!mismatched! versus!matched! grafts! in! the! first! month! post! LT! (Oertel,!Kohlhaw!et!al.!2001);!however!no!longitudinal!changes!were!found.!Subsequent!studies! have! noted! transient! alterations! in! NK! cell! frequency! and! activating!receptor!expression!early!post!LT! that!did!not!persist! at!12months! (Varchetta,!Oliviero!et!al.!2009,!Pham,!PiardMRuster!et!al.!2012).!!Thus,! as! detailed! characterization! of! longitudinal! changes! in!NK! activation! has!not!previously!been!done,!a!longitudinal!study!was!performed,!with!individuals!recruited! at! assessment! for! liver! transplant! eligibility.! In! those! individuals!
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transplanted,! samples!were! taken! at! intervals!postMLT! and!phenotyping! assays!were!performed.!Comparison!of!NK!cell!activation!preM!and!postMtransplant!was!performed!to!assess!the!evolution!of!changes!in!the!first!year!post!LT.!!!! !
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Furthermore! the! timing! of! blood! sampling! proved! problematic.! It! was!anticipated! that! blood! samples! would! be! taken! at! specific! intervals! post!transplant! (eg! at! weeks! 1,! 4,! 8,! 16,! 24,! and! 48),! but! a! combination! of! factors!ultimately! made! this! unachievable.! The! two! main! factors! were! patients! not!attending!scheduled!appointments,!and!the!fact!that!the!appointments!were!at!a!different! site! (Kings! College! Hospital)! from! the! academic! department! and!laboratory!where!I!was!based!(Imperial!College!London).!!
Table, 6.1! shows! the! timing!and!number!of! sample!obtained! in! this! study.!The!number!of!post!transplant!samples!collected!ranged!from!1M3!collected!between!week!7!and!week!49!postMtransplant.!!!
Patient, Timing,of,sample,post,liver,transplant!
#1, Week!7! ! !
#2, ! Week!36! Week!49!
#3, ! ! Week!45!
#4, Week!8! Week18! Week!36!
#5, Week!8! ! Week!34!
#6, Week!9! ! Week!30!













displayed.8 The8 proportion8 of8 NK8 cells8 did8 not8 significantly8 change,8 but8 in8 28 individuals,8
there8was8a8substantial8increase8post8LT.8The8relative8proportion8of8the8CD56bright8subset8of8
NK8 cells8 reduced8 in8 58 of8 the8 78 patients,8 and8modestly8 increased8 in8 the8 other8 2.8C' and' D8
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6.2,Activating,receptor,expression,The! expression! of! the! NK! cell! activating! receptors! NKp30,! NKp46! and!NKG2D!were!assessed! through!FACS!analysis!as!described! in! the!crossMsectional!study.!The!expression! levels!as!determined!by!MFI!were!compared!between!preM!and!post!transplant!samples.!The!results!are!depicted!in!figure,6.3.!!!
Figure'6.3'Longitudinal'changes'in'activating'receptor'expression.'
AJC8 shows8 the8 individual8 patient8 data8 comparing8 pre"LT8 with8 mean8 post8 LT8 activating8
receptor8expression.8There8were8no8consistent8changes8of8any8of8the8receptors8analysed.8DJ
F:8 pooled8 data8 categorizing8 the8 post8 LT8 samples8 into8 time8 periods.8 NKp308 expression8
declined8 to8 week8 34,8 with8 levels8 recovering8 by8 week8 50.8 NKp468 expression8 initially8
upregulated8 to8 week8 128 but8 then8 declined8 to8 week8 50,8 whereas8 NKG2D8 expression8
remained8stable.88!Overall! there!was!no!consistent!downM!or!upMregulation!of! receptor!expression!observed.!The!individual!patient!data!is!shown!in!figure,6.3ABC!and!the!pooled!data! categorizing! samples! into! time!periods!post!LT!are! summarised! in! figure,
6.3DBF.!There!was!a!slight!reduction! in!NKp30!expression!between!preMLT!and!
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week! 34! postMLT! which! returned! to! baseline! between! weeks! 34! and! 50.!Conversely,! NKp46! expression! increased! at! weeks! 0M12,! and! then! steadily!declined! up! to! week! 50! postMLT.! The! levels! of! NKG2D! remained! stable!throughout!the!12Mmonth!followMup!period.!!!
6.3,Longitudinal,changes,in,NKG2C,and,CD16,expression,!As!altered!NK!cell!maturation!was!shown!to!be!associated!with!a!tolerant!NK!cell!phenotype,!with!increased!NK!cell!expression!of!NKG2C!demonstrated!in!LT,!the!surface!expression!of!maturation!markers!NKG2C!and!CD16!was!also!evaluated!in!the!longitudinal!cohort.!!There!was!a!wide!variation!in!baseline!CD16!expression!preMLT!as!seen!in!figure,
6.4A.!There!was!no!significant!change! in!the!mean!post!LT!expression!of!CD16!and! this! was! also! true! of! NKG2C! expression! (figure, 6.4B).! The! changes! in!expression! of! these!markers! over! the! 12Mmonth! period! are! depicted! in, figure,










6.4,Discussion,!In! this!study!an!attempt!an!attempt!was!made!to!elucidate!the!evolution!of!NK!cell! changes! towards! the! tolerant! phenotype! previously! described.! Somewhat!surprisingly,! the! crossMsectional! findings! were! not! recapitulated,! with! no!significant!changes!in!NK!activation,!and!no!alterations!in!NK!subsets.!!!One! possible! explanation! for! these! disparate! findings! is! that! NK! tolerance!through! hypofunctionality! develops! over! a! longer! time! period! than! the! 12!
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months! evaluated! in! this! study.! Perhaps! repeated! and! prolonged! interactions!between! recipient!NK! cells! and! the! graft! are! required! in! order! to!promote! the!conditions! necessary! for! NK! cell! tolerance.! This! would! be! consistent! with! an!anergy!type!model!of!NK!tolerance,!whereby!persistent!NK!stimulation!leads!to!exhaustion!and!hypofunctionality.!Two!previous!studies!have!evaluated!NK!cell!changes! longitudinally! post! LT.! In! a! paediatric! cohort! increased! expression! of!both!NKp30!and!NKG2D!was!observed!in!the!first!week!post!transplant,!and!this!subsequently! returned! to!baseline! (Pham,!PiardMRuster!et!al.!2012).!There!was!also!a!reduction!in!total!circulating!NK!cells!early!post!transplant!but!once!again!this!did!not!persist.! !The!second!study!evaluating!NK!changes!in!recurrent!HCV!infection!after!liver!transplantation!also!reported!a!transient!decrease!in!NK!cells!early!post!transplant,!but!no!persistent!changes!(Varchetta,!Oliviero!et!al.!2009).!There!was!also!a!transient!decrease!in!NKG2D!and!a!slowly!progressive!increase!in!NKG2C! positive!NK! cells,! but! no! changes! in!NCR! expression!were! reported.!These! studies! are! largely! consistent! with! the! data! presented! in! this! chapter,!demonstrating! little! persistent! measurable! changes! overall! in! NK! activating!phenotype!in!the!first!12!months!after!liver!transplant.!The!differences!that!are!present! could! be! attributed! to! the! distinctive! patient! cohorts! –! ie.! paediatric!patients!and!HCV!infection.!!!The!major!weaknesses! in! this! longitudinal! study! relate! to! the! lack! of! numbers!and! inconsistency! in! sample! collection! post! transplant.! Whilst! a! reasonable!number! of! patients! were! initially! recruited! (28),! the! problems! with! dropMout!were! not! anticipated.! In! particular,! the! followMup! of! patients! at! geographically!distant!sites!(Belfast!and!Plymouth)!presented!a!genuine!challenge.!I!established!
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!!Natural!killer!cells!are!key!effectors! in! the! immune!response! to!cellular! insults!caused!by!viral! infection!and!tumour! transformation.!The!mechanisms!through!which! NK! cells! discriminate! between! self! and! nonMself! are! pivotal! in! their!function!as!early!players! in! the! immune!response.! Importantly,!NK!cells!do!not!depend!on!preMsensitisation! and! recognition!of! specific! alloantigens! to!become!activated,!as!employed!by!TM!and!BMcells.!Rather,! in!health,!NK!cells!are!kept! in!constitutive! inhibition! through! dominant! interactions! between! inhibitory!surface! receptors! and!MHC! classMI! ligands,!which! are! present! on! healthy! cells.!The!KIR!comprise!the!major!family!of!polymorphic!inhibitory!NK!cell!receptors!recognizing!HLAMA,! MB!and!–C! ligands.!Several! layers!of!complexity!exist!within!the!KIRMHLA!system,! the!nuances!of!which!have!only! recently!been!elucidated.!!For! instance!KIR!and!HLA!class! I!are!highly!polymorphic!and!NK!receptors!are!expressed!in!a!stochastic!fashion!so!that,!even!within!an!individual,!there!is!great!variability! of! receptor! expression! between! clones.! Furthermore! strength! of!binding!and!inhibitory!signal!transduction!between!KIR!and!HLA!vary!depending!on!the!specific!KIR!and!HLA!allelic!subtypes.!!Thus!there!is!extensive!variation!in!NK! cell! repertoire,! target! cell! specificity! and! activation! threshold! within! an!individual,!between!individuals!and!at!the!population!level.!!In! order! to! ensure! that!NK! cells! are! not! autoMreactive,! they! undergo! a! process!termed!‘education’,!whereby!only!those!cells!expressing!inhibitory!receptors!for!self!are!allowed!to!mature!and!develop!full!functionality!(termed!‘licensing’).!It!is!
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here! that! our! understanding! of! NK! cell! biology! is! limited,! as! although! several!plausible!mechanisms! for!NK!education!and! licensing!have!been!proposed,! full!characterization!of!the!processes!involved!remains!elusive.!!!Organ!transplantation!presents!a!particular!challenge!when!it!comes!to!NK!cell!reactivity.! Recipient! NK! cells! would! be! predicted! to! be! alloreactive! to! donor!grafts!in!any!scenario!where!the!donor!expresses!HLA!that!is!not!present!in!the!recipient! (HLA!mismatch).! In! liver! transplantation! this! situation! is! common,!as!HLA!matching! is! not! routinely! employed.! Yet! in! clinical! practice! NKMmediated!rejection!is!not!observed!and!outcomes!are!generally!good.!Little!is!known!as!to!the! functionality! of! recipient! NK! cells! in! LT! or!whether! HLA!mismatch! causes!activation.! Additionally,! conflicting! data! has! caused! controversy! as! to!whether!any!donor!or!recipient!HLA!allotype!confers!a!benefit!in!LT.!!!The! role! of! NK! cell! reactivity! after! solid! organ! transplantation! is! currently!unresolved.!The!conventional!view!that!NK!cells!do!not!significantly!contribute!to!alloreactivity!was!based!on!early!NK!depletion!studies!in!animals.!Since!then,!a!number! of! animal! models! have! shown! that! NK! cells! may! well! influence! graft!tolerance!(Dresske,!Zhu!et!al.!1997,!Russell,!Chase!et!al.!2001,!Uehara,!Chase!et!al.!2005,!Uehara,!Chase!et!al.!2005,!Feng,!Ke!et!al.!2009).!!!The! phenotype! and! function! of! recipient! natural! killer! cells! after! liver!transplantation!was!assessed!using!flow!cytometry!based!assays.!I!found!several!key! differences! in! NK! cells! between! LT! recipients! and! healthy! controls.! In! LT!there!was!an!increase!in!the!relative!abundance!of!immature!CD56bright!NK!cells!
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compared! to! CD56dim.! I! showed! that! the! mature! CD56dim! subset! has! a!downregulated! activating! phenotype,! with! reduced! expression! of! the! natural!cytotoxicity! receptors! NKp30! and! NKp46! but! not! downregulation! of! NKG2D.!Furthermore,! in! KIR+! NK! cells,! which! are! conventionally! considered! to! be!‘licensed’,!the!difference!in!receptor!expression!was!most!striking.!!!CD56bright!and!CD56dim!dim!NK!cells!form!distinct!subsets,!differing!in!their!stage!of!maturation,!cytotoxicity,!cytokine!production!and!KIR!expression.!During!NK!cell! development! NK! cells! mature! from! CD56bright! into! CD56dim! cells,! and!therefore! the! data! suggests! that! in! the! presence! of! a! liver! allograft,! NK! cell!maturation!alters,!with!down!regulation!of!activating!receptors!between!the!two!stages!of!development.!!!NK!cell! function!was!assessed! through!response! to! incubation!with!K562!cells.!This!cell! line!stimulates!activation!of!NK!cells!and! is!highly!sensitive! to!NK!cell!killing!as!it!lacks!expression!of!MHC!class!I.!In!LT!there!was!significantly!reduced!NK!killing!of!K562!cells!as!measured!by!specific!cytotoxicity.!The!other!readMouts!of! NK! function! analysed! were! surface! expression! of! CD107a! (LAMPM1),! and!intracellular!expression!of!the!cytokines!IFNγ!and!TNFα.!Compared!with!healthy!controls,! in! LT! there! was! reduced! expression! of! CD107a! and! IFNγ! after!incubation!of!NK!cells!with!K562!cells.!!!These!data!provide!evidence!of!altered!development!of!recipient!NK!cells!in!liver!transplantation.!NK!cell!precursors!arise!from!CD34+!haematopoeitic!progenitor!cells!and!therefore!early!development!occurs!in!the!bone!marrow.!(Raulet!1999,!
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Colucci,!Caligiuri!et!al.!2003,!Yokoyama,!Kim!et!al.!2004).!However,!the!pathways!and! location! of! NK! cell! development! and! maturation! have! not! been! fully!characterised.!There!is!some!evidence!that!committed!NK!cell!precursors!traffic!from! the! bone! marrow! into! secondary! lymphoid! tissue! (SLT),! such! as! lymph!nodes!where!terminal!differentiation!occurs!in8situ8(Di!Santo!2006).!The!NK!cells!in! SLT! are! nearly! all! CD56bright,! whilst! the! majority! (~90%)! of! circulating!peripheral! blood! NK! cells! are! CD56dim,! and! it! is! generally! understood! that!CD56bright!NK! cells!mature!directly! into!CD56dim! cells! (Caligiuri!2008).!The! less!mature!CD56bright!subset!are!potent!producers!of!cytokines,!but!do!not!kill!target!cells!efficiently,!unlike!their!more!differentiated!CD56dim!counterparts.!In!our!LT!recipient!cohort,! the!higher!relative!abundance!of!peripheral!CD56bright!NK!cells!is! suggestive! of! a! change! in! maturation! induced! by! allograft.! ! An! increase! in!CD56bright! proportion! has! been! observed! in! other! conditions! including!immunodeficiency! and! chronic! infection! (Zimmer,! Bausinger! et! al.! 2007,!Barcelos,! SathlerMAvelar! et! al.! 2008,! VillaMForte,! de! la! Salle! et! al.! 2008).! In! our!study,!the!observed!downregulation!of!activation!in!CD56dim!NK!cells,!but!not!in!the!CD56bright! subset!suggests! that!LT! induces!a!maturation!defect!between!the!two! stages! of! NK! development,! and! that! this! results! in! hypofunctionality.! A!similar! observation!was! recently! reported! in!NK! cells! from! an! individual!with!suspected!immunodeficiency!exhibiting!a!maturation!defect!leading!to!increased!CD56bright! NK! cells,! and! CD56dim! cells! which! could! not! acquire! a! terminally!differentiated!phenotype!(Domaica,!Fuertes!et!al.!2012).!!The!limited!data!from!the!longitudinal!cohort!suggests!that!the!changes!observed!in! recipient!NK! cells! do! not! occur! during! the! first! 12!months! after! LT.! This! is!
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consistent!with!previous! studies!demonstrating!modest! changes! in!NK! subsets!and! activating! receptor! expression! very! early! on! after! LT! but! few! persistent!phenotypic! changes! at! one! year! (Varchetta,! Oliviero! et! al.! 2009,! Pham,! PiardMRuster!et!al.!2012).!The!disparate! findings!between! the! longitudinal!and!crossMsectional! study! (where! median! follow! up! was! 55! months)! implies! that! the!development! of! tolerant! NK! tolerance! is! a! slow,! evolving! process.! It! may! be!postulated! that! this! requires! multiple! interactions! between! recipient! NK! cells!and! the! liver!allograft;! the! repeated! interactions! could! result! in! the!altered!NK!maturation,! and! associated! hypofunctionality! or! even! exhaustion,! in! a! process!analogous!to!the!anergy!that!occurs!in!T!cells.!!!The! lifespan! of! NK! cells! is! of! particular! importance! when! considering! the!recipient! immune! response! to! solid! organ! transplantation.! Until! relatively!recently,! the! dogma! has! been! that! mature! NK! cells! in! the! periphery! were!terminally!differentiated!and!unable!to!proliferate.!A!mature!NK!cell!was!thought!to!die!soon!after!performing!its!effector!functions!after!activation,!or!if!it!did!not!become! activated,! it! would! be! shortMlived,! dying! with! a! halfMlife! of! around! 2!weeks! (Jamieson,! Isnard! et! al.! 2004).! However! more! recent! data! in! mice! and!humans!has!demonstrated! that!NK!cells!are!able! to!become! longMlived!and! last!several! months! or! even! years! after! becoming! activated! (Cooper,! Elliott! et! al.!2009,! Sun,! Beilke! et! al.! 2011).! Therefore! it! is! likely! that! in! the! setting! of! liver!transplantation,!mature!recipient!NK!cells,!educated!and!licensed!pre!transplant,!persist! in! the! periphery! for! at! least! a! few! months.! These! NK! cells! maintain!functionality! and! this! could! explain! why! the! tolerant! phenotype! was! not!
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observed! in! the! longitudinal! analysis,! assessing! NK! activation! in! the! first! 12!months.!!!Several!studies!have!demonstrated!that!donor!immune!cells!within!the!engrafted!liver,! soMcalled! passenger! leucocytes,! persist! within! the! recipient! (Schlitt,!Kanehiro! et! al.! 1993,! Lukomska,! Winnock! et! al.! 1997).! Circulating! donor!haematopoietic! cells! can! be! found! in! the! recipient! for! up! to! 4! weeks! post!transplant! it!has!been!postulated! that! this!donor!chimerism!explains!why! liver!transplants!are!tolerogenic!(Starzl,!Demetris!et!al.!1993,!Rao,!Starzl!et!al.!1996,!Verdonk,! Haagsma! et! al.! 2011).! Given! that! the! liver! immune! population! is!enriched!with!NK!cells,!comprising!up!to!40%!of!hepatic!lymphocytes!(Nakatani,!Kaneda! et! al.! 2004),! NK! chimerism! potentially! plays! an! important! role! in! the!recipient! immune! response.! Moroso! and! colleagues! (2010)! assessed! the!phenotype! and! function! of! donor! derived!NK! cells! after! LT.! They! found! that! a!high! proportion! of! hepatic! NK! cells!were! CD56bright! which! unusually! exhibited!strong! cytotoxicity,! and! they! proposed! that! these! could! exert! alloreactivity!against! recipient! immune! cells! entering! the! liver,! thus! protecting! the! allograft.!They!also!noted!that!donor!CD56dim!NK!cells,!B!cells,!dendritic!cells,!macrophages!and! T! cells! mix! with! recirculating! recipient! NK! cells! for! up! to! 2! weeks! post!transplant.! This! provides! a! potential! mechanism! for! donorMrecipient! immune!interactions!to! influence!the!recipient!NK!response! in! the!early!post! transplant!period.!However,!as!the!chimerism!is!not!thought!to!persist!beyond!a!month,!it!is!not!clear!whether!it!has!a!significant!influence!in!the!longer!term.!!!None!of!the!reduced!activation!phenomena!were!observed!in!NK!cells!from!liver!
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transplant! recipients! with! HCV! infection.! I! propose! that! this! is! related! to! the!opposing! effects! of! LT! on! NK! cells! (NCR! downMregulation)! and! HCV! infection!(NCR!upMregulation).!!In!the!nonMtransplant!HCV!setting,!NK!cells!are!thought!to!be! chronically! activated,! and! have! been! shown! to! express! higher! levels! of!activating! receptors! NKp30,! NK44,! NKp46! and! NKG2D! (De! Maria,! Fogli! et! al.!2007,! Ahlenstiel,! Titerence! et! al.! 2010,! Harrison,! Ettorre! et! al.! 2010)! with!increased! cytotoxicity! (Duesberg,! Schneiders! et! al.! 2001,! GoldenMMason,!MadrigalMEstebas!et! al.! 2008,!Oliviero,!Varchetta! et! al.! 2009,!Yoon,! Shiina!et! al.!2009).! Furthermore,! in! a! recent! published! study,! intrahepatic!NK! cells! in!HCV!infection! were! shown! to! retain! functionality! against! target! cells! (Cosgrove,!Berger!et!al.!2014).! !As!HCV!recurrence! is!universal!after! liver! transplantation,!this!may! similarly! result! in! recipient!NK! cell! activation.!My! data! suggests! that!this!does!indeed!occur,!and!overcomes!transplant!related!hypofunctionality!and!tolerance.!!As! well! as! exhibiting! a! hypofunctional! phenotype,! I! demonstrated! that! LT!recipient! NK! cells! have! altered! gene! expression! in! pathways! particularly!involving!activation!and!cell!differentiation.! Specifically! I!discovered! that! in!LT!recipients!there!are!reduced!levels!of!STAT4!mRNA!with!associated!reduction!in!STAT4!phosphorylation! in! response! to! ILM12! stimulation.! ! I! propose! that! these!changes!in!the!STAT4!signalling!pathway!are!related!to!the!NK!hypofunctionality!and! altered! maturation! observed! in! LT! recipients.! ! The! low! levels! of! STAT4!observed!are!not!related!purely!to!an! increase! in!the!CD56bright!subset!as! it!has!been! shown! that! STAT4! levels! are! similar! between! the! CD56dim! and! CD56bright!subsets! in! humans! (Yu,! Mao! et! al.! 2010).! The! gene! expression! data! also!
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demonstrated!a!trend!towards!lower!expression!of!IKZF2,8also!known!as8helios,8in! LT! recipient! NK! cells.!Helios! encodes! a!member! of! the! Ikaros! transcription!factor! family,! and! in! a! murine! model,! helios! downregulation! was! shown! to!regulate! NK! cell! reactivity! via! NKp46! (NarniMMancinelli,! Jaeger! et! al.! 2012).!Interestingly! the! authors! postulated! that! NKp46! engagement! actually!downregulates!NK! cell! responsiveness! and! that! silencing! of!helios! restores!NK!activation,!in!an!MHCMindependent!education!process.!Our!data!provides!further!evidence! that! helios! may! be! involved! in! altered! NK! differentiation,! with!associated!downMregulation!of!NKp46.!!!!The!development!of!NK!cells!between!mice!and!humans!is!difficult!to!compare!as!mice!do!not!have!CD56!as!an!NK!cell!marker,!and!therefore!it!is!difficult!to!draw!exact! parallels! between! the! two! species.! ! However! consistent! with! miRM155!being! a! STAT4! target! in! both! species! I! observed! downregulation! of! this!microRNA! in!NK!cells! from!LT!patients.! ! Interestingly! in! the!mouse!miRM155! is!important! for! viral! driven! NK! cell! proliferation! and! NK! “memory”! responses!(Zawislak,!Beaulieu!et!al.!2013).!!In!its!absence!there!are!more!mature!NK!cells.!!As!I!found!increased!NKG2C!expression!in!LT!nonMHCV,!but!not!LT!HCV,!my!data!suggests! that! in! humans,! miRM155! may! also! be! associated! with! NK! cell!maturation!and!their!response!to!viral!infection.!!The! effect! of! immunosuppressive! drugs! used! in! transplantation! on!NK! cells! is!controversial.!A! study!analysing!phenotypic!and! functional! changes! in!NK!cells!incubated! with! Cyclosporine! in8 vitro! demonstrated! a! reduction! in!
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CD56dimCD16+KIR+! NK! cells! but! these! cells! retained! their! cytotoxicity,! and!expressed! increased! NKp30! (Wang,! Grzywacz! et! al.! 2007).! Several! other!investigations! into! immunosuppressant! effects! of! NK! cells! have! reported!conflicting!results,!and!no!clear!consensus!has!been!reached!(Wasik,!Gorski!et!al.!1991,!Poggi!and!Zocchi!2005,!VacherMCoponat,!Brunet!et!al.!2006,!Wai,!Fujiki!et!al.! 2008,! Kim,! Kim! et! al.! 2010,! Morteau,! Blundell! et! al.! 2010,! Moustaki,!Argyropoulos! et! al.! 2011).! In! order! to! determine! whether! any! of! the! changes!observed! were! the! result! of! immunosuppressive! drugs,! I! performed! in8 vitro8incubation8assays! of!NK! cells!with! commonly! used! immunosuppressants.! Over!90%!of! the! cohort!was! taking! calcineurin! inhibitor!based! immunosuppression,!and! thus! the! assays! were! representative! of! the! recipient! population.! By!performing! the! assays! with! drug! concentrations! spanning! the! therapeutic!ranges,!I!was!able!to!exclude!a!dose!effect!of!the!medications!on!the!expression!of!activating! receptors.! Neither! the! phenotypic,! functional! or! gene! expression!findings! observed! in! recipient! LT! were! recapitulated! in! these! assays.! Whilst!there! are! limitations! to! these! shortMterm! incubation! experiments,! it! is! unlikely!that!the!effects!observed!are!related!to!the!direct!effects!of!immunosuppressive!agents!on!mature!NK!cells,!but!more! likely!due! to!more!complex!effects!on!NK!cell!maturation!during!the!CD56bright!to!CD56dim!transition:!the!point!at!which!NK!cells!acquire!inhibitory!receptors!for!HLAMA,!MB!and!MC.!!!!Consistent! with! this! I! did! not! observe! any! relationship! with! expression! of!inhibitory!receptors,!HLAMC!and!hypofunctionality.!!Thus!it!is!unlikely!that!in!LT!tolerance!of!NK!cells!to!the!allograft!is!mediated!by!KIR:HLAMC!interactions.! !As!the!phenotypic!and!functional!changes!were!largely!seen!in!CD56dim!NK!cells,!but!
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In! summary! I! have! demonstrated! that! after! liver! transplantation! there! is! a!significant!change!within!recipient!NK!cells,!with!an!expansion!of!the!CD56bright!population,! and! downregulation! of! expression! of! the! activating! natural!cytotoxicity! receptors! NKp30! and! NKp46.! This! effect! is! most! marked! in! the!mature! KIR+! CD56dim! subset! of! NK! cells,! and! there! is! associated!hyporesponsiveness,! with! reduced! cytotoxicity,! degranulation! and! cytokine!production.! This! implies! a! defect! in! NK! maturation,! and! to! investigate! this!further,! I!performed!gene!expression!analysis!using!microarray!and!qRT!PCR.! I!demonstrated! that! genes! involved! in! activation! and! differentiation! signalling!pathways!are!differentially!expressed!in!LT!recipient!NK!cells,!and!that!there!is!perturbation! in! the! STAT4! pathway!with! associated! downregulation! of! a!miRM155,!a!key!microRNA!target!of!STAT4.!MiRM155!is!influential!in!NK!maturation!in!mice,!and!our!data!supports!a!role!for!miRM155!in!human!NK!cell!development.!DonorMrecipient! genetic! analysis! demonstrated! no! influence! of! HLAMKIR!matching!on!NK!activation!or!clinical!outcomes,!consistent!with! the!hypothesis!that!NK!tolerance!in!LT!occurs!independent!of!KIRMligand!interactions.!Analysis!of!HCV!infected!LT!recipients!demonstrated!that!the!NK!function!was!preserved,!yet! STAT4! expression! was! still! downregulated.! This! suggests! that! HCV! has! a!counteracting!effect!to!LT!on!NK!cells,!leading!to!activation,!which!abrogates!the!tolerising!effect!of!LT.!!Important! directions! for! future! studies! would! be! aimed! at! further!characterization! of! the!mechanisms! underlying!NK! cell! tolerance.! In! particular!
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study named above. ! 
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5. I understand that donated samples may be used to research the genetic causes of serious diseases. ! 
6. I understand that donated samples will not be used for genetic tests that could adversely affect my 
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7. I understand that if the research produces results that are of direct clinical importance to me, or my 
family, I will be informed. I agree that my GP may also be informed. ! 
8. I understand that it may be necessary to send samples to other institutions for specialist tests. No 
identifying information or clinical information would ever be sent with such samples. 
 
! 
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relevant regulations and which have approval from an independent ethics committee. Under these 
circumstances, my samples would be retained indefinitely in a secure and properly regulated 
biobank for future use [OPTIONAL] 
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participating in this study. ! 
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PATIENT INFORMATION SHEET 
 
 
Title of Research Project: Assessing NK cell function after Liver Transplantation 
Principal Investigators:   Professor Salim Khakoo 
Study number:      
 
 
Dear Sir or Madam, 
 
You are being invited to take part in a research study. Before you decide it is important for you to 
understand why the research is being done and what it will involve. Please take time to read the 
following information carefully and discuss it with others if you wish. 
 
This information sheet aims to explain the purpose of the study and what will happen to you if you 
take part. The later sections give you more detailed information about the conduct of the study.  
 
Ask us if there is anything that is not clear or if you would like more information. Take time to 
decide whether or not you wish to take part. 
 
Thank you for taking the time to read this information sheet. 
 
 
Salim Khakoo      
Professor of Hepatology     
Department of Hepatology   
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Introduction 
The departments of Hepatology at Kings College London and Imperial College London carry out 
research into many different diseases of the liver. These diseases include liver cancer, infections 
and inflammatory diseases.  
 
Our work involves staff at Kings College Hospital, London, and St Mary’s Hospital, London   
 
What is the purpose of this study? 
Liver diseases are an increasingly common problem in the UK and around the world. One of the 
treatments for severe liver disease is liver transplantation. In most patients liver transplantation is 
very successful, but rejection does sometimes occur. The reasons why some people suffer rejection 
whilst others do not are unclear. 
 
We wish to analyse cells from the immune system of patients after liver transplantation to study 
whether there is a link between genetic make-up and rejection of the organ. This may help us 
decide whether specific ‘matching’ patients to livers improves outcomes after liver transplantation. 
 
One of the biggest problems in liver transplantation is that in patients with hepatitis C, the new liver 
almost always becomes infected. This can lead to severe damage and may even result in liver 
failure.  
  
As part of our study, we will analyse immune system cells in patients who have liver transplants for 
hepatitis C. We will compare patients who develop severe re-infection with those that do not, and 
assess whether there are genetic factors involved in determining outcomes. 
 
In summary, our aims are: 
• To understand more about why certain patients suffer rejection after a liver transplant 
• To assess why some patients with hepatitis C have a worse outcome than others. 
 
Why have I been chosen? 
You have been chosen because you are being seen in a clinic or other department that is working 
with us. The doctor or nurse looking after you has suggested that you may be suitable to participate 
in this study. We believe that it would be useful to include your blood in our study for analysis, (or if 
you are having a biopsy, the liver tissue that will be removed as a standard part of your care).  
 
 
In summary, we are asking for volunteers from the following group: 
• Patients who have undergone liver transplantation for chronic liver disease 
 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take part you will be given 
this information sheet to keep and be asked to sign a consent form. If you decide to take part you 
are still free to withdraw at any time and without giving a reason. A decision to withdraw at any time, 
or a decision not to take part, will not affect the standard of care you receive in any way. 
 
 
What will happen if I take part? What do I have to do? 
All patients who agree to participate will be asked to: 
 
• Read and sign a consent form 
• Provide a blood sample. This may be done at the same time as your routine blood tests in 
the clinic or arranged at another time. 20ml of blood will be taken (the equivalent of 4 
teaspoonsful) with a needle from a vein.  
• Allow us to collect some details from your medical records (in strict confidence) 
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• You may be asked to provide further blood samples at the same time as routine blood 
samples are taken as part of your standard care. 
 
The consent form highlights some of the key points about participating in this study. You will be 
asked to initial a number of paragraphs and sign & date the form. You will be given a copy of this 
form. 
 
The whole study will take up to three years to complete, but your involvement would be much more 
limited. Some patients will be asked for a blood sample just once, and others will be asked to 
provide samples at several time points. At most your total participation will be around 1 hour.  
 
You will not have to attend any further extra appointments or undergo any other extra tests. 
 
What if I am to undergo a biopsy. 
If you are going to have a liver biopsy as part of your normal care, your doctor will have explained 
why and what this involves. You will not undergo a biopsy or operation as part of this study. 
 
If you do undergo a biopsy we would look at the results of the standard tests performed as part of 
your routine care. No extra tissue will be taken, other than that which is required for your biopsy or 
operation. You will not have to undergo any extra procedure.  
 
 
What will you do with the samples? 
The samples will be studied in a variety of ways. We will analyse the proteins, DNA and other 
chemicals in them. We will compare the levels of these different chemicals in patients with different 
diseases and outcomes after liver transplantation. 
 
Sometimes it is necessary to send samples to external laboratories – in the UK or abroad – for 
specialist tests. Only anonymised samples would be sent to an external lab, no personal details or 
clinical details about your case would be shared. 
 
What are the possible side effects of taking part? What are the possible disadvantages and 
risks of taking part? 
As you will not receive any extra treatment we do not foresee any potential side effects. 
 
Some patients may develop a bruise after giving a blood sample. This will heal naturally with no 




What are the possible benefits of taking part? 
We do not anticipate any direct benefit to you. However, the information we get may help improve 
the future diagnosis or treatment of people with liver disease. You will not be paid for participating in 
this study. 
 
What if something goes wrong? 
It is highly unlikely that anything will go wrong during your participation in this study. 
 
Imperial College London holds insurance policies which apply to this study.  If you experience 
serious and enduring harm or injury as a result of taking part in this study, you may be eligible to 
claim compensation without having to prove that Imperial College is at fault. !!!!!
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This does not affect your legal rights to seek compensation.  If you are harmed due to someone’s 
negligence, then you may have grounds for a legal action.  Regardless of this, if you wish to 
complain, or have any concerns about any aspect of the way you have been treated during the 
course of this study then you should immediately inform the Investigator (Dr Khaleel Jamil – details 
below).  The normal National Health Service complaint complaints mechanisms are also available to 
you.  If you are still not satisfied with the response, you may contact the Imperial AHSC Joint 
Research Office.  !
 
Will my taking part in this study be kept confidential? 
All information that is collected about you during the course of the research will be kept strictly 
confidential. Any information about you that leaves the hospital will have your name and address 
removed so that you cannot be recognised from it. 
 
Our procedures for handling, processing, storage and destruction of their data are compliant with 
the Data Protection Act 1998. 
 
It is unlikely that we will discover any information that is of direct importance to you or your family. If 
we do so, we will contact you and your GP to inform you of this.  If you DO NOT wish us to contact 
you or your GP about any such information, please discuss this with the researcher. Your wishes 
will be recorded and observed.  
 
What happens when the research study stops? What will happen to the results of the 
research study? 
When the study stops we will analyse all of the results. The study will be written up and may be 
published in medical journals and presented at conferences. No patients will identifiable in any 
published results.  
 
Our results will also be shared with the organisations and charities that support our work, including 
patient support groups. Again, no patients will be identifiable in any information that is shared with 
these groups. 
 
If you wish to receive feedback on the study, you can contact us and we will send you a summary of 
the results and conclusions of the study. The contact details are listed below. 
 
Any remaining samples will be kept securely, complying with rules set out in the Human Tissue Act. 
They may be used in future research projects that have received approval from an independent 
ethics committee. You would not be contacted again for further permission to use the samples in 
such future studies. Any samples kept beyond the end of this study may be held securely in a 
properly regulated biobank. The biobank will ensure that any samples are kept safely and are only 
used in ethically approved studies into human diseases. If you would rather that your samples were 
not used in this way, you may specify this on the consent form at Section 9. 
 
Who is organising and funding the research? 
This study is being organised by the Hepatology Department at Imperial College London, in co-
operation with the following NHS Trusts: 
• Imperial College Healthcare NHS Trust (St Mary’s Hospital) 
• Kings College Hospital NHS Trust 
 
It is being funded by a the Wellcome Trust 
 
Who has reviewed the study? 
This study was given a favourable ethical opinion for conduct in the NHS by Surrey Research Ethics 
Committee (REC). 
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Contact for further information 
Dr K Jamil (khaleel.jamil@nhs.net) 
 
Department of Hepatology, 10th Floor QEQM Building, St Mary’s Hospital, London, W2 1PG 
Tel: +44 (0)207 886 6454 
 
Thank you for reading this information and considering participation in this study. 
You are asked to retain this Patient Information Sheet for your future reference
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Appendix,3,
Differentially,Expressed,Genes,on,Microarray,
Common%elements%in%“LT%HCV%vs%LT%non1HCV”,%“LT%HCV%vs%HC”%and%“LT%non1HCV%vs%HC”:%
XLOC_l2_013783!
lincRNA:chr2:878560"
878991_F!
FAM57B!
ENST00000523112!
LOC389033!
!
Common%elements%in%"LT%HCV%vs%LT%non1HCV"%and%"LT%HCV%vs%HC":%
GSTM2! A_33_P3423845!
TMED3! APBB1!
lincRNA:chr1:119700127"119706377_R! AMY1C!
BCORP1! SIGLECP3!
lincRNA:chr6:43815372"43929922_R! ENST00000425471!
RGPD5! IL29!
KLHL29! ZCCHC17!
HIST1H2BD! SNORA74A!
SIGLEC15! HEBP2!
PTAR1! A_33_P3324904!
GLT25D2! AP3S2!
TBKBP1! LSS!
DVL3! HIST2H4B!
YPEL4! lincRNA:chr10:67332969"67346819_R!
LOH12CR1! LOC153577!
lincRNA:chr9:23671778"23672397_F! PAXIP1!
ENST00000409590! SLC26A11!
lincRNA:chr16:87325199"87333574_F! ZNF226!
A_33_P3327140! GOLGA6L9!
SSTR3! PDE4D!
LYG1! SLC27A3!
PRSS53! SIL1!
PXN!
!lincRNA:chr6:155203224"155205268_F!
!STX4!
!HIST1H2BB!
!LOC440944!
!LONP1!
!CDK11B!
!TUBGCP6!
!lincRNA:chr8:37264155"37278889_F!
!CHKB!
!NDE1!
!SMPD3!
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Common%elements%in%"LT%HCV%vs%LT%non1HCV"%and%"LT%non1HCV%vs%HC":%
ACBD7! LOC100506380!
LGALS1! AMN!
A_33_P3247077! NCOR1!
THC2668129! C17orf59!
CT47A11! LGALS3BP!
ITM2A! NR1H2!
KIF21B! DLEU1!
A_33_P3345614! THC2630254!
ENST00000366116! PSMG2!
HIST1H2BO! PRRC2A!
FMNL1! LUZP6!
ZNF713! THC2566648!
ENST00000397064! ATP2B4!
lincRNA:chr6:86386083"86388435_R! SBNO1!
CYP4F30P! GSDMD!
LOC100128714! LINC00092!
PNRC2! WDR11!
lincRNA:chr3:106619835"106630535_R! ASGR2!
ESRRA! BC157839!
A_33_P3311646! lincRNA:chrX:102074319"102166119_F!
A_33_P3229390! ATP13A3!
LOC100134663! ENTPD1!
BAP1! AURKAPS1!
GBA2! TTC28!
A_33_P3244361! FBRSL1!
PANK4! RPS2P32!
LOC100287314! Q9N083!
DPEP3! HIPK2!
NADKD1! PPP1R14A!
ENST00000366347! CR604878!
lincRNA:chr10:101192360"101200085_R! lincRNA:chr1:94159362"94171362_F!
EFCAB4B! ADAMTS7!
XLOC_l2_007876! AI198876!
lincRNA:chrX:102074319"102166119_R! CDC34!
COX6B2! NEK1!
ZMYND11! LOC100507645!
TRABD! ZSCAN2!
KIAA1875! IKZF1!
C1orf177! HCFC2!
AK097143! SNCB!
GBP6! A_33_P3381292!
KLHL22! RNFT1!
lincRNA:chr16:86511545"86542401_F! ATP11B!
GPATCH1! A_33_P3406255!
FAM156B! ENST00000447197!
LOC284379! RNF168!
A_33_P3258846! SERPINB9!
MAPK3! DDX39B!
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Common%elements%in%"LT%HCV%vs%HC"%and%"LT%non1HCV%vs%HC":%
TOP3A! ENST00000357658!
lincRNA:chr18:74524062"74532337_R! NIPSNAP3A!
lincRNA:chr6:167312435"167323185_R! DUSP18!
A1BG"AS1! STYXL1!
DYRK1B! ENST00000522992!
AY358225! EIF2C1!
RPP14! ENST00000356801!
IQGAP1! PLOD3!
lincRNA:chr14:58744247"58760847_R! CXorf49B!
C20orf141! C9orf102!
THC2780215! TCHP!
ITGB3BP! CEP95!
MPDU1! lincRNA:chr13:33868250"33874375_R!
lincRNA:chr20:37075485"37076211_R! WDR41!
LOC100506035! lincRNA:chr7:104639816"104641977_R!
ZBTB37! MSH3!
PAPL! lincRNA:chr5:93440069"93451144_F!
HEBP1! PPIP5K2!
IL18BP! lincRNA:chr6:22056867"22194604_R!
ZNF683! LOC100505854!
LEPREL2! GNAZ!
CYTH3! AX721280!
SOX13! MST1!
FAM27A! TRIT1!
C7orf55! FCHO2!
lincRNA:chr19:24218385"24247285_F! KRT81!
ENST00000391681! C6orf64!
lincRNA:chr16:88812349"88821799_F! lincRNA:chr7:105525814"105538089_F!
PET112! ANKRD33!
lincRNA:chr13:48380599"48492024_R! RPS24!
MYOM2! SMC4!
WDR19! lincRNA:chr8:58126971"58142821_R!
AIF1L! CHPT1!
SYNE1! MDH1B!
PBX4! MED7!
LINC00339! PAWR!
LOC100133050! lincRNA:chr14:61529972"61553247_R!
SPATA5L1! LRR1!
C2orf49! SPATA13!
TNFRSF18! OXSR1!
RELB! SMAD7!
ACSF3! KRT86!
BEGAIN! INSL3!
LOC400099! NUDT18!
GUSBP1!
!!!
  240!
,
Elements%only%in%"LT%non1HCV%vs%HC":%
%FAM118A! TCP11L1!
CERS3! CSDA!
lincRNA:chr2:64434091"64478485_R! HLA"DQB1!
IFT88! lincRNA:chr19:57751638"57764913_F!
UBE2M! ZNF274!
CREB3L1! MEX3D!
LCE1D! PDSS2!
SEH1L! NAA60!
lincRNA:chr7:139115835"139124860_F! lincRNA:chr11:94380477"94405252_F!
lincRNA:chr6:43988722"43993947_R! IP6K2!
lincRNA:chr3:114043485"114052926_R! ARHGEF6!
HNRNPA2B1! B3GALNT2!
lincRNA:chr2:193943030"194203155_R! lincRNA:chr4:120400703"120402090_F!
lincRNA:chr10:6623494"6637944_F! PCDHGA7!
LOC645553! DND1!
XLOC_005365! MT1F!
lincRNA:chr1:180915452"180922102_R! HDGFRP2!
DCP2! TMEM9!
SPRNP1! ZBTB43!
A_33_P3287388! ARFRP1!
lincRNA:chr8:143489971"143501023_F! KIR3DL2!
TPT1! A_33_P3362239!
lincRNA:chrX:100696094"100725244_R! A_33_P3278303!
CCL24! C2CD4C!
lincRNA:chr11:130730240"130745290_F! GFRA3!
UTRN! GPA33!
INPP1! lincRNA:chr8:123989344"123994919_F!
PMS2P5! TSTD1!
lincRNA:chr6:42166947"42172520_R! AK130723!
RBM20! CRIP1!
SFTPA2! LOC100507637!
EIF2C3! FAM131C!
MYOM1! lincRNA:chr3:194190336"194206820_R!
PITX3! AS3MT!
LNPEP! lincRNA:chr5:95919519"95995094_R!
lincRNA:chr20:47715043"47723493_F! A_33_P3233000!
LY75! GABPB2!
CNST! MAN2B1!
A_33_P3349597! UTP18!
ENST00000297020! RAD23B!
FAM21C! C16orf45!
lincRNA:chr2:216473880"216713730_R! NFATC2!
RB1! lincRNA:chr4:24814752"24827052_F!
lincRNA:chr6:44046036"44046378_R! SEC23A!
NKIRAS2! lincRNA:chr2:55388021"55396371_F!
A_33_P3240340! TAOK3!
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ATRN! LOC648987!
ZNF138! UCP2!
KCNQ1!
!C16orf87! CYGB!
ORAI2! GNS!
FAT3! ATXN7L1!
lincRNA:chr12:54360060"54360161_F! lincRNA:chr11:75122727"75130002_F!
CAB39L! TPRA1!
ARAF2P! LGALS9C!
ALG13! GRB2!
ATF7IP! LEMD3!
LOC399744! lincRNA:chr2:204620380"204666130_F!
SKP2! ZHX3!
PDXDC1! FUT7!
lincRNA:chr2:179375079"179386329_F! TIMMDC1!
INTS8! lincRNA:chr6:81153106"81172770_R!
ITGB7! MCMBP!
RBM39! MDM4!
ADSL! lincRNA:chrX:53707005"53710958_R!
STX2! RNF19B!
WBSCR16! BSCL2!
COQ10B! ADI1!
ASNS! APEX1!
A_33_P3391167! HPS4!
MCEE! AK091697!
GNB2! LTBP4!
TRAIP! RBBP9!
DIABLO! LAX1!
FGR! lincRNA:chr1:201509727"201545677_F!
lincRNA:chr14:23982560"23989835_F! ENST00000474213!
CD4! LPP!
PER2! MAN1A1!
LRFN3! DDX31!
lincRNA:chr8:104254399"104295074_F! lincRNA:chr1:173831852"173837251_R!
ZNF248! LOC100130654!
DRAM2! YKT6!
FKBP4! A_33_P3326312!
CK825926! FAM76B!
ENST00000378340! JAK3!
TTC15! KIAA0195!
METTL16! CTNS!
FAM106CP! ALPPL2!
TOMM34! PIM2!
CAND1! C6orf204!
A_24_P307065! KIAA0748!
lincRNA:chr18:59236195"59282370_F! CDH22!
lincRNA:chr11:2017748"2019065_F! lincRNA:chr6:155240958"155286533_R!
LOC284373! EPB41L4A!
A_33_P3273399! SNX18!
  242!
MIA3! DPYSL2!
SLC38A10! A_33_P3287314!
PMS2P4!
C1orf112!
C20orf72!
SPINK7!
lincRNA:chr17:38667099"38690799_F!
ANKRD20A8P!
lincRNA:chr7:130614967"130616965_R!
PPA1!
C1orf162!
ENST00000390539!
C1orf109!
lincRNA:chr12:32571608"32576908_F!
HLA"C!
ZNF484!
TRAPPC3!
NOTCH2NL!
lincRNA:chr21:30749379"30901454_R!
A_33_P3231319!
WDR24!
FRYL!
STAMBPL1!
GINS2!
ADAM10!
lincRNA:chr20:56156369"56171644_R!
RNPEP!
MAD1L1!
lincRNA:chr5:134465126"134478076_R!
OGFOD1!
ATG4D!
lincRNA:chr7:63922340"63962340_F!
UBAP1!
CEACAM21!
SLC20A2!
MT3!
DCAF5!
RBM4!
FLJ42200!
GFM2!
RPS6KC1!
NBPF10!
FBXO3!
AK025047!
lincRNA:chr2:42076869"42077718_F!
STAT4!
EIF4A1!
CD86!
BCAP29!
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!
Elements%only%in%"LT%HCV%vs%LT%non1HCV":%
%RGS14! FNIP1!
DCAF15! DA938875!
ANAPC7! SLC35B2!
SLC25A46! TYK2!
ADAMTS10! CCDC142!
VPS39! ILF3!
ENST00000398067! CLK2!
HIST1H2BL! IL11RA!
KRTAP3"3! PIK3CD!
NP105946! SH3GLB2!
S100A5! KBTBD13!
A_24_P212565! PTGER2!
MTMR9! CHI3L2!
MRGPRG! PDGFRB!
PRKACA! MTMR1!
HIST1H2BK! FAM73B!
LRRC37A2! C20orf94!
MAST3! AP2A1!
HIST1H2BG! RAB27B!
AGPAT4! CASP10!
LOC100130152! ZBTB24!
TMEM87B! TMEM141!
DOHH! lincRNA:chr12:2947389"2952675_R!
HRAS! SEPT7L!
lincRNA:chr18:33016877"33028102_F! EEF1DP3!
EGLN2! SRP68!
lincRNA:chr3:65012510"65037885_F! UBTF!
GAA! AXIN1!
lincRNA:chr20:37049482"37049747_F! GLCCI1!
A_33_P3381762! HIST1H2AH!
TOX2! FAR1!
HIST2H2AC! C22orf43!
SURF6! lincRNA:chr5:52531518"52727218_R!
RNF123! Q8WY88!
ZRANB2! lincRNA:chr6:42725472"42759772_F!
lincRNA:chr1:147706526"147727651_R! ARHGAP17!
CHAT! HIST1H1C!
MED25! M6PR!
UBE2Q1! PTRHD1!
ZNRF2! ANKRD12!
HIST1H3I! OLA1!
lincRNA:chr3:106526585"106630535_R! KATNAL1!
ZNF346! KIAA1841!
KLHL17! SIN3B!
SNX1! BRPF1!
HIST1H2BN! AK096443!
ARHGEF1! SCARNA7!
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TSC22D4! ZNF559!
SNORA70B! SNORA81!
RNF40! PSTPIP1!
TCF25! WDFY2!
IQSEC1! CATSPER2!
EXOC7! lincRNA:chr10:43471994"43482194_F!
TOR1AIP1! lincRNA:chr4:8357036"8359103_R!
TBC1D3! C21orf2!
ZNF862! CCNC!
lincRNA:chr1:207971227"208042127_F! MIDN!
RBM18! lincRNA:chr10:102495660"102501110_F!
IRAK2! NUP107!
DGKD! lincRNA:chr1:150582126"150591026_R!
lincRNA:chr5:33162475"33162948_R! SCARNA6!
AKAP8L! USP3!
LOC148413!
!AFG3L1P!
!ASB2!
!SMU1!
!UNC119!
!HIST1H1E!
!PKNOX1!
!MAFK!
!CENPBD1!
!CEP350!
!FAM108A1!
!EML4!
!SIPA1!
!A_24_P280897!
!lincRNA:chr10:80511394"80516912_F!
!A_33_P3374215!
!ZNF687!
!ZNF793!
!HIST1H2AK!
!SGK494!
!ZFC3H1!
!lincRNA:chr10:114583921"114587485_F!
!RNU1"5!
!HIST1H4A!
!ZNF641!
!MCFD2!
!CHPF2!
!FUS!
!A_33_P3348744!
!SMPD1!
!THC2525667!
!IDE!
!
  245!
Elements%only%in%"LT%HCV%vs%HC":%
%TMEM187! RPL26L1!
lincRNA:chr4:56038043"56055418_F! BRMS1!
SCARNA13! lincRNA:chr14:92220122"92237072_R!
CYTH4! ZDHHC24!
GTPBP1! TBC1D14!
RTN4IP1! GALC!
TMEM95! GSTO1!
CLCN6! FANCA!
TOMM20L! JPH3!
MED15! ABHD4!
LOC100131262! PCNXL2!
COG7! ENO2!
ADAT2! PSMG4!
FAM162A! OTUD5!
NDUFS5! DYM!
KCNK12! lincRNA:chr16:1430124"1444892_R!
SFI1! TCAP!
RUFY1! VASP!
CC2D1A! MRPL14!
LUC7L3! RAB11FIP3!
CD84! POLR3C!
ENST00000435366! AOAH!
SGSH! WBP1!
GRAP2! SEMA4D!
lincRNA:chr5:172139570"172159241_R! CACNA2D2!
AXL! PPOX!
SIGIRR! LPHN1!
lincRNA:chr11:61394124"61405874_R! ABCA5!
RDH5! TRIM13!
WDR37! SDR39U1!
C17orf89! DYNC1H1!
ENST00000413112! CEACAM19!
AGER! CCDC9!
UBAP1L! ANKAR!
UBE2Z! WDR13!
TTC28"AS1! RRM1!
KRT18! ZNF83!
CD3G! HSF2!
TMX2! RUNX1!
FAM60A! PCSK7!
SOCS1! A_33_P3316379!
ABCA2! NUP85!
DENND1C! IL18!
ANGEL2! MGEA5!
SCAI! MAD2L1!
lincRNA:chr2:231271206"231276381_F! ZRSR2!
CCDC146! LRCH4!!
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PRTN3! ANAPC4!
MRPS34! PSMG1!
HMBOX1! TTC17!
C16orf53! PSMA4!
ALKBH7! ENSA!
ANP32D! lincRNA:chr3:13020350"13034850_R!
PPP5C! TMEM80!
ANTXR2! lincRNA:chr15:81249645"81265045_F!
ZCCHC11! EHMT2!
GGA1! MLH3!
EFHD2! ZNF767!
TMEM14B! LOC399753!
CCL3L3! NET1!
lincRNA:chr8:142273943"142310368_R! ELL2!
DOM3Z! GLB1!
SCAND2! POC1A!
SCML4! lincRNA:chr4:76462801"76476026_F!
BCL2L13! OSBPL2!
ZNF564! EIF3H!
lincRNA:chr3:114031960"114042235_F! ZNF142!
CEP250! COMMD4!
PELI2! XRCC4!
CREM! APLP2!
OIP5"AS1! ERI1!
PANK3! ITPR3!
TIMD4! DECR2!
AF336885! CCND2!
UBA7! DDX26B!
LOC729668! lincRNA:chr8:599650"609000_R!
ALG8! TSC2!
FHOD1! A_24_P409661!
KLF6! lincRNA:chr20:10607175"10613750_F!
SLC6A16! C4orf46!
MS4A7! NFAT5!
lincRNA:chr7:105525814"105538089_R! KRTAP10"12!
DNAJC2! NLRP1!
HIST1H4D! XLOC_009544!
ATP9A! RNF111!
RPA3! ZNF585B!
NPIPL2! LOC338799!
PIAS3! lincRNA:chr7:130619611"130620827_R!
LOC729799! RBM5!
GNAL! TOR1A!
LDLR! BRF2!
C16orf79! GJD4!
ATP5O! NFATC3!
ILDR1! TMEM116!!
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TMEM179B!
MLXIP!
VPS45!
MRPL21!
DEDD2!
LEPR!
SLC22A18!
DDX55!
LIX1L!
A_33_P3306327!
DMTF1!
C1orf122!
STARD3!
CG030!
VRK1!
MFN1!
ACADVL!
HEXA!
A_33_P3397473!
P2RY8!
NDST2!
KRT72!
X81001!
BZW2!
FAH!
RASSF7!!
 !
